Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ACAA1 ENSG00000060971 "Acetyl-CoA acyltransferase 1" P09110 3 38103129-38137242 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Acyltransferase, Transferase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 152.1" "Cell type enhanced" "Detected in all" 9 "Hepatocytes: 651.0;Proximal tubular cells: 601.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "OE19: 51.9;SK-BR-3: 82.5" "Low region specificity" "Detected in all" "HPA006764, HPA007244" Enhanced Supported Peroxisomes NA NA 4300000 Peroxisomes "HPA006764: AB_1078085, HPA007244: AB_1078084" "prognostic favorable (3.00e-4)" "unprognostic (5.57e-2)" "unprognostic (4.54e-2)" "prognostic favorable (7.53e-4)" "unprognostic (2.63e-1)" "prognostic favorable (1.23e-4)" "unprognostic (9.35e-3)" "unprognostic (2.91e-2)" "unprognostic (8.11e-2)" "unprognostic (2.22e-1)" "unprognostic (2.24e-1)" "unprognostic (4.90e-1)" "prognostic favorable (6.99e-9)" "unprognostic (1.72e-1)" "unprognostic (1.99e-1)" "unprognostic (2.50e-2)" "unprognostic (1.65e-2)" 9.5 12.7 11.0 5.6 11.9 9.6 10.2 8.1 14.3 6.7 16.1 12.5 10.6 23.4 4.9 13.3 12.1 4.6 16.0 17.7 10.2 8.9 48.7 152.1 8.2 5.9 14.0 9.4 5.0 19.2 7.4 5.9 6.8 11.0 13.4 12.4 7.3 11.5 9.4 9.8 6.2 23.8 4.8 12.7 10.0 8.5 4.4 10.9 5.7 9.3 10.1 10.2 9.4 7.0 9.2 47.0 32.8 45.2 17.8 19.3 18.8 8.1 8.9 3.0 9.5 13.1 7.7 10.6 7.5 10.9 8.6 8.2 11.9 9.2 4.8 5.4 12.0 4.2 5.4 8.2 12.7 4.7 7.0 8.5 6.2 7.9 33.7 8.5 14.3 14.0 14.2 9.1 7.4 5.3 5.4 11.6 11.8 5.8 5.7 9.5 10.6 13.8 10.2 3.2 51.9 10.8 3.1 5.8 8.1 24.2 24.2 2.6 4.1 7.3 82.5 5.2 4.4 8.5 11.5 8.4 5.2 5.0 10.4 10.3 7.6 4.8 3.8 8.5 12.5 8.3 15.3 29.9 32.8 13.6 40.7 11.4 9.2 13.1 13.3 47.0 8.7 13.0 12.1 20.4 17.8 45.2 27.7 19.3 18.8 11.0 11.9 8.1 14.3 10.2 8.9 14.0 9.4 11.0 10.9 38.7 31.4 45.5 55.9 29.7 37.5 2.4 109.5 17.4 19.4 62.8 13.7 77.1 140.9 89.4 3.0 25.4 292.3 23.3 69.3 52.5 32.7 64.1 18.5 651.0 74.1 7.9 52.9 34.4 86.5 6.4 33.1 68.8 55.6 86.6 63.2 33.0 78.8 122.8 31.1 601.4 14.2 32.3 25.8 17.5 11.7 31.0 83.1 42.0 60.0 69.8 AKR1B1 "ALDR1, AR" ENSG00000085662 "Aldo-keto reductase family 1 member B" P15121 7 134442350-134459284 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "adrenal gland: 302.2;seminal vesicle: 109.3" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 615.9;Cytotrophoblasts: 969.9;Extravillous trophoblasts: 1080.2;Syncytiotrophoblasts: 1691.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A549: 122.4;BJ hTERT+: 224.5;RPTEC TERT1: 106.2;U-87 MG: 101.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026425, CAB027391, CAB047353, HPA052751" Enhanced Supported Nucleoplasm,Cytosol No No 1700000 Cytosol Nucleoplasm "CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: AB_2681935" "unprognostic (2.76e-2)" "unprognostic (2.84e-2)" "unprognostic (2.02e-2)" "unprognostic (1.37e-2)" "unprognostic (6.81e-2)" "unprognostic (2.26e-1)" "unprognostic (4.18e-2)" "unprognostic (5.09e-2)" "unprognostic (2.51e-3)" "unprognostic (2.47e-1)" "unprognostic (2.98e-2)" "unprognostic (8.78e-2)" "unprognostic (2.81e-2)" "prognostic unfavorable (2.44e-5)" "unprognostic (2.03e-1)" "unprognostic (1.39e-1)" "prognostic unfavorable (7.00e-4)" 5.9 302.2 7.5 4.7 13.7 2.5 9.5 6.9 10.9 4.4 3.9 8.2 50.4 2.7 4.6 6.1 4.2 4.6 5.2 24.2 7.3 8.4 17.7 2.5 6.9 10.0 9.5 9.0 8.2 7.2 9.4 8.0 24.8 11.9 5.5 4.1 5.8 4.4 109.3 37.6 2.8 4.8 5.6 7.9 6.7 5.0 5.2 5.9 7.3 6.0 10.3 7.6 7.1 3.7 31.4 34.8 22.5 26.0 26.3 42.7 47.2 13.5 122.4 13.8 19.5 59.5 16.2 36.8 13.1 224.5 19.3 25.0 5.6 12.4 0.0 6.1 21.9 85.2 5.7 15.0 13.1 15.4 4.8 13.7 6.9 18.4 16.6 85.3 0.0 0.0 15.1 9.8 27.6 7.3 18.9 27.2 13.6 0.0 4.6 21.3 0.2 20.3 9.3 22.9 0.9 0.1 21.2 8.8 10.2 106.2 66.2 10.3 22.9 91.9 0.1 9.6 9.4 0.0 10.3 21.4 19.1 8.9 1.7 14.2 12.6 13.9 34.2 101.0 0.0 11.4 22.5 26.0 1.2 37.9 17.0 34.0 31.4 32.4 36.7 34.8 28.5 42.7 41.1 2.1 26.3 8.9 4.9 22.0 47.2 7.5 13.7 6.9 10.9 7.3 8.4 9.5 9.0 11.9 5.9 11.9 23.7 50.6 46.4 18.3 34.0 127.0 30.6 24.1 23.9 615.9 7.9 969.9 139.3 102.5 3.0 53.2 0.7 0.0 35.6 1080.2 76.5 15.6 52.0 1.3 331.4 68.3 29.7 89.6 135.4 11.5 73.4 69.6 28.7 93.8 13.6 46.3 62.2 5.8 72.9 43.7 20.2 58.2 30.9 20.7 70.9 10.2 1691.2 45.4 5.0 37.4 AKR1B10 "AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI" ENSG00000198074 "Aldo-keto reductase family 1 member B10" O60218 7 134527592-134541408 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 41.5;intestine: 99.7;stomach 1: 68.6" "Group enriched" "Detected in many" 5 "Cholangiocytes: 275.2;Enterocytes: 221.4;Pancreatic endocrine cells: 89.4" "Cancer enhanced" "Detected in many" "liver cancer: 353.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 99 "A549: 217.4;Hep G2: 60.3;OE19: 227.4" "HPA020280, CAB070163, HPA073633" Enhanced Supported "Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 68000000 Cytosol "Plasma membrane" "CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620" "unprognostic (1.29e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.91e-4)" "unprognostic (6.03e-2)" "unprognostic (4.67e-2)" "unprognostic (2.57e-1)" "unprognostic (2.16e-3)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (3.18e-2)" "unprognostic (4.65e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (4.80e-9)" "unprognostic (2.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" 0.6 0.8 0.6 2.2 0.6 0.0 0.6 0.6 0.6 13.1 11.5 0.6 0.6 99.7 0.6 0.9 41.5 0.0 28.9 0.6 0.6 0.0 4.0 6.3 2.0 0.6 0.6 0.6 0.6 0.6 0.0 2.5 0.6 0.6 2.0 7.3 1.3 6.1 0.6 0.6 1.0 54.1 7.1 0.6 0.6 68.6 0.8 0.6 0.9 0.7 28.6 3.6 16.3 22.9 0.4 0.1 1.8 0.2 0.4 0.2 0.1 0.0 217.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.1 60.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 227.4 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.2 1.8 0.4 0.1 0.1 0.1 0.1 0.6 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 0.0 0.0 0.5 1.9 2.5 0.0 0.4 275.2 5.3 1.2 0.0 0.0 0.2 0.0 21.5 0.3 0.0 221.4 23.3 23.1 0.1 0.1 0.3 0.0 31.6 0.0 0.0 3.4 3.7 1.6 0.4 3.1 0.0 0.0 1.0 11.7 0.0 89.4 24.6 1.8 1.4 0.0 0.0 0.9 0.0 0.0 9.2 0.2 0.0 41.3 5.2 AKR1C1 "DD1, DDH, DDH1, HAKRC, MBAB" ENSG00000187134 "Aldo-keto reductase family 1 member C1" Q04828 10 4963253-4983283 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 145.9;tongue: 74.5" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 239.5;Exocrine glandular cells: 290.3;Hepatocytes: 511.8" "Cancer enhanced" "Detected in many" "liver cancer: 64.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 4.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 8 "ASC diff: 185.8;Hep G2: 315.1;OE19: 134.5" "CAB047303, HPA068265" Enhanced Enhanced "Endoplasmic reticulum,Cytosol" NA NA "Endoplasmic reticulum, Cytosol" "CAB047303: , HPA068265: AB_2685966" "unprognostic (1.54e-2)" "prognostic favorable (3.05e-4)" "unprognostic (4.04e-2)" "unprognostic (8.38e-2)" "unprognostic (3.18e-2)" "unprognostic (7.05e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (1.70e-1)" "unprognostic (1.63e-1)" "unprognostic (8.38e-2)" "unprognostic (4.65e-1)" "unprognostic (1.82e-2)" "prognostic favorable (8.03e-9)" "unprognostic (1.19e-1)" "unprognostic (1.22e-1)" "unprognostic (5.72e-2)" "unprognostic (6.30e-2)" 52.0 3.8 2.1 3.4 4.1 1.4 36.0 2.6 2.7 2.2 3.2 2.6 1.2 6.2 1.4 4.0 19.2 1.7 16.1 22.1 2.6 2.6 32.0 145.9 11.2 2.5 5.4 1.4 3.8 4.9 0.6 4.1 0.7 6.6 5.1 3.2 3.8 13.1 3.4 17.1 4.7 4.6 4.8 6.8 0.9 21.9 5.2 3.2 0.0 11.5 74.5 5.0 17.4 10.8 0.0 0.9 4.2 0.1 0.3 1.7 0.8 0.0 25.5 0.1 25.7 185.8 22.4 0.0 0.8 5.7 0.3 0.2 0.4 0.0 0.0 0.3 5.7 4.4 0.2 0.0 1.3 0.1 0.0 0.0 0.7 4.1 315.1 1.8 0.1 0.0 11.4 1.6 2.6 1.6 0.0 0.6 0.1 5.4 0.0 4.4 0.1 0.0 0.0 0.0 134.5 0.0 0.0 0.0 0.2 1.4 4.8 0.0 0.1 1.4 0.0 0.0 0.0 0.0 0.4 5.0 2.2 0.1 5.9 0.2 0.1 0.0 0.0 7.9 0.7 0.0 4.2 0.1 1.1 1.7 0.0 0.1 0.0 0.7 0.4 0.2 0.0 0.3 1.5 0.9 0.3 0.0 0.9 0.4 0.8 2.1 4.1 2.6 2.7 2.6 2.6 5.4 1.4 6.6 3.2 62.5 27.2 1.5 11.8 18.8 2.5 2.4 239.5 96.4 128.5 59.3 0.0 0.0 11.6 33.9 14.9 17.8 9.3 70.0 290.3 0.0 13.4 11.4 4.6 511.8 0.3 0.0 1.7 26.4 14.5 8.0 140.4 3.8 101.3 8.2 1.7 47.9 184.6 0.9 138.6 40.8 4.3 0.0 14.4 1.7 0.7 17.9 0.1 0.9 2.6 140.8 AKR1C2 "BABP, DD, DD2, DDH2, HAKRD, MCDR2, TDD" ENSG00000151632 "Aldo-keto reductase family 1 member C2" P52895 10 4987400-5018031 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 71.9;liver: 122.7;tongue: 111.8" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 135.0;Hepatocytes: 341.7;Pancreatic endocrine cells: 140.7" "Group enriched" "Detected in many" 6 "cervical cancer: 21.7;head and neck cancer: 31.5;liver cancer: 50.2;lung cancer: 69.0;urothelial cancer: 35.7" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.4" "Group enriched" "Detected in some" 4 "A549: 130.6;ASC diff: 162.1;Hep G2: 243.7;OE19: 168.2;RT4: 74.6" "CAB047304, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB047304: , HPA068265: AB_2685966" "unprognostic (6.77e-2)" "unprognostic (8.88e-3)" "unprognostic (3.02e-2)" "unprognostic (2.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.72e-2)" "unprognostic (2.86e-2)" "unprognostic (8.65e-2)" "unprognostic (5.03e-2)" "unprognostic (2.58e-1)" "unprognostic (1.02e-1)" "unprognostic (6.25e-3)" "unprognostic (8.58e-2)" "unprognostic (1.09e-2)" "unprognostic (8.60e-3)" "unprognostic (1.46e-2)" "unprognostic (8.30e-2)" 60.4 4.0 1.8 2.0 3.3 0.0 71.9 2.5 2.1 1.3 2.9 1.0 1.2 5.5 1.0 3.0 17.4 1.5 19.4 9.3 1.7 2.3 4.8 122.7 5.9 1.1 4.7 0.9 1.9 2.4 0.0 1.8 0.1 4.2 8.1 2.4 2.0 12.0 2.4 19.8 4.2 2.4 4.4 3.9 0.6 26.2 2.3 2.6 0.1 4.2 111.8 5.5 25.3 11.9 0.0 1.4 0.3 0.0 0.0 0.0 0.0 0.0 130.6 0.1 13.8 162.1 5.6 0.0 0.0 0.5 0.0 0.1 0.5 0.0 0.0 0.7 0.9 0.6 3.6 0.0 0.6 0.0 0.0 0.0 0.0 36.8 243.7 0.3 0.0 0.0 14.5 8.2 0.6 0.6 0.0 0.0 0.0 5.0 0.0 1.3 0.2 0.0 0.0 0.0 168.2 0.0 0.0 0.0 2.1 1.2 74.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.5 0.3 0.1 4.8 0.0 0.0 0.0 0.0 1.7 1.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 1.8 3.3 2.5 2.1 1.7 2.3 4.7 0.9 4.2 2.6 11.9 3.2 0.0 3.2 10.5 1.8 3.7 135.0 18.7 19.4 0.0 0.0 0.0 0.0 12.3 18.3 8.7 9.3 0.0 93.5 0.1 15.0 4.5 0.0 341.7 0.1 3.2 1.7 12.3 13.7 5.6 73.4 1.1 8.5 1.0 2.8 33.8 140.7 7.0 73.9 2.6 2.6 0.0 7.6 0.3 0.3 11.8 0.0 1.3 7.4 79.1 AKR1C3 "DDX, HAKRB, HSD17B5, KIAA0119, PGFS" ENSG00000196139 "Aldo-keto reductase family 1 member C3" P42330 10 5035354-5107686 "Enzymes, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.1;intestine: 52.3" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 261.7;Exocrine glandular cells: 644.1;Pancreatic endocrine cells: 362.8;Proximal tubular cells: 434.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 50.1;gdT-cell: 26.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 115.0;ASC diff: 66.2;Hep G2: 48.3;OE19: 226.4;RT4: 45.4" "CAB010874, HPA068265" Enhanced Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 11000000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "CAB010874: AB_476751, HPA068265: AB_2685966" "unprognostic (4.20e-3)" "unprognostic (2.70e-2)" "unprognostic (8.92e-2)" "unprognostic (1.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.81e-3)" "prognostic unfavorable (1.96e-4)" "unprognostic (1.41e-1)" "unprognostic (6.74e-2)" "unprognostic (5.08e-2)" "unprognostic (1.31e-1)" "unprognostic (4.33e-2)" "prognostic unfavorable (1.22e-4)" "unprognostic (4.45e-1)" "unprognostic (3.70e-2)" "unprognostic (1.79e-3)" "unprognostic (4.24e-3)" 16.6 6.6 3.2 3.2 3.9 3.5 12.8 3.2 3.9 3.2 17.3 3.2 3.2 52.3 3.2 3.2 6.0 4.5 32.2 4.8 4.4 1.0 20.1 34.4 5.5 3.2 3.2 3.2 3.2 4.2 1.8 3.2 3.2 4.2 3.2 11.4 3.2 4.4 3.2 13.0 2.6 31.1 4.2 3.2 3.2 28.6 3.2 3.2 3.2 3.2 3.2 3.2 12.3 3.2 0.1 9.6 50.1 0.7 4.6 26.7 9.7 0.0 115.0 0.0 33.6 66.2 23.8 0.0 0.0 1.6 0.0 0.1 3.4 1.9 0.0 6.2 1.5 3.4 0.9 0.1 2.3 0.0 0.2 0.0 0.2 35.6 48.3 0.3 0.0 0.0 13.2 4.7 1.5 0.0 1.9 2.2 0.2 0.7 0.0 3.0 0.2 0.7 0.1 0.0 226.4 0.3 0.2 0.7 3.4 11.3 45.4 0.0 0.2 16.5 0.0 0.0 0.0 0.0 0.0 16.0 0.3 0.3 6.9 0.2 0.0 0.0 0.0 3.8 4.5 0.3 50.1 0.7 1.1 26.7 0.2 1.7 0.0 5.0 4.8 0.5 0.1 3.2 2.4 1.9 4.6 0.3 9.6 4.9 9.7 3.2 3.9 3.2 3.9 4.4 1.0 3.2 3.2 4.2 3.2 41.7 4.0 1.5 1.1 10.6 1.7 3.6 0.0 88.3 61.4 34.9 0.0 0.1 36.5 85.3 2.9 61.2 261.7 0.0 644.1 0.0 13.8 0.7 5.7 0.0 1.6 1.6 18.4 0.0 0.0 2.1 72.5 19.0 20.3 5.4 31.0 121.7 362.8 121.1 100.4 434.1 3.6 25.8 8.0 0.3 0.7 9.4 0.0 0.0 103.0 27.3 AKR1C4 "3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581" ENSG00000198610 "Aldo-keto reductase family 1 member C4" P17516 10 5195462-5218949 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "liver: 127.0" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 437.4" "Cancer enriched" "Detected in some" 86 "liver cancer: 108.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "basophil: 1.2;gdT-cell: 1.1" "Group enriched" "Detected in many" 6 "granulocytes: 1.2;T-cells: 1.1" "Group enriched" "Detected in some" 4 "HDLM-2: 11.6;OE19: 5.1" "HPA044720, HPA068265" Uncertain Approved "Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol" NA NA 1800000 "Nucleoplasm, Cytosol" "Nucleoli fibrillar center, Endoplasmic reticulum" "HPA044720: AB_2679058, HPA068265: AB_2685966" "unprognostic (2.21e-1)" "unprognostic (3.04e-1)" "unprognostic (5.15e-2)" "unprognostic (1.25e-1)" "unprognostic (5.99e-2)" "unprognostic (9.40e-2)" "unprognostic (2.32e-1)" "unprognostic (1.26e-1)" "unprognostic (1.52e-2)" "unprognostic (1.29e-1)" "unprognostic (3.31e-1)" "unprognostic (7.34e-2)" "unprognostic (1.45e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 127.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.2 0.0 0.0 1.1 0.1 0.0 1.5 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.5 0.3 1.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 5.1 0.0 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.2 45.9 2.7 1.2 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 23.3 0.6 0.0 0.0 0.0 0.0 437.4 0.0 0.0 0.0 14.1 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.6 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 COQ6 CGI-10 ENSG00000119723 "Coenzyme Q6, monooxygenase" Q9Y2Z9 14 73949926-73963670 "Disease related genes, Predicted intracellular proteins" "Ubiquinone biosynthesis" "Monooxygenase, Oxidoreductase" "Deafness, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "Early spermatids: 157.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051371 Uncertain NA NA "HPA051371: AB_2681459" "unprognostic (1.41e-1)" "unprognostic (1.35e-2)" "unprognostic (2.26e-2)" "unprognostic (2.22e-1)" "unprognostic (1.12e-1)" "unprognostic (2.88e-1)" "unprognostic (1.75e-2)" "unprognostic (2.77e-1)" "unprognostic (1.21e-1)" "unprognostic (8.33e-3)" "unprognostic (9.45e-3)" "unprognostic (2.90e-1)" "prognostic favorable (1.05e-6)" "unprognostic (1.19e-1)" "unprognostic (1.94e-1)" "unprognostic (7.46e-2)" "unprognostic (1.89e-1)" 8.5 30.9 6.9 6.9 11.8 4.6 10.8 10.6 15.8 9.3 9.0 11.3 11.4 9.1 7.9 11.0 7.9 8.0 9.5 26.5 10.1 6.4 20.8 20.9 6.5 7.4 8.8 10.2 8.6 6.2 12.5 11.4 8.8 9.9 9.2 8.9 11.7 11.0 12.2 30.5 6.4 8.5 9.1 6.1 8.1 9.6 15.6 5.3 6.3 8.9 13.2 7.7 9.8 7.5 9.8 11.8 8.6 13.3 13.3 16.7 8.5 7.7 14.2 7.4 17.0 9.0 7.4 10.3 9.7 9.1 14.7 12.5 10.6 13.9 6.8 9.2 10.0 10.1 12.5 11.0 9.7 14.0 10.3 8.8 4.7 8.9 9.2 12.4 4.6 16.1 12.5 12.9 13.3 13.2 9.5 9.2 14.2 4.1 6.3 12.7 21.3 7.4 7.4 2.6 15.9 17.3 7.5 9.4 4.9 15.3 9.8 11.2 5.9 16.6 14.3 9.2 5.0 24.2 8.6 6.1 16.8 15.5 12.5 6.9 6.0 5.6 5.8 9.2 6.8 11.1 5.3 11.3 8.6 11.8 13.3 11.5 9.8 11.7 11.8 11.8 5.8 16.7 10.0 2.2 13.3 12.0 8.9 7.3 8.5 6.9 11.8 10.6 15.8 10.1 6.4 8.8 10.2 9.9 5.3 23.8 30.5 9.3 7.7 4.1 17.9 9.6 10.2 10.7 20.5 12.2 11.8 23.4 16.6 9.2 157.7 6.7 8.5 0.0 9.7 10.4 10.4 5.9 24.3 13.9 14.2 19.1 4.6 11.1 4.1 29.2 10.0 7.7 10.1 8.2 8.0 11.8 6.4 6.5 11.7 29.8 27.1 19.4 11.3 21.4 18.3 5.3 19.9 10.0 9.3 4.2 CYP11A1 "CYP11A, P450SCC" ENSG00000140459 "Cytochrome P450 family 11 subfamily A member 1" P05108 15 74337759-74367740 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Steroidogenesis, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 145.3;placenta: 157.2" "Group enriched" "Detected in some" 5 "Extravillous trophoblasts: 305.6;Syncytiotrophoblasts: 1214.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 36 "basal ganglia: 14.8" "Cell type enriched" "Detected in single" 37 "basophil: 15.8" "Lineage enriched" "Detected in single" 37 "granulocytes: 15.8" "Group enriched" "Detected in some" 4 "BEWO: 44.0;HEL: 35.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA016436 Enhanced NA NA "HPA016436: AB_1847423" "unprognostic (8.89e-2)" "unprognostic (6.96e-2)" "unprognostic (4.95e-3)" "unprognostic (9.31e-2)" "unprognostic (9.42e-4)" "unprognostic (1.90e-1)" "unprognostic (1.55e-3)" "unprognostic (8.06e-2)" "unprognostic (3.04e-1)" "unprognostic (2.95e-1)" "unprognostic (1.77e-2)" "unprognostic (5.45e-2)" "unprognostic (9.66e-4)" "unprognostic (2.40e-2)" "unprognostic (2.74e-1)" "unprognostic (3.04e-2)" "unprognostic (7.95e-2)" 0.4 145.3 0.4 0.1 14.8 0.0 0.4 0.3 0.3 0.2 0.2 7.6 0.1 0.0 0.3 0.5 1.5 0.3 0.0 0.3 0.3 0.2 0.1 0.7 0.1 0.0 0.3 0.2 9.2 0.1 0.0 0.4 157.2 0.2 0.2 0.0 0.3 0.1 0.6 0.3 0.1 0.1 0.3 0.3 5.7 0.1 20.4 0.1 0.0 0.1 0.3 0.7 0.2 0.2 0.0 0.0 15.8 0.0 0.4 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.3 44.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 1.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.1 35.0 1.0 0.3 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 8.9 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 15.8 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.4 14.8 0.3 0.3 0.3 0.2 0.3 0.2 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 2.5 0.0 0.0 0.0 0.0 139.8 1.7 0.0 1.4 0.0 0.0 0.0 0.0 305.6 0.6 0.1 0.0 3.4 19.4 0.0 0.0 0.0 0.0 2.9 45.1 0.0 0.0 1.0 0.0 5.1 0.2 0.0 163.4 0.0 0.0 0.0 0.0 3.2 3.1 0.0 1214.3 0.0 0.0 0.0 CYP11B1 "CPN1, CYP11B, FHI, P450C11" ENSG00000160882 "Cytochrome P450 family 11 subfamily B member 1" P15538 8 142872356-142879846 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroidogenesis" "Monooxygenase, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 781 "adrenal gland: 224.9" "Group enriched" "Detected in some" 119 "Early spermatids: 41.1;Late spermatids: 67.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "SCLC-21H: 3.1;SH-SY5Y: 1.3" "HPA049171, HPA056348, HPA057752" Supported NA NA "HPA049171: AB_2680661, HPA056348: AB_2683104, HPA057752: AB_2683516" 0.0 224.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 CYP11B2 "ALDOS, CPN2, CYP11B, CYP11BL, P-450C18, P450aldo" ENSG00000179142 "Cytochrome P450 family 11 subfamily B member 2" P19099 8 142910559-142917843 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism, Steroidogenesis" "Monooxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 259 "adrenal gland: 51.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049171, HPA056348, HPA057752" Supported NA NA "HPA049171: AB_2680661, HPA056348: AB_2683104, HPA057752: AB_2683516" 0.0 51.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP17A1 "CPT7, CYP17, P450C17, S17AH" ENSG00000148795 "Cytochrome P450 family 17 subfamily A member 1" P05093 10 102830531-102837533 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Steroidogenesis "Lyase, Monooxygenase, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "adrenal gland: 425.4" "Cell type enhanced" "Detected in some" 17 "Distal tubular cells: 18.3;Early spermatids: 40.8;Proximal tubular cells: 39.5" "Cancer enriched" "Detected in many" 5 "liver cancer: 22.7" "Region enriched" "Detected in single" 103 "basal ganglia: 19.7" "Cell type enhanced" "Detected in single" "neutrophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "Group enriched" "Detected in some" 4 "HMC-1: 8.0;SCLC-21H: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA048533 Enhanced "Intracellular and membrane" NA NA "HPA048533: AB_2680432" "unprognostic (1.07e-2)" "unprognostic (8.84e-2)" "unprognostic (3.01e-2)" "unprognostic (9.08e-2)" "unprognostic (1.91e-1)" "unprognostic (6.29e-2)" "unprognostic (2.92e-3)" "unprognostic (2.39e-4)" "unprognostic (8.26e-2)" "unprognostic (2.35e-1)" "unprognostic (5.92e-3)" "unprognostic (1.13e-1)" "prognostic favorable (5.43e-7)" "unprognostic (1.07e-1)" "unprognostic (5.56e-2)" "unprognostic (1.66e-2)" "unprognostic (2.94e-4)" 0.0 425.4 0.0 0.1 19.7 0.0 0.0 0.1 0.1 0.1 0.0 78.5 0.0 0.0 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.0 6.4 1.7 0.1 0.0 0.0 0.0 3.2 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 82.3 0.0 0.1 2.2 0.0 0.0 0.1 0.0 0.0 0.0 1.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 8.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.1 0.1 3.1 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.0 0.0 19.7 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.3 0.1 0.6 0.6 0.0 0.0 0.0 1.8 0.0 0.3 18.3 0.0 40.8 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.0 3.2 0.1 1.6 0.0 0.0 0.0 8.3 1.7 0.2 0.0 0.0 0.0 0.2 1.2 0.0 0.0 39.5 1.3 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.1 CYP19A1 "ARO, ARO1, aromatase, CPV1, CYAR, CYP19, P-450AROM" ENSG00000137869 "Cytochrome P450 family 19 subfamily A member 1" P11511 15 51208057-51338610 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 49 "placenta: 440.1" "Cell type enriched" "Detected in some" 36 "Syncytiotrophoblasts: 1678.9" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in single" 8 "basal ganglia: 5.9" "Cell type enriched" "Detected in single" 17 "neutrophil: 1.7" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "ASC TERT1: 45.7;HDLM-2: 7.9;HSkMC: 15.3;SuSa: 8.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000355, HPA051194" Enhanced Uncertain Mitochondria NA NA Mitochondria "CAB000355: , HPA051194: AB_2681381" "unprognostic (9.41e-2)" "unprognostic (7.44e-2)" "unprognostic (9.52e-5)" "unprognostic (6.81e-2)" "unprognostic (2.72e-1)" "unprognostic (4.25e-4)" "unprognostic (5.18e-5)" "unprognostic (1.54e-3)" "unprognostic (2.38e-2)" "unprognostic (2.52e-1)" "unprognostic (1.97e-1)" "unprognostic (5.37e-2)" "unprognostic (1.54e-5)" "unprognostic (2.52e-3)" "unprognostic (2.11e-1)" "unprognostic (1.40e-2)" "unprognostic (1.11e-1)" 9.0 4.6 0.2 0.2 5.9 0.1 2.1 0.2 0.3 0.9 0.3 0.3 0.2 0.4 0.2 0.3 0.3 0.2 0.3 1.3 0.2 0.7 0.3 0.2 0.6 0.2 0.2 0.2 4.4 0.6 0.1 0.2 440.1 0.2 0.5 0.1 0.2 0.9 1.4 0.8 2.3 0.2 0.7 0.5 0.5 0.1 3.0 0.2 0.3 3.0 0.2 0.2 1.2 0.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 45.7 2.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 7.9 0.0 0.3 0.1 3.7 0.3 0.0 0.0 15.3 0.0 0.1 1.9 0.1 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 8.1 0.0 0.2 0.0 0.1 0.0 0.1 0.0 1.4 0.6 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.2 5.9 0.2 0.3 0.2 0.7 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 46.8 0.0 0.0 2.2 0.0 0.0 0.0 0.0 6.9 1.4 0.0 0.0 0.0 13.4 0.0 0.0 0.0 1.6 4.5 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 6.5 0.3 7.7 0.2 0.0 1678.9 0.0 0.0 0.0 CYP1A1 "CP11, CYP1, P1-450, P450-C, P450DX" ENSG00000140465 "Cytochrome P450 family 1 subfamily A member 1" P04798 15 74719542-74725610 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Lyase, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "liver: 38.3;lung: 144.1;urinary bladder: 40.0" "Cell type enhanced" "Detected in some" 21 "Glandular cells: 1.5;Hepatocytes: 6.0;Urothelial cells: 3.2" "Group enriched" "Detected in some" 24 "liver cancer: 18.6;urothelial cancer: 54.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 22.0;hTCEpi: 12.0;HUVEC TERT2: 11.5;SK-BR-3: 9.0;SuSa: 23.3" "Not detected" "Not detected" "Not detected" "Not detected" CAB018654 Uncertain NA NA "CAB018654: AB_2088699" "unprognostic (1.71e-2)" "unprognostic (7.86e-2)" "unprognostic (2.57e-2)" "unprognostic (2.89e-1)" "unprognostic (5.45e-3)" "unprognostic (6.34e-2)" "unprognostic (3.08e-1)" "unprognostic (6.24e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-1)" "unprognostic (1.41e-1)" "unprognostic (1.03e-1)" "unprognostic (4.21e-2)" "unprognostic (6.70e-2)" "unprognostic (2.20e-1)" "unprognostic (4.77e-1)" "unprognostic (1.28e-1)" 9.3 0.4 0.1 0.4 0.2 0.2 7.7 0.2 0.5 2.3 0.7 0.4 3.9 0.5 3.8 4.4 1.2 0.2 11.3 3.0 0.1 0.0 0.7 38.3 144.1 0.2 0.1 0.1 0.5 0.5 0.2 0.1 3.5 0.3 0.2 0.2 0.8 2.1 0.5 1.5 8.1 10.7 5.9 0.2 0.2 0.4 0.3 0.1 0.1 0.8 0.8 8.0 40.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 1.3 0.1 0.0 0.3 0.0 7.2 0.0 0.0 0.4 0.2 22.0 0.9 0.2 5.9 0.0 5.4 6.9 0.4 4.4 0.2 0.0 0.6 0.3 1.5 3.2 0.1 0.2 7.1 0.0 12.0 0.1 0.9 0.2 11.5 0.2 1.3 0.2 0.0 0.4 0.0 0.2 0.1 7.2 1.8 0.7 0.0 0.2 0.0 1.4 0.3 0.1 1.0 9.0 2.3 23.3 0.3 0.1 0.6 1.0 0.3 3.2 0.0 0.4 0.1 0.3 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.2 0.3 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.5 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.0 0.0 0.0 3.2 CYP1A2 "CP12, P3-450" ENSG00000140505 "Cytochrome P450 family 1 subfamily A member 2" P05177 15 74748844-74756202 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Lyase, Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 31 "liver: 143.0" "Cell type enriched" "Detected in some" 18 "Hepatocytes: 44.0" "Group enriched" "Detected in some" 22 "liver cancer: 25.3;urothelial cancer: 6.5" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" CAB016531 Enhanced NA NA "CAB016531: AB_629359" "unprognostic (1.54e-4)" "unprognostic (1.29e-1)" "unprognostic (1.98e-1)" "unprognostic (1.74e-1)" "unprognostic (1.59e-2)" "unprognostic (1.76e-1)" "unprognostic (1.17e-2)" "unprognostic (5.48e-2)" "unprognostic (2.33e-2)" "unprognostic (7.41e-2)" "unprognostic (2.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.7 1.1 4.5 1.2 1.1 0.7 0.3 1.1 0.9 2.7 2.1 0.2 0.0 1.6 0.7 0.0 0.0 0.2 0.6 1.3 2.2 0.5 0.0 1.8 1.2 0.1 0.2 0.1 0.5 1.2 2.8 1.6 0.8 0.1 1.9 1.1 0.4 0.3 0.1 0.0 0.7 0.2 3.9 1.9 4.0 0.0 0.8 2.5 1.3 1.7 0.9 0.6 2.6 2.4 0.9 0.0 2.2 2.2 1.1 2.1 6.0 0.4 2.3 1.6 1.0 0.4 1.1 1.4 1.1 1.2 1.0 0.7 1.6 1.1 2.4 1.2 3.2 1.2 1.2 0.6 0.6 0.5 0.8 0.7 0.5 0.4 1.7 0.7 0.7 4.5 1.1 0.8 1.1 0.4 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 44.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 CYP1B1 "CP1B, GLC3A" ENSG00000138061 "Cytochrome P450 family 1 subfamily B member 1" Q16678 2 38066973-38109902 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism, Steroid metabolism" "Lyase, Monooxygenase, Oxidoreductase" "Disease mutation, Glaucoma, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 45.0;lung: 39.2" "Cell type enhanced" "Detected in many" 11 "Glandular cells: 345.6;Leydig cells: 147.9;Peritubular cells: 160.5;Urothelial cells: 295.9" "Low cancer specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "classical monocyte: 45.0" "Lineage enriched" "Detected in many" 22 "monocytes: 45.0" "Cell line enhanced" "Detected in many" "ASC diff: 24.6;ASC TERT1: 26.4;HSkMC: 105.7;hTERT-RPE1: 24.4;SiHa: 49.2;U-87 MG: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB011705, HPA026863" Approved Uncertain Mitochondria NA NA Mitochondria "CAB011705: AB_731810, HPA026863: AB_10600900" "unprognostic (7.25e-3)" "unprognostic (2.28e-1)" "unprognostic (1.24e-3)" "unprognostic (2.27e-1)" "unprognostic (2.04e-2)" "unprognostic (1.68e-1)" "unprognostic (5.45e-2)" "unprognostic (1.80e-1)" "unprognostic (3.38e-1)" "unprognostic (9.69e-2)" "unprognostic (4.20e-1)" "unprognostic (1.84e-1)" "prognostic unfavorable (4.39e-6)" "unprognostic (1.87e-3)" "unprognostic (1.81e-1)" "unprognostic (6.67e-2)" "prognostic unfavorable (2.76e-4)" 9.1 3.1 0.5 9.4 1.2 0.0 11.4 1.0 1.2 11.4 2.1 0.7 4.5 0.0 12.8 5.9 3.5 15.0 6.9 17.5 1.2 8.8 3.5 39.2 26.3 3.1 1.0 6.1 3.6 0.0 1.3 0.8 3.3 10.7 0.0 19.3 0.0 13.0 4.8 0.5 1.4 10.6 5.1 15.7 0.3 3.9 0.5 5.1 2.5 1.1 4.2 6.9 2.1 0.0 0.4 2.0 45.0 0.0 0.0 16.2 1.2 13.2 0.4 0.0 24.6 26.4 0.0 0.1 0.8 0.2 2.3 0.0 5.5 0.0 3.6 3.2 0.5 10.8 0.0 0.7 0.4 1.0 0.7 0.0 4.0 0.0 6.8 0.0 0.0 105.7 10.3 5.7 0.2 24.4 0.0 0.0 0.1 0.0 0.1 5.2 0.0 4.0 1.4 1.8 2.5 0.0 0.0 0.0 2.5 0.1 0.1 0.4 49.2 7.2 0.0 1.4 9.1 1.9 0.0 0.2 0.0 20.2 0.0 0.0 0.0 0.0 26.8 0.0 2.2 0.4 45.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 2.0 0.0 5.5 0.2 0.0 16.2 17.9 50.6 0.5 98.2 15.8 0.9 2.7 0.0 12.0 35.2 43.6 0.0 0.4 13.3 5.0 11.7 36.8 0.0 0.0 0.5 0.7 41.1 345.6 3.5 9.7 12.6 0.0 1.7 5.5 116.2 8.6 147.9 28.1 16.9 39.7 0.3 0.5 0.4 0.0 160.5 0.8 0.3 19.4 20.8 1.0 1.8 12.4 0.2 0.0 0.8 295.9 CYP21A2 "CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B" ENSG00000231852 "Cytochrome P450 family 21 subfamily A member 2" P08686 6 32038265-32041670 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Steroidogenesis "Monooxygenase, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 23 "adrenal gland: 170.9" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 14.4" "Cancer enhanced" "Detected in some" "liver cancer: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 11.8;Hep G2: 1.9;Karpas-707: 3.2" "Not detected" "Not detected" "HPA048979, HPA053371" Enhanced "Intracellular and membrane" NA NA "HPA048979: AB_2680584, HPA053371: AB_2682131" "unprognostic (1.03e-2)" "unprognostic (1.65e-1)" "unprognostic (1.02e-4)" "unprognostic (2.58e-1)" "unprognostic (2.97e-1)" "unprognostic (2.93e-2)" "unprognostic (2.76e-2)" "unprognostic (8.75e-2)" "unprognostic (1.39e-1)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (6.67e-7)" "unprognostic (7.39e-2)" "unprognostic (5.24e-2)" "unprognostic (1.09e-1)" "unprognostic (1.82e-1)" 0.1 170.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 6.7 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.3 7.4 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 3.6 0.0 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.8 0.3 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.3 0.3 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 1.1 14.4 0.0 0.0 1.7 0.0 0.0 0.0 0.6 0.0 1.7 0.0 0.0 0.2 0.5 0.0 0.0 1.7 0.4 0.0 0.2 0.5 0.4 0.0 0.0 0.0 0.0 0.0 CYP2A13 "CPAD, CYP2A" ENSG00000197838 "Cytochrome P450 family 2 subfamily A member 13" Q16696 19 41088472-41096195 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 20 "liver: 30.7" "Cell type enriched" "Detected in single" 7 "Early spermatids: 3.0" "Cancer enriched" "Detected in single" 5 "liver cancer: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 2.1;NTERA-2: 1.6" "HPA046713, HPA047262" Supported "Intracellular and membrane" NA NA "HPA046713: AB_2679767, HPA047262: AB_2680005" "unprognostic (9.79e-2)" "unprognostic (1.00e-1)" "unprognostic (4.51e-3)" "unprognostic (4.92e-2)" "unprognostic (1.99e-1)" "unprognostic (1.49e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 1.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 30.7 1.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 CYP2A6 "CPA6, CYP2A, CYP2A3" ENSG00000255974 "Cytochrome P450 family 2 subfamily A member 6" P11509 19 40843538-40850447 "Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 165 "liver: 199.5" "Cell type enriched" "Detected in some" 13 "Hepatocytes: 161.7" "Cancer enriched" "Detected in some" 12 "liver cancer: 281.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 1.3;HL-60: 2.9;K-562: 1.4;RH-30: 4.4;SiHa: 2.2;TIME: 1.0;U-698: 1.0;U-937: 1.0" "HPA046713, HPA047262" Supported "Intracellular and membrane" NA NA "HPA046713: AB_2679767, HPA047262: AB_2680005" "unprognostic (5.40e-2)" "unprognostic (2.36e-2)" "unprognostic (1.21e-1)" "unprognostic (4.10e-1)" "unprognostic (5.05e-2)" "unprognostic (2.64e-2)" "prognostic favorable (5.38e-5)" "unprognostic (4.98e-3)" "unprognostic (4.86e-2)" "unprognostic (6.23e-2)" "unprognostic (5.20e-2)" "unprognostic (1.95e-1)" "unprognostic (2.25e-2)" "unprognostic (8.83e-3)" "unprognostic (2.46e-1)" "unprognostic (3.07e-2)" "unprognostic (2.55e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 199.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.1 5.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 161.7 0.0 0.0 0.0 12.9 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 CYP2A7 CYP2A ENSG00000198077 "Cytochrome P450 family 2 subfamily A member 7" P20853 19 40875439-40882752 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 134 "liver: 53.7" "Cell type enhanced" "Detected in some" 29 "Hepatocytes: 29.0;Ito cells: 12.3;Kupffer cells: 5.7" "Group enriched" "Detected in some" 238 "breast cancer: 9.2;liver cancer: 25.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HL-60: 2.0" "CAB033510, HPA046713, HPA047262" Enhanced "Intracellular and membrane" NA NA "CAB033510: AB_782366, HPA046713: AB_2679767, HPA047262: AB_2680005" "unprognostic (2.18e-1)" "unprognostic (3.60e-2)" "unprognostic (2.65e-3)" "unprognostic (8.89e-2)" "unprognostic (1.39e-2)" "unprognostic (3.95e-1)" "unprognostic (9.21e-2)" "unprognostic (8.71e-2)" "unprognostic (3.99e-2)" "unprognostic (1.06e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 53.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.0 0.2 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 29.0 0.0 0.0 0.0 12.3 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 CYP2B6 "CPB6, CYP2B, CYPIIB6" ENSG00000197408 "Cytochrome P450 family 2 subfamily B member 6" P20813 19 40991250-41018398 "Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 44 "liver: 137.3" "Cell type enriched" "Detected in some" 7 "Hepatocytes: 326.3" "Cancer enhanced" "Detected in many" "liver cancer: 28.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 7.0;OE19: 4.9" "Not detected" "Not detected" "CAB033866, HPA048124, HPA062973" Enhanced Approved "Nucleoplasm,Nuclear membrane,Cytosol" "Intracellular and membrane" NA NA "Nuclear membrane" "Nucleoplasm, Cytosol" "CAB033866: AB_2292644, HPA048124: AB_2680274, HPA062973: AB_2684914" "unprognostic (1.86e-1)" "unprognostic (1.23e-2)" "unprognostic (1.13e-2)" "unprognostic (6.13e-2)" "unprognostic (4.59e-2)" "unprognostic (4.63e-2)" "unprognostic (4.41e-2)" "unprognostic (1.73e-1)" "unprognostic (5.78e-2)" "unprognostic (1.04e-3)" "unprognostic (2.19e-1)" "unprognostic (9.43e-2)" "unprognostic (5.44e-1)" 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.1 0.1 0.1 0.8 0.1 0.1 0.9 0.1 0.1 0.1 0.0 0.5 0.1 0.1 0.0 3.0 137.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 1.6 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.9 1.8 3.1 0.8 0.7 0.9 0.1 0.4 0.4 0.5 0.4 0.1 0.0 0.4 0.2 0.3 0.0 0.1 1.5 0.0 0.3 0.3 0.2 0.1 7.0 0.4 0.1 0.1 0.3 0.6 0.4 0.7 0.4 0.4 0.4 0.4 0.0 0.4 0.3 0.1 0.3 0.5 0.7 0.4 0.1 0.2 0.1 0.8 1.8 0.6 4.9 0.4 0.2 0.5 0.4 1.7 0.1 0.9 0.2 0.3 0.1 0.5 0.3 0.7 1.1 0.8 0.6 0.3 0.7 0.5 0.3 0.7 0.9 0.2 1.1 0.3 3.1 0.8 0.4 0.4 0.5 0.4 0.6 0.6 0.4 0.1 1.9 0.5 0.8 2.7 0.7 0.3 1.8 0.9 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.2 2.5 1.4 1.2 1.8 0.0 0.0 0.0 0.0 0.0 0.0 9.9 46.7 0.2 0.0 0.0 0.1 0.0 326.3 0.0 0.0 0.0 10.4 11.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 7.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 3.2 0.6 CYP2C18 "CPCI, CYP2C, CYP2C17, P450IIC17" ENSG00000108242 "Cytochrome P450 family 2 subfamily C member 18" P33260 10 94683621-94736190 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 62.9;liver: 56.1" "Cell type enriched" "Detected in some" 6 "Hepatocytes: 113.1" "Cancer enhanced" "Detected in many" "liver cancer: 18.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "basophil: 1.7" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.7" "Cell line enhanced" "Detected in some" "BEWO: 7.9;hTCEpi: 2.3;OE19: 4.4" "Intracellular and membrane" NA NA "unprognostic (2.40e-1)" "unprognostic (1.75e-2)" "unprognostic (2.69e-1)" "unprognostic (1.10e-2)" "unprognostic (1.32e-2)" "unprognostic (2.57e-1)" "unprognostic (2.71e-1)" "unprognostic (9.78e-2)" "unprognostic (2.28e-1)" "unprognostic (4.22e-3)" "unprognostic (1.62e-3)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (6.81e-3)" 0.2 0.0 0.2 0.8 0.2 0.0 0.2 0.2 0.2 2.4 29.2 0.3 0.2 30.2 0.2 0.2 13.5 0.0 6.7 0.2 0.2 0.0 0.2 56.1 0.5 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.5 0.2 0.2 0.5 0.2 2.4 0.2 0.2 1.7 62.9 0.2 0.2 0.2 19.0 0.2 0.2 0.3 0.2 5.0 3.8 0.2 3.7 0.0 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.3 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.1 0.0 0.0 0.1 0.0 2.3 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 4.4 0.0 0.0 0.0 0.9 0.5 0.2 0.3 0.6 0.2 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.3 0.2 0.6 0.1 0.5 0.0 0.1 0.2 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 3.5 0.0 0.0 0.1 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 14.7 0.0 6.4 0.1 0.0 0.0 0.0 113.1 0.0 0.0 0.0 1.8 1.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 5.3 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.5 1.3 0.0 1.5 0.0 CYP2C19 "CPCJ, CYP2C, P450IIC19" ENSG00000165841 "Cytochrome P450 family 2 subfamily C member 19" P33261 10 94762681-94853205 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "intestine: 47.7;liver: 76.4" "Cell type enriched" "Detected in single" 31 "Hepatocytes: 10.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 1.8;RPMI-8226: 1.6" HPA015066 Supported "Intracellular and membrane" NA NA "HPA015066: AB_1847433" "unprognostic (3.15e-2)" "unprognostic (2.13e-1)" "unprognostic (2.48e-1)" "unprognostic (1.83e-2)" "unprognostic (1.53e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 30.0 0.0 0.0 14.7 0.0 0.0 1.0 0.0 3.7 0.0 0.0 0.0 0.0 76.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 47.7 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP2C8 CPC8 ENSG00000138115 "Cytochrome P450 family 2 subfamily C member 8" P10632 10 95036772-95069497 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 131 "liver: 247.5" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 1616.5" "Cancer enriched" "Detected in some" 82 "liver cancer: 102.3" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 9 "gdT-cell: 1.8" "Lineage enriched" "Detected in single" 9 "T-cells: 1.8" "Cell line enhanced" "Detected in some" "Daudi: 1.8;HL-60: 2.7;SiHa: 3.0;U-266/70: 3.0;U-266/84: 2.3" "HPA013547, HPA013970, HPA015066" Enhanced "Intracellular and membrane" NA NA "HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433" "unprognostic (3.33e-2)" "unprognostic (1.38e-1)" "unprognostic (1.53e-1)" "unprognostic (1.55e-1)" "unprognostic (4.41e-2)" "unprognostic (1.09e-2)" "unprognostic (1.80e-3)" "unprognostic (4.29e-2)" "unprognostic (1.03e-1)" "unprognostic (3.38e-1)" "prognostic favorable (9.82e-4)" "unprognostic (2.85e-1)" "unprognostic (1.44e-3)" "unprognostic (2.63e-1)" "unprognostic (7.88e-2)" "unprognostic (1.39e-1)" "unprognostic (4.05e-4)" 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 1.0 0.1 0.1 0.2 0.3 247.5 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.0 0.1 1.1 0.2 0.0 0.2 0.0 0.7 1.0 0.0 1.0 0.5 2.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.3 0.4 0.3 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 3.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 2.3 1.2 0.0 0.9 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 21.0 0.0 0.0 0.9 0.2 155.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 4.9 0.0 0.0 70.0 0.2 0.0 0.0 0.1 0.0 1616.5 0.0 4.8 1.7 61.4 65.7 5.1 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 1.6 0.0 0.0 2.1 0.6 0.0 0.0 0.0 0.0 0.1 CYP2C9 "CYP2C10, P450IIC9" ENSG00000138109 "Cytochrome P450 family 2 subfamily C member 9" P11712 10 94938658-94989391 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 233.0" "Cell type enriched" "Detected in some" 48 "Hepatocytes: 1765.4" "Cancer enriched" "Detected in some" 41 "liver cancer: 118.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 3.5;NB-4: 1.7;RPMI-8226: 2.5;SiHa: 1.6" "HPA015066, CAB016123" Enhanced "Intracellular and membrane" NA NA "CAB016123: AB_629363, HPA015066: AB_1847433" "unprognostic (3.37e-1)" "unprognostic (5.68e-2)" "unprognostic (9.67e-2)" "unprognostic (4.16e-2)" "unprognostic (1.83e-2)" "prognostic favorable (2.83e-6)" "unprognostic (2.37e-1)" "unprognostic (2.05e-2)" "unprognostic (4.93e-2)" "unprognostic (1.26e-4)" "unprognostic (7.55e-2)" "unprognostic (1.12e-1)" "unprognostic (2.45e-2)" "unprognostic (1.24e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 45.8 0.0 0.0 13.6 0.0 0.6 1.1 0.0 1.0 0.0 0.0 0.0 0.5 233.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 43.8 0.0 0.0 0.1 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.1 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.7 0.4 0.9 0.0 0.0 0.3 2.5 0.4 0.0 0.1 0.1 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 30.6 0.0 0.0 1.8 0.0 0.0 0.0 4.7 0.0 0.0 4.2 23.3 0.6 0.0 0.0 0.0 0.0 1765.4 0.0 0.0 0.0 36.8 31.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.3 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.3 0.0 CYP2D6 "CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, P450-DB1, P450C2D" ENSG00000100197 "Cytochrome P450 family 2 subfamily D member 6" P10635 22 42126499-42130906 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Cholesterol metabolism, Fatty acid metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "liver: 78.0" "Cell type enriched" "Detected in many" 38 "Hepatocytes: 435.9" "Cancer enriched" "Detected in many" 35 "liver cancer: 90.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 4.4;HMC-1: 6.2;Karpas-707: 1.9;REH: 3.6;T-47d: 2.3;U-266/70: 4.3" HPA045223 Enhanced Approved "Golgi apparatus" No No "Golgi apparatus" "HPA045223: AB_10962927" "unprognostic (4.40e-3)" "unprognostic (7.68e-3)" "unprognostic (5.45e-2)" "unprognostic (1.22e-3)" "unprognostic (1.24e-1)" "unprognostic (1.29e-4)" "unprognostic (3.83e-2)" "unprognostic (7.27e-3)" "unprognostic (1.13e-1)" "unprognostic (1.71e-1)" "unprognostic (4.03e-4)" "unprognostic (2.11e-2)" "unprognostic (5.61e-5)" "unprognostic (3.01e-1)" "unprognostic (2.23e-1)" "unprognostic (4.08e-1)" "unprognostic (4.82e-5)" 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 2.2 0.1 0.1 3.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 78.0 0.1 0.1 0.1 0.1 0.5 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.0 11.2 0.1 0.1 0.1 0.1 0.7 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.1 4.4 0.0 0.1 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.9 0.0 0.3 0.2 0.0 0.6 0.0 0.2 3.6 0.0 1.1 0.0 0.0 0.1 0.3 1.2 0.1 0.0 0.0 2.3 0.0 0.0 0.0 1.7 0.0 0.3 4.3 0.0 0.0 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.6 0.0 0.5 0.5 6.5 0.3 2.5 1.4 0.0 1.8 2.0 0.1 1.7 0.6 2.9 0.3 3.9 0.0 0.5 0.1 0.2 0.5 0.0 435.9 0.1 11.1 1.2 6.7 6.2 11.4 0.0 0.0 0.0 0.0 1.0 0.9 0.5 2.9 1.4 0.5 2.0 0.0 0.2 0.7 0.3 1.0 0.3 0.5 0.8 0.2 CYP2E1 CYP2E ENSG00000130649 "Cytochrome P450 family 2 subfamily E member 1" P05181 10 133520406-133561220 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 87 "liver: 802.4" "Cell type enriched" "Detected in many" 65 "Hepatocytes: 5979.1" "Cancer enriched" "Detected in some" 278 "liver cancer: 265.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "MAIT T-cell: 3.9;myeloid DC: 9.1" "Group enriched" "Detected in many" 17 "dendritic cells: 9.1;T-cells: 3.9" "Cell line enhanced" "Detected in many" "HaCaT: 9.8;HL-60: 7.6;HMC-1: 8.1;NB-4: 20.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA009128, HPA029564" Enhanced Approved "Endoplasmic reticulum,Mitochondria" "Intracellular and membrane" NA NA "Endoplasmic reticulum, Mitochondria" "HPA009128: AB_1078613, HPA029564: AB_10602213" "unprognostic (6.32e-2)" "unprognostic (1.51e-2)" "unprognostic (3.83e-5)" "unprognostic (1.27e-1)" "unprognostic (3.37e-2)" "unprognostic (1.26e-1)" "unprognostic (2.92e-3)" "unprognostic (6.36e-3)" "unprognostic (2.41e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" "unprognostic (3.21e-2)" "unprognostic (1.70e-4)" "unprognostic (1.72e-1)" "unprognostic (8.36e-2)" "unprognostic (3.78e-1)" "unprognostic (9.59e-2)" 0.1 0.0 0.1 0.1 0.2 0.0 0.1 0.6 0.3 0.1 0.1 0.2 0.7 0.0 0.1 0.3 0.8 0.2 1.3 0.1 0.1 0.1 0.3 802.4 0.1 0.1 0.1 0.1 0.1 0.4 0.0 0.1 0.1 0.3 0.1 0.0 0.2 0.1 1.1 0.1 0.6 0.1 0.1 0.1 0.4 0.1 0.3 0.1 0.1 0.2 0.2 1.5 0.1 0.1 0.0 9.1 0.0 0.3 0.2 3.9 0.3 0.1 0.0 0.3 0.9 3.2 1.8 0.7 1.4 4.0 0.0 0.3 0.0 2.4 1.3 0.2 0.4 0.0 9.8 0.0 0.2 0.3 0.2 1.4 1.5 0.1 1.1 0.5 7.6 8.1 0.9 0.2 0.0 0.6 1.7 0.0 2.8 0.5 0.4 0.9 0.6 0.5 20.6 5.6 3.7 0.4 0.3 5.5 0.0 1.8 0.0 0.0 0.0 3.7 0.0 0.6 0.1 0.2 0.8 0.0 1.3 0.4 2.0 0.9 2.0 0.8 2.8 1.3 6.4 0.1 0.0 0.0 0.0 0.1 0.0 3.9 0.0 1.7 1.0 9.1 0.0 0.1 0.0 0.0 0.2 0.3 0.1 0.0 0.3 0.1 0.2 0.6 0.3 0.1 0.1 0.1 0.1 0.3 0.1 0.0 0.6 21.0 0.2 2.1 4.5 2.2 50.9 2.7 2.3 0.0 2.0 0.0 0.0 0.3 1.3 0.4 0.0 23.3 1.2 0.1 0.4 0.5 1.1 5979.1 0.0 7.9 0.0 68.2 91.8 1.9 1.4 0.0 0.0 0.0 0.0 1.0 2.6 0.0 2.5 0.0 5.2 0.0 0.5 3.6 2.2 6.6 0.1 8.7 0.0 0.0 CYP2F1 CYP2F ENSG00000197446 "Cytochrome P450 family 2 subfamily F member 1" P24903 19 41114432-41128366 "Enzymes, Predicted intracellular proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lung: 10.4;lymphoid tissue: 6.1;pituitary gland: 4.6;testis: 4.9" "Cell type enhanced" "Detected in some" 29 "Ciliated cells: 22.7;Club cells: 48.9;Spermatocytes: 9.1" "Cancer enhanced" "Detected in some" "testis cancer: 1.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 7 "basophil: 1.6" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.6" "Cell line enriched" "Detected in some" 7 "HMC-1: 7.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Intracellular and membrane" NA NA "unprognostic (2.04e-1)" "unprognostic (8.79e-2)" "unprognostic (4.63e-1)" "unprognostic (4.60e-2)" "unprognostic (2.54e-1)" "unprognostic (7.29e-3)" "unprognostic (6.23e-3)" "unprognostic (2.87e-2)" "unprognostic (3.91e-2)" "unprognostic (1.58e-6)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (9.90e-2)" "unprognostic (1.50e-1)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.4 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.9 0.0 0.0 0.0 3.1 6.1 0.0 2.0 0.0 0.0 1.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 22.7 48.9 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 4.8 0.0 0.0 0.0 0.0 0.0 CYP2J2 ENSG00000134716 "Cytochrome P450 family 2 subfamily J member 2" P51589 1 59893308-59926790 "Enzymes, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 44.9;intestine: 46.6;liver: 74.6" "Cell type enhanced" "Detected in many" 15 "Cardiomyocytes: 84.7;Cytotrophoblasts: 107.4;Syncytiotrophoblasts: 201.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 6.0;naive CD8 T-cell: 5.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "OE19: 9.9;RT4: 36.0;SK-BR-3: 9.7" "Low region specificity" "Detected in all" "Intracellular and membrane" NA NA "unprognostic (3.53e-2)" "unprognostic (1.22e-2)" "unprognostic (1.35e-2)" "unprognostic (1.99e-2)" "unprognostic (2.51e-2)" "unprognostic (2.28e-1)" "unprognostic (1.61e-1)" "unprognostic (3.16e-1)" "unprognostic (1.15e-1)" "unprognostic (2.84e-2)" "unprognostic (7.29e-2)" "unprognostic (2.66e-1)" "prognostic unfavorable (5.54e-7)" "unprognostic (4.96e-1)" "unprognostic (8.45e-2)" "unprognostic (4.25e-1)" "unprognostic (9.70e-2)" 0.8 0.9 8.8 1.2 12.0 0.7 5.8 7.9 8.5 1.2 13.1 22.1 0.0 17.9 1.2 1.1 7.2 1.1 1.7 44.9 9.1 6.9 2.2 74.6 1.4 0.8 13.2 6.3 0.7 1.8 0.6 0.7 11.9 12.3 2.4 12.0 0.5 7.2 1.0 12.2 5.3 46.6 1.6 10.1 0.7 3.0 0.9 15.5 0.0 0.7 0.5 2.3 5.8 1.8 1.8 1.2 0.0 0.0 0.7 6.0 1.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.0 0.7 0.2 1.6 0.0 0.5 0.0 2.1 0.5 0.0 0.6 0.0 0.0 1.0 0.0 0.0 0.2 0.0 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.3 1.8 0.0 0.0 0.9 9.9 1.6 0.0 3.8 0.0 2.0 36.0 0.5 2.3 0.0 9.7 0.3 0.1 2.4 0.0 0.0 1.2 1.5 0.0 0.5 1.1 0.1 0.0 0.4 0.0 4.0 0.0 0.0 0.0 0.2 0.0 1.2 1.8 0.7 0.4 0.1 0.9 6.0 5.2 0.0 0.7 0.0 1.2 0.0 1.0 8.8 12.0 7.9 8.5 9.1 6.9 13.2 6.3 12.3 15.5 3.0 2.6 0.5 1.2 0.3 0.0 84.7 12.7 29.4 35.2 0.0 0.0 107.4 0.0 9.1 16.8 0.0 23.8 0.0 0.8 7.3 1.0 0.8 0.0 44.3 6.1 0.0 8.6 0.0 0.6 19.0 0.0 0.0 0.0 1.0 21.4 11.9 1.8 21.0 0.0 2.9 1.0 0.0 0.0 0.3 0.1 1.9 201.5 0.0 23.6 0.9 CYP2S1 ENSG00000167600 "Cytochrome P450 family 2 subfamily S member 1" Q96SQ9 19 41193049-41207539 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Lyase, Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.1;gallbladder: 29.1;intestine: 62.7;stomach 1: 45.9" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 16.5;Enterocytes: 23.2;Mucus-secreting cells: 29.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "classical monocyte: 9.5;myeloid DC: 33.1" "Group enriched" "Detected in many" 121 "dendritic cells: 33.1;monocytes: 9.5" "Cell line enhanced" "Detected in many" "A549: 31.3;CACO-2: 16.1;HaCaT: 16.8;NTERA-2: 23.7;OE19: 51.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA049227, HPA069248" Approved Supported "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA049227: AB_2680681, HPA069248: AB_2732128" "unprognostic (1.49e-2)" "unprognostic (7.45e-2)" "unprognostic (2.45e-2)" "unprognostic (6.03e-2)" "unprognostic (3.93e-2)" "unprognostic (7.46e-2)" "unprognostic (1.27e-2)" "unprognostic (4.85e-2)" "unprognostic (2.18e-1)" "unprognostic (1.54e-2)" "unprognostic (6.25e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.60e-6)" "unprognostic (1.06e-1)" "unprognostic (1.10e-1)" "unprognostic (1.02e-1)" "unprognostic (7.66e-2)" 1.2 0.8 0.8 2.3 1.0 0.5 0.6 0.1 1.0 1.7 18.3 1.2 0.5 37.6 0.3 0.9 10.1 2.4 29.1 1.0 1.4 1.6 0.9 2.1 3.8 3.3 5.6 0.4 0.8 0.6 0.0 0.9 1.6 4.5 0.9 7.2 1.1 3.8 0.3 0.1 2.0 62.7 0.6 1.1 4.0 45.9 0.5 1.2 2.6 0.4 15.8 21.0 3.2 2.7 0.0 33.1 0.0 9.5 0.0 0.1 3.9 1.2 31.3 0.0 0.0 0.0 0.0 1.5 0.2 0.2 0.3 0.0 16.1 4.5 0.0 3.7 0.2 0.0 16.8 5.5 8.5 0.1 0.0 0.1 4.2 1.7 5.8 6.6 0.0 0.1 0.2 0.4 0.4 0.2 0.0 0.2 1.4 1.9 0.1 0.0 0.6 0.1 0.0 23.7 51.4 4.1 0.0 0.0 0.3 0.5 6.7 0.0 0.2 3.1 0.0 0.0 9.7 4.1 1.6 3.6 0.0 1.3 0.6 0.0 0.1 0.0 0.0 0.1 0.7 0.0 0.0 9.5 0.0 0.0 2.3 0.1 0.0 0.0 0.0 33.1 0.0 0.0 0.0 0.0 0.0 1.2 1.3 0.0 3.9 0.8 1.0 0.1 1.0 1.4 1.6 5.6 0.4 4.5 1.2 0.0 8.6 0.0 1.6 2.3 0.0 0.8 0.0 8.1 7.9 1.8 0.0 16.5 0.0 0.8 0.3 0.0 23.2 0.0 0.9 0.6 1.3 0.4 1.1 0.0 12.8 0.0 0.0 0.6 4.7 0.0 0.0 11.5 0.0 8.2 29.0 0.0 13.8 14.8 0.0 0.0 0.0 0.0 0.3 0.1 0.4 2.5 8.6 0.0 13.9 0.1 CYP2U1 SPG49 ENSG00000155016 "Cytochrome P450 family 2 subfamily U member 1" Q7Z449 4 107931369-107953457 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "lymphoid tissue: 122.7" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 18.6;Peritubular cells: 16.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041622, HPA046754, HPA064827" Uncertain Approved "Nucleoplasm,Golgi apparatus,Vesicles" NA NA "Golgi apparatus" "Nucleoplasm, Vesicles" "HPA041622: AB_2677583, HPA046754: AB_2679787, HPA064827: AB_2685362" "unprognostic (3.54e-1)" "unprognostic (2.45e-1)" "unprognostic (3.08e-1)" "unprognostic (2.84e-1)" "unprognostic (5.16e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-2)" "unprognostic (1.20e-3)" "unprognostic (3.19e-1)" "unprognostic (8.97e-3)" "unprognostic (5.41e-3)" "unprognostic (3.02e-1)" "prognostic favorable (2.75e-5)" "prognostic unfavorable (6.97e-4)" "unprognostic (1.19e-1)" "unprognostic (1.17e-2)" "unprognostic (1.11e-1)" 8.6 7.9 7.7 4.4 9.1 0.4 7.3 11.3 9.2 7.8 7.3 7.0 4.1 4.0 9.5 4.6 6.3 9.8 6.6 8.8 7.1 7.9 6.4 6.8 6.6 6.7 8.3 5.2 12.0 2.6 10.3 8.1 2.7 7.8 12.4 4.7 8.6 4.5 11.0 4.3 3.1 6.0 12.3 7.0 8.5 4.6 3.9 7.4 122.7 4.7 3.5 5.4 7.3 5.3 2.6 2.7 0.7 5.9 1.6 1.7 0.4 2.5 1.2 3.4 6.3 18.8 9.0 0.5 10.8 16.3 6.6 10.5 0.0 1.7 6.9 0.8 6.4 5.2 0.1 5.3 4.0 10.4 1.9 1.6 1.4 2.4 0.3 7.5 2.0 0.0 10.1 3.4 3.1 2.1 13.5 2.5 7.8 0.1 3.3 5.5 1.8 7.4 0.0 3.5 0.2 3.0 4.2 4.1 0.0 2.1 4.3 6.7 5.0 2.7 4.7 11.5 3.0 2.3 1.0 6.8 4.3 0.5 6.1 4.3 14.0 13.2 2.2 3.5 0.0 4.8 0.0 0.3 0.7 1.2 1.1 0.9 2.0 0.9 1.0 2.2 2.6 1.7 1.3 0.0 1.6 5.9 2.7 0.0 0.4 7.7 9.1 11.3 6.9 7.1 7.9 8.3 5.2 7.8 7.4 3.0 3.8 3.2 3.2 1.0 4.3 3.4 2.5 13.4 3.4 8.7 3.9 0.4 0.0 0.9 9.6 5.8 2.6 0.0 1.7 0.3 5.1 1.7 4.6 6.8 1.9 1.6 2.9 6.7 6.1 6.1 16.4 4.6 18.6 3.6 1.1 9.9 0.4 0.0 16.6 2.4 3.3 0.0 5.2 0.9 4.3 1.3 0.2 1.3 1.6 0.7 CYP3A4 CYP3A3 ENSG00000160868 "Cytochrome P450 family 3 subfamily A member 4" P08684 7 99756960-99784265 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 45 "intestine: 145.3;liver: 464.6" "Cell type enriched" "Detected in some" 45 "Hepatocytes: 2276.5" "Cancer enriched" "Detected in some" 240 "liver cancer: 351.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 4.2;NB-4: 4.5;RPMI-8226: 6.7;SCLC-21H: 2.6;SH-SY5Y: 5.0" "CAB033671, HPA072245, HPA075539" Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "CAB033671: AB_782375, HPA072245: , HPA075539: " "unprognostic (4.55e-2)" "unprognostic (8.95e-2)" "unprognostic (8.08e-2)" "unprognostic (1.63e-1)" "unprognostic (5.89e-2)" "unprognostic (5.37e-2)" "unprognostic (7.07e-3)" "unprognostic (9.09e-2)" "unprognostic (8.27e-3)" "unprognostic (4.92e-2)" "unprognostic (3.78e-2)" "unprognostic (6.42e-2)" "unprognostic (1.89e-8)" "unprognostic (2.59e-1)" "unprognostic (1.75e-2)" "unprognostic (9.79e-2)" "unprognostic (6.82e-2)" 0.1 0.4 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 145.3 0.1 0.1 56.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 464.6 0.1 0.1 0.1 0.1 0.1 6.8 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 126.7 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.6 0.2 0.6 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.2 0.0 1.9 0.4 0.0 1.2 0.0 0.4 0.0 0.0 0.1 0.5 0.0 0.5 0.0 0.1 4.5 0.3 0.0 0.0 0.0 2.2 6.7 0.0 0.5 2.6 5.0 0.5 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 1.4 0.0 0.7 0.1 0.7 0.1 0.7 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.6 0.6 0.0 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 4.3 1.0 0.3 0.0 0.3 40.8 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 2.6 46.7 0.8 0.0 0.0 0.5 0.0 2276.5 0.0 0.0 0.0 39.3 50.2 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.4 0.9 CYP3A43 ENSG00000021461 "Cytochrome P450 family 3 subfamily A member 43" Q9HB55 7 99828013-99866102 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 32.5" "Cell type enhanced" "Detected in some" 15 "Early spermatids: 6.3;granulocytes: 2.3;Hepatocytes: 6.8;Late spermatids: 2.5" "Cancer enriched" "Detected in single" 18 "liver cancer: 1.4" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "HPA066463, HPA072245, HPA075539" Enhanced Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA066463: AB_2685670, HPA072245: , HPA075539: " "unprognostic (1.20e-3)" "unprognostic (4.74e-2)" "unprognostic (3.64e-3)" "unprognostic (7.24e-2)" "unprognostic (2.52e-1)" "prognostic favorable (3.41e-4)" "unprognostic (1.68e-2)" "unprognostic (1.44e-1)" "unprognostic (2.38e-1)" "unprognostic (1.12e-1)" "unprognostic (6.45e-2)" "unprognostic (1.23e-2)" "unprognostic (6.46e-2)" "unprognostic (5.90e-2)" "unprognostic (3.10e-1)" "unprognostic (6.37e-4)" 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.0 0.2 0.9 0.1 0.0 0.1 0.1 0.1 0.0 0.2 32.5 0.1 0.1 0.1 0.1 0.1 8.0 0.0 2.2 0.1 0.1 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 0.1 0.0 0.5 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.5 1.6 0.6 0.3 0.6 0.2 0.1 0.0 0.9 0.3 1.1 0.2 0.2 0.0 0.2 0.2 0.2 1.2 0.7 1.5 0.3 0.3 0.1 1.3 0.2 0.0 0.7 0.2 0.5 0.9 1.5 1.3 0.3 0.9 1.3 0.0 0.7 0.0 0.0 0.6 0.5 0.1 1.0 1.0 0.0 0.0 0.0 0.6 0.4 0.3 0.0 0.9 0.0 0.2 0.8 1.6 0.5 0.4 0.6 1.7 0.0 0.7 0.5 0.0 1.6 0.5 0.2 1.1 0.7 1.1 1.2 0.1 0.8 0.4 0.2 1.5 0.6 0.4 0.6 0.2 0.3 0.3 0.3 0.2 0.1 0.6 0.5 0.5 1.6 0.3 0.2 0.5 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 6.3 0.2 0.0 0.0 0.0 0.0 0.0 0.5 2.3 6.8 0.1 1.6 0.0 0.0 0.0 2.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.9 0.2 0.3 0.0 0.0 0.0 0.0 CYP3A5 "CP35, P450PCN3, PCN3" ENSG00000106258 "Cytochrome P450 family 3 subfamily A member 5" P20815 7 99648194-99680026 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Monooxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "intestine: 72.9;liver: 73.4;stomach 1: 21.3" "Cell type enhanced" "Detected in many" 11 "Cholangiocytes: 346.5;Enterocytes: 640.5;Hepatocytes: 330.1;Urothelial cells: 352.8" "Cancer enhanced" "Detected in many" "liver cancer: 38.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 8.3;CAPAN-2: 5.6;Hep G2: 5.7;OE19: 23.6" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " "unprognostic (2.13e-1)" "unprognostic (4.36e-2)" "unprognostic (4.04e-2)" "unprognostic (1.00e-1)" "unprognostic (1.06e-2)" "unprognostic (2.73e-1)" "prognostic favorable (3.72e-5)" "unprognostic (1.37e-3)" "unprognostic (1.21e-2)" "unprognostic (7.29e-3)" "unprognostic (3.85e-1)" "unprognostic (4.05e-2)" "unprognostic (1.46e-1)" "unprognostic (1.00e-1)" "unprognostic (1.93e-1)" "unprognostic (2.39e-4)" "unprognostic (6.58e-3)" 1.0 3.3 0.4 2.0 0.5 0.0 1.3 0.6 0.6 1.9 32.6 0.6 1.0 30.3 0.7 0.5 5.2 0.5 8.2 0.4 0.4 0.0 6.8 73.4 2.4 0.8 0.4 0.4 0.6 12.1 0.0 1.8 0.6 0.8 4.9 5.1 0.4 0.6 1.3 0.4 4.3 72.9 0.6 0.5 0.4 21.3 0.7 0.4 0.5 0.4 2.2 4.0 3.0 2.7 0.0 0.2 0.1 0.6 0.0 0.7 0.2 0.0 2.1 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 8.3 5.6 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.1 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.1 0.0 0.3 0.2 23.6 0.0 0.1 0.0 0.6 0.5 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.2 0.4 0.5 0.6 0.6 0.4 0.0 0.4 0.4 0.8 0.4 11.9 11.3 11.2 107.3 41.0 13.1 1.0 346.5 14.7 12.5 3.5 11.8 1.3 0.0 58.0 1.7 2.5 640.5 46.7 44.6 1.0 3.8 166.5 9.3 330.1 0.6 7.9 52.5 9.8 8.3 0.0 2.3 4.6 3.3 7.2 117.1 6.0 69.5 210.5 2.5 4.2 20.2 0.0 3.5 6.8 4.2 51.6 1.3 12.9 85.2 352.8 CYP3A7 "CP37, P450-HFLA" ENSG00000160870 "Cytochrome P450 family 3 subfamily A member 7" P24462 7 99684957-99735196 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 82.6" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 135.0" "Cancer enriched" "Detected in some" 43 "liver cancer: 38.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "BEWO: 1.9;BJ hTERT+: 3.3;Hep G2: 6.4;HHSteC: 3.7;RT4: 1.9" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " "unprognostic (8.10e-3)" "unprognostic (1.45e-1)" "unprognostic (3.12e-1)" "unprognostic (5.47e-2)" "unprognostic (1.73e-1)" "unprognostic (1.44e-1)" "unprognostic (4.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.34e-2)" "unprognostic (8.28e-2)" "unprognostic (8.18e-2)" "unprognostic (1.97e-1)" "unprognostic (1.06e-11)" "unprognostic (2.02e-2)" "unprognostic (5.87e-2)" "unprognostic (2.97e-1)" "unprognostic (1.34e-3)" 0.1 0.4 0.1 0.1 0.0 0.0 2.6 0.1 0.1 0.0 0.7 0.0 0.0 0.1 0.3 0.1 0.2 0.0 3.9 0.0 0.1 0.0 2.8 82.6 0.6 0.0 0.0 0.1 0.1 0.3 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.1 1.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.4 1.9 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.4 3.7 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.1 0.0 0.0 0.0 135.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 18.4 0.1 0.0 0.0 4.9 3.7 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.2 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 CYP3A7-CYP3A51P ENSG00000282301 "CYP3A7-CYP3A51P readthrough" P24462 7 99685226-99735093 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 73.9" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 7.6" "Cell type enhanced" "Detected in single" "eosinophil: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC TERT1: 4.3;U-87 MG: 2.6" "HPA072245, HPA075539" Approved Vesicles,Cytosol NA NA Cytosol Vesicles "HPA072245: , HPA075539: " 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.1 73.9 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.2 1.1 0.0 0.0 0.5 0.0 0.3 0.5 1.6 0.5 0.2 4.3 0.0 0.6 0.2 0.0 0.0 0.0 1.3 0.1 0.4 0.0 0.1 0.3 0.0 0.0 0.0 0.4 0.9 1.4 1.9 0.0 0.0 0.5 0.3 0.4 0.4 0.0 0.4 0.5 0.0 0.8 0.5 1.1 0.1 0.2 1.2 0.5 0.2 0.5 0.2 0.1 0.4 1.5 0.0 0.0 0.4 0.2 0.0 0.5 0.6 0.6 0.0 0.1 0.4 0.3 0.5 0.5 0.6 0.9 0.7 0.1 2.6 0.7 0.1 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CYP4B1 ENSG00000142973 "Cytochrome P450 family 4 subfamily B member 1" P13584 1 46757838-46819413 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 92.0" "Group enriched" "Detected in some" 5 "Alveolar cells type 1: 1140.4;Ciliated cells: 602.3;Club cells: 304.8" "Cancer enhanced" "Detected in many" "urothelial cancer: 56.9" "Region enhanced" "Detected in single" "midbrain: 1.7" "Cell type enriched" "Detected in single" 11 "memory CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 11 "T-cells: 1.1" "Cell line enriched" "Detected in some" 8 "RT4: 81.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA004331 Approved Supported Vesicles NA NA Vesicles "HPA004331: AB_1078616" "unprognostic (2.29e-2)" "prognostic favorable (5.99e-4)" "unprognostic (7.01e-2)" "unprognostic (1.11e-1)" "unprognostic (2.28e-1)" "unprognostic (8.31e-2)" "unprognostic (1.16e-2)" "unprognostic (1.98e-2)" "unprognostic (2.65e-1)" "unprognostic (2.59e-1)" "unprognostic (6.12e-2)" "unprognostic (5.46e-2)" "unprognostic (7.33e-2)" "unprognostic (1.80e-1)" "unprognostic (1.15e-1)" "unprognostic (1.22e-3)" "unprognostic (6.69e-3)" 41.6 2.2 0.0 0.6 0.1 0.3 45.5 0.1 0.3 9.5 6.7 0.1 7.2 0.7 2.1 2.8 17.9 18.5 0.8 13.5 0.0 0.0 1.4 0.2 92.0 1.5 1.7 0.1 3.3 0.9 0.5 4.8 0.9 0.8 15.4 0.5 2.8 5.0 6.9 14.4 10.4 3.4 6.8 3.5 0.5 3.0 1.7 0.1 0.7 12.7 4.5 5.7 36.5 18.9 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.5 0.0 0.0 0.0 3.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.2 0.0 0.0 1.7 0.1 0.8 0.1 1140.4 70.0 0.0 114.6 0.5 0.0 4.8 0.0 602.3 304.8 0.0 0.0 0.9 0.0 0.0 0.5 2.1 0.0 0.0 0.0 0.2 4.7 3.9 5.8 0.0 0.6 0.0 0.0 2.5 0.0 0.8 0.6 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 3.6 0.7 0.0 0.0 142.5 CYP4F11 ENSG00000171903 "Cytochrome P450 family 4 subfamily F member 11" Q9HBI6 19 15912367-15934867 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "liver: 88.6" "Cell type enhanced" "Detected in many" 17 "Ductal cells: 13.3;Hepatocytes: 48.8;Urothelial cells: 13.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 7.6;CAPAN-2: 30.3;EFO-21: 11.4;Hep G2: 14.7;RPMI-8226: 7.9;RT4: 9.1" "HPA017265, CAB033648, HPA058960" Enhanced "Intracellular and membrane" NA NA "CAB033648: AB_2088410, HPA017265: AB_1847451, HPA058960: AB_2683862" "prognostic favorable (4.05e-4)" "unprognostic (4.12e-2)" "unprognostic (1.79e-1)" "unprognostic (5.99e-2)" "unprognostic (5.92e-3)" "unprognostic (1.06e-2)" "unprognostic (1.24e-1)" "unprognostic (1.65e-1)" "unprognostic (2.33e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (9.28e-4)" "unprognostic (4.44e-2)" "unprognostic (9.50e-3)" "unprognostic (2.14e-2)" "unprognostic (2.24e-1)" "unprognostic (2.78e-2)" "unprognostic (4.64e-2)" 0.4 2.2 3.6 0.5 4.4 0.5 1.7 1.8 5.4 1.1 2.5 4.4 0.0 7.5 0.5 11.8 7.9 2.2 12.9 0.4 3.9 1.4 4.9 88.6 2.4 0.4 2.1 3.8 0.3 3.5 0.2 0.6 0.2 8.3 2.4 1.9 0.6 2.6 3.4 0.5 0.8 15.7 0.2 9.7 0.9 2.7 1.0 3.0 0.0 2.2 2.8 1.8 4.8 2.0 0.1 0.1 0.8 1.2 0.0 0.2 0.1 7.6 1.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.3 0.1 11.4 0.0 6.5 0.9 0.0 3.9 0.0 0.0 0.0 0.0 2.3 14.7 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 6.1 0.0 1.1 0.0 0.1 0.0 6.7 0.0 0.0 0.1 7.9 2.1 9.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.1 0.1 0.1 0.1 0.3 0.1 0.2 0.9 0.0 0.8 0.5 0.0 0.1 1.2 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.3 0.0 0.7 0.1 0.0 0.1 3.6 4.4 1.8 5.4 3.9 1.4 2.1 3.8 8.3 3.0 0.0 0.0 0.0 7.8 0.1 0.0 0.3 0.0 4.0 1.2 8.7 0.0 0.0 1.7 13.3 0.0 0.0 5.3 0.0 9.9 0.0 0.0 7.8 0.0 48.8 0.0 0.0 1.2 0.0 1.6 0.0 0.3 0.0 0.0 0.0 3.0 2.5 7.5 2.9 0.0 5.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 1.7 13.3 CYP4F12 ENSG00000186204 "Cytochrome P450 family 4 subfamily F member 12" 19 15672757-15697174 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "intestine: 53.0;liver: 24.2" "Cell type enhanced" "Detected in many" 16 "Enterocytes: 95.3;Paneth cells: 35.4;Undifferentiated cells: 26.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 39 "basophil: 5.3;eosinophil: 13.2" "Lineage enriched" "Detected in single" 76 "granulocytes: 13.2" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.6;HaCaT: 18.7;Hep G2: 5.2;Karpas-707: 12.6;OE19: 27.1" HPA058960 Approved NA NA "HPA058960: AB_2683862" "unprognostic (4.30e-4)" "prognostic favorable (1.21e-4)" "unprognostic (1.86e-1)" "unprognostic (1.48e-2)" "unprognostic (1.37e-2)" "unprognostic (5.32e-3)" "unprognostic (1.84e-3)" "unprognostic (9.13e-2)" "unprognostic (9.11e-2)" "unprognostic (2.50e-1)" "unprognostic (4.32e-2)" "unprognostic (1.47e-1)" "unprognostic (1.66e-3)" "unprognostic (6.20e-2)" "unprognostic (5.45e-2)" "unprognostic (3.17e-1)" "prognostic favorable (2.33e-4)" 1.9 0.7 1.6 6.1 0.9 0.6 3.5 0.0 1.9 3.9 24.6 5.6 1.4 24.6 1.4 1.8 11.5 2.1 10.8 1.7 1.9 0.3 1.1 24.2 0.9 0.3 3.0 3.5 1.9 0.2 0.1 0.3 0.4 2.7 4.4 5.1 1.4 3.0 1.5 0.4 12.9 53.0 5.1 0.8 0.7 8.0 0.4 4.8 0.2 0.6 8.9 6.3 10.1 6.5 0.0 0.0 13.2 0.0 0.0 0.1 0.0 0.0 2.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.3 0.0 0.0 0.1 18.7 0.0 0.0 0.0 1.0 0.0 0.0 0.7 5.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.1 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 5.3 0.0 13.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.6 0.9 0.0 1.9 1.9 0.3 3.0 3.5 2.7 4.8 0.0 2.6 0.8 10.1 12.5 0.0 1.0 5.1 2.7 0.0 0.0 0.0 0.1 0.0 0.3 1.1 1.5 95.3 0.0 0.0 0.1 3.0 2.8 0.0 24.2 0.4 0.0 7.5 0.6 0.3 2.2 3.7 0.0 1.7 0.0 24.4 2.7 1.1 35.4 1.1 2.1 0.0 0.0 0.8 0.1 0.0 18.4 0.2 0.7 26.0 18.3 CYP4F8 ENSG00000186526 "Cytochrome P450 family 4 subfamily F member 8" P98187 19 15615218-15630638 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Fatty acid metabolism, Lipid metabolism" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 155 "ductus deferens: 265.6;seminal vesicle: 360.6" "Cell type enhanced" "Detected in some" 14 "Glandular cells: 1.7;granulocytes: 1.1;Urothelial cells: 2.4" "Group enriched" "Detected in some" 31 "breast cancer: 2.5;prostate cancer: 3.3;urothelial cancer: 10.4" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 9 "OE19: 2.1;RT4: 1.6;SK-BR-3: 4.4" HPA058960 Approved NA NA "HPA058960: AB_2683862" "unprognostic (1.70e-2)" "unprognostic (5.46e-3)" "unprognostic (3.21e-2)" "unprognostic (3.97e-6)" "unprognostic (3.51e-3)" "unprognostic (2.72e-1)" "unprognostic (1.15e-1)" "unprognostic (8.25e-2)" "unprognostic (1.15e-2)" "unprognostic (1.02e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 265.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 360.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 4.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 1.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 2.4 CYP4V2 CYP4AH1 ENSG00000145476 "Cytochrome P450 family 4 subfamily V member 2" Q6ZWL3 4 186191520-186213456 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Sensory transduction, Vision" "Monooxygenase, Oxidoreductase" "Corneal dystrophy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 64.7" "Cell type enhanced" "Detected in many" 7 "Hepatocytes: 92.7;Muller glia cells: 64.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 13.1;SK-MEL-30: 19.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029122 Approved Approved "Nuclear speckles" NA NA "Nuclear speckles" "HPA029122: AB_10601806" "unprognostic (1.65e-1)" "unprognostic (5.37e-2)" "unprognostic (2.35e-1)" "prognostic favorable (5.86e-4)" "unprognostic (1.45e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.85e-4)" "unprognostic (6.66e-2)" "unprognostic (5.84e-2)" "unprognostic (2.05e-1)" "unprognostic (6.49e-2)" "unprognostic (9.89e-2)" "prognostic favorable (1.49e-7)" "unprognostic (3.25e-2)" "unprognostic (8.96e-2)" "unprognostic (1.02e-1)" "unprognostic (3.14e-2)" 6.6 16.6 7.8 5.0 12.4 1.6 5.5 8.9 7.5 6.7 8.0 8.9 4.9 11.4 5.7 4.2 5.2 6.2 13.7 7.4 7.7 4.6 21.6 64.7 7.3 4.1 7.7 9.0 6.3 12.1 30.8 16.1 3.0 6.7 5.6 8.2 19.1 6.2 9.1 3.3 2.8 14.7 6.4 7.0 7.5 5.2 3.2 7.4 4.4 11.9 2.1 3.8 8.0 5.1 2.3 2.5 0.0 6.2 1.3 4.0 1.5 2.6 1.8 0.6 0.0 11.3 4.6 0.1 3.8 8.1 1.4 2.0 0.0 10.9 1.0 0.5 2.5 5.7 1.3 1.3 1.2 0.4 6.5 1.3 4.1 0.4 0.5 3.4 2.2 2.0 4.2 0.5 1.4 0.7 4.7 0.1 4.2 1.6 13.1 4.7 2.3 2.5 0.6 1.4 1.1 0.0 2.1 0.5 1.1 4.6 5.2 2.8 4.1 0.9 0.0 19.4 0.2 1.9 3.5 4.2 3.0 0.7 3.3 1.6 0.0 0.0 0.5 9.0 8.3 3.6 0.0 1.2 0.0 4.0 4.1 2.5 1.0 2.5 3.4 1.5 2.3 2.7 2.3 0.0 1.3 6.2 2.5 2.1 1.5 7.8 12.4 8.9 7.5 7.7 4.6 7.7 9.0 6.7 7.4 6.0 7.8 8.3 3.1 2.3 31.1 15.3 45.9 12.0 10.3 14.0 29.5 1.8 8.3 16.1 2.4 5.5 19.2 0.0 19.5 1.7 8.4 5.5 6.9 92.7 11.5 4.8 16.3 9.2 11.2 1.7 4.6 7.1 3.3 0.0 19.1 64.2 11.0 10.5 6.0 31.8 27.1 0.0 10.2 8.1 5.4 2.8 0.8 10.7 8.9 5.0 CYP4X1 MGC40051 ENSG00000186377 "Cytochrome P450 family 4 subfamily X member 1" Q8N118 1 47023568-47050751 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 38.1" "Cell type enriched" "Detected in many" 6 "Ciliated cells: 156.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 3.7;CACO-2: 6.2;NTERA-2: 2.9;SCLC-21H: 3.8;T-47d: 13.5" "Low region specificity" "Detected in all" HPA017661 Approved NA NA "HPA017661: AB_2669633" "unprognostic (1.19e-1)" "unprognostic (2.28e-2)" "unprognostic (1.53e-1)" "unprognostic (1.78e-2)" "unprognostic (9.88e-2)" "unprognostic (1.56e-3)" "unprognostic (2.30e-1)" "unprognostic (2.34e-2)" "unprognostic (1.10e-2)" "unprognostic (2.35e-2)" "unprognostic (1.46e-1)" "unprognostic (2.76e-2)" "unprognostic (3.03e-2)" "unprognostic (1.79e-3)" "unprognostic (3.65e-2)" "unprognostic (8.56e-2)" "unprognostic (5.03e-2)" 7.9 3.6 9.0 1.1 14.9 0.5 16.0 7.1 16.9 38.1 2.0 1.6 2.5 2.1 3.6 3.2 12.0 9.7 2.0 6.7 4.8 10.6 6.3 10.0 8.9 2.0 3.3 13.5 1.7 2.0 2.0 4.1 1.5 7.8 8.0 2.3 17.6 23.7 3.4 4.5 5.0 1.8 2.4 2.0 1.0 14.3 4.2 0.9 0.0 4.0 6.9 8.8 3.9 5.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.1 0.0 0.1 0.0 0.0 6.2 0.0 0.0 0.7 0.0 1.7 0.0 0.0 0.0 0.0 0.5 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.2 0.0 0.0 0.9 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 2.9 1.0 0.0 0.0 0.5 0.0 0.6 0.2 3.8 0.0 0.0 0.3 0.0 0.2 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 14.9 7.1 16.9 4.8 10.6 3.3 13.5 7.8 0.9 20.8 10.5 0.0 23.5 2.3 0.9 1.0 0.0 156.6 27.3 0.0 0.0 0.0 0.0 0.3 6.0 2.3 0.0 0.0 0.6 0.0 1.9 10.7 0.0 2.5 2.9 0.0 0.0 0.6 0.3 5.6 9.8 0.6 5.0 0.0 0.0 0.0 0.2 0.0 19.4 1.3 0.7 0.0 14.5 0.0 1.5 1.3 0.1 0.0 0.6 26.2 CYP4Z1 CYP4A20 ENSG00000186160 "Cytochrome P450 family 4 subfamily Z member 1" Q86W10 1 47067488-47118319 "Enzymes, Predicted membrane proteins" "Monooxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "breast: 23.1" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 1: 8.9" "Cancer enriched" "Detected in some" 50 "breast cancer: 42.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 39 "HDLM-2: 13.7;SK-BR-3: 5.9" NA NA "unprognostic (4.11e-2)" "unprognostic (2.57e-2)" "unprognostic (2.46e-1)" "unprognostic (5.12e-2)" "unprognostic (1.37e-1)" "unprognostic (4.33e-4)" "unprognostic (1.10e-1)" "unprognostic (3.53e-3)" "unprognostic (7.76e-3)" "unprognostic (1.21e-1)" "unprognostic (3.53e-1)" "unprognostic (6.82e-3)" "unprognostic (5.09e-3)" "unprognostic (3.88e-2)" "unprognostic (6.46e-2)" "unprognostic (3.49e-3)" 2.5 0.2 0.4 0.4 0.9 0.0 23.1 0.4 2.0 1.0 0.4 0.4 0.4 0.0 0.4 0.8 0.8 0.7 0.4 0.4 0.4 1.8 0.4 1.5 2.1 0.4 0.4 0.4 0.4 0.4 0.3 0.4 0.4 0.7 1.3 0.0 0.4 1.5 0.8 0.5 2.2 0.4 0.4 0.4 0.4 0.2 1.0 0.4 0.6 0.4 0.4 0.5 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.4 2.0 0.4 1.8 0.4 0.4 0.7 0.4 8.9 0.6 0.0 0.4 0.1 0.0 0.2 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 CYP7B1 SPG5A ENSG00000172817 "Cytochrome P450 family 7 subfamily B member 1" O75881 8 64587763-64798761 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism" "Monooxygenase, Oxidoreductase" "Disease mutation, Hereditary spastic paraplegia, Intrahepatic cholestasis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Melanocytes: 16.9;Smooth muscle cells: 16.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 36 "basophil: 6.4;eosinophil: 6.2" "Lineage enriched" "Detected in single" 36 "granulocytes: 6.4" "Cell line enhanced" "Detected in some" "HSkMC: 16.9;NTERA-2: 3.2;SH-SY5Y: 6.2;WM-115: 12.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017761 Uncertain NA NA "HPA017761: AB_1847455" "unprognostic (3.19e-2)" "unprognostic (1.91e-1)" "unprognostic (1.50e-1)" "unprognostic (6.89e-3)" "unprognostic (1.07e-1)" "unprognostic (5.80e-3)" "unprognostic (3.80e-1)" "unprognostic (5.50e-2)" "unprognostic (6.11e-3)" "unprognostic (2.46e-1)" "unprognostic (1.61e-1)" "unprognostic (3.19e-2)" "unprognostic (1.87e-2)" "unprognostic (2.38e-3)" "unprognostic (4.00e-1)" "unprognostic (3.04e-3)" "unprognostic (6.75e-3)" 10.1 8.5 5.0 7.5 12.2 0.8 9.8 2.1 10.8 8.7 3.8 20.7 3.5 2.4 4.1 3.9 10.8 5.4 8.0 6.6 5.8 4.2 10.0 24.6 11.0 5.7 5.0 7.8 5.6 8.2 31.0 4.4 1.7 13.5 5.8 4.8 7.3 6.6 7.1 1.8 6.7 3.5 6.1 12.6 19.1 3.9 3.2 7.5 0.2 16.2 5.5 3.8 8.4 10.1 0.0 0.1 6.4 0.0 0.0 0.1 0.0 1.9 0.8 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.1 6.2 0.0 0.1 2.6 1.1 0.0 1.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.5 6.4 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.0 12.2 2.1 10.8 5.8 4.2 5.0 7.8 13.5 7.5 0.0 4.3 0.0 6.1 9.4 5.5 2.0 0.0 1.4 1.2 7.0 2.0 0.0 3.3 3.3 6.0 1.4 0.0 0.0 4.4 0.1 7.2 3.7 12.7 7.8 0.2 3.2 1.7 2.5 0.3 5.7 5.5 0.0 16.9 1.8 0.0 8.1 1.4 0.0 4.6 2.9 0.5 12.9 16.1 1.7 3.0 11.0 0.0 1.0 0.0 2.6 EHHADH ECHD ENSG00000113790 "Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase" Q08426 3 185190624-185281990 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "kidney: 37.1;liver: 91.2" "Group enriched" "Detected in many" 7 "Hepatocytes: 227.5;Proximal tubular cells: 124.0" "Group enriched" "Detected in all" 7 "liver cancer: 42.2;renal cancer: 25.4" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 16.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036401, HPA042021" Enhanced NA NA "HPA036401: AB_10670165, HPA042021: AB_2677801" "unprognostic (1.20e-1)" "unprognostic (5.99e-2)" "unprognostic (2.17e-3)" "unprognostic (2.69e-2)" "unprognostic (6.82e-2)" "unprognostic (1.48e-1)" "unprognostic (4.79e-3)" "unprognostic (1.25e-1)" "unprognostic (1.73e-1)" "unprognostic (3.89e-2)" "unprognostic (3.19e-3)" "unprognostic (1.87e-1)" "prognostic favorable (1.28e-5)" "unprognostic (1.93e-1)" "unprognostic (1.53e-1)" "unprognostic (2.96e-2)" "unprognostic (2.80e-1)" 4.1 1.2 1.2 1.7 1.4 0.1 1.5 0.5 1.2 1.7 6.4 0.8 0.4 5.2 1.0 2.0 2.9 0.8 3.0 3.2 1.2 0.9 37.1 91.2 1.9 1.0 1.7 0.7 0.8 2.5 2.7 0.9 1.3 2.1 1.7 2.6 8.3 2.7 0.4 0.7 1.1 9.9 1.0 1.4 1.7 2.4 0.9 0.9 1.4 2.1 1.7 1.2 1.8 1.0 1.5 6.0 0.2 2.2 2.7 2.7 1.1 8.3 3.5 1.0 0.0 5.3 4.5 1.1 4.0 1.2 2.6 3.0 15.2 5.3 0.0 15.9 4.0 1.0 4.1 0.0 3.3 5.5 11.1 3.7 5.9 0.9 15.4 3.5 0.7 0.1 6.4 4.3 2.7 2.4 3.6 3.8 0.0 3.8 4.3 5.0 4.3 0.1 3.5 2.1 3.0 4.4 0.0 7.1 0.3 11.0 4.7 3.2 4.6 7.8 4.6 7.3 9.1 16.8 6.9 1.8 1.7 2.6 1.3 0.3 1.2 3.8 0.3 0.6 2.6 2.8 0.2 2.2 0.0 1.6 2.1 1.0 1.5 1.1 2.4 6.0 0.2 1.6 2.7 0.1 2.7 2.0 2.4 1.4 1.1 1.2 1.4 0.5 1.2 1.2 0.9 1.7 0.7 2.1 0.9 14.9 7.5 13.7 1.5 1.3 0.2 17.9 25.5 4.0 4.5 19.2 3.9 7.2 16.6 2.0 0.1 2.8 13.8 0.0 5.9 2.1 1.5 1.8 0.0 227.5 3.7 0.0 7.5 12.3 12.4 0.0 0.6 1.3 3.3 15.4 11.6 1.7 3.3 8.6 0.4 124.0 0.9 0.0 2.0 3.9 4.1 0.4 1.1 3.2 10.6 1.6 HADH "HADH1, HADHSC, SCHAD" ENSG00000138796 "Hydroxyacyl-CoA dehydrogenase" Q16836 4 107989714-108035175 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 98.3" "Cell type enhanced" "Detected in all" 4 "Enterocytes: 244.0;Hepatocytes: 229.1;Proximal tubular cells: 241.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039588, HPA043888" Supported Supported Mitochondria No No 8700000 Mitochondria "HPA039588: AB_10673425, HPA043888: AB_2678716" "unprognostic (1.73e-1)" "unprognostic (3.32e-3)" "unprognostic (3.05e-3)" "unprognostic (8.86e-3)" "unprognostic (1.83e-1)" "unprognostic (6.83e-2)" "unprognostic (9.26e-3)" "unprognostic (1.55e-2)" "unprognostic (9.22e-2)" "unprognostic (3.24e-2)" "unprognostic (2.96e-1)" "unprognostic (1.18e-2)" "prognostic favorable (0.00e+0)" "unprognostic (1.67e-1)" "unprognostic (4.22e-2)" "unprognostic (5.67e-2)" "unprognostic (1.88e-2)" 36.6 19.5 8.5 15.6 9.2 6.1 41.7 5.4 9.7 15.2 29.7 10.6 9.4 23.3 18.3 13.3 20.5 15.7 12.4 98.3 7.8 8.1 37.2 60.3 10.6 8.8 10.0 7.0 17.1 17.8 9.8 6.8 5.1 9.2 15.6 25.0 11.6 20.4 12.5 64.6 9.0 37.1 19.6 10.2 8.0 19.1 12.6 7.2 40.9 16.1 38.0 13.1 14.2 10.6 18.6 22.6 5.6 10.7 20.2 13.0 8.9 8.7 8.2 17.7 12.9 42.7 13.8 8.6 12.9 19.2 14.0 13.8 5.9 16.5 49.8 6.9 10.5 9.1 11.8 23.6 17.8 15.5 15.2 12.3 11.6 15.6 13.0 6.8 24.4 5.4 14.3 9.5 9.9 9.1 11.5 9.4 35.0 14.3 26.5 15.8 15.9 41.4 9.7 8.4 38.7 10.9 31.6 24.9 24.9 15.1 35.6 21.5 12.3 12.4 44.5 12.7 10.8 21.2 19.3 5.2 9.9 5.6 13.9 7.0 15.0 17.3 21.6 13.5 16.6 7.6 0.0 6.1 5.6 10.1 7.8 12.5 18.6 11.4 12.1 19.7 15.5 13.0 13.0 0.7 20.2 10.7 22.6 10.0 8.9 8.5 9.2 5.4 9.7 7.8 8.1 10.0 7.0 9.2 7.2 26.8 26.0 29.0 45.8 13.9 7.3 194.2 61.1 81.7 36.4 33.2 3.9 27.5 135.9 37.9 159.1 14.3 244.0 46.7 28.1 33.2 15.5 29.6 10.4 229.1 96.2 6.4 31.2 19.0 32.4 78.4 42.8 17.2 20.3 6.4 71.1 24.6 30.7 84.2 33.2 241.4 5.7 38.8 30.8 25.1 20.1 15.8 14.2 16.2 172.2 38.7 HADHA "GBP, LCEH, LCHAD, MTPA" ENSG00000084754 "Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha" P40939 2 26190635-26244726 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Lyase, Multifunctional enzyme, Oxidoreductase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015536, HPA056070" Approved Enhanced Mitochondria NA NA 2700000 Mitochondria "HPA015536: AB_1850473, HPA056070: AB_2683026" "unprognostic (2.02e-1)" "unprognostic (1.38e-2)" "unprognostic (2.55e-1)" "unprognostic (3.43e-1)" "unprognostic (2.67e-2)" "unprognostic (3.23e-2)" "unprognostic (1.25e-2)" "unprognostic (2.02e-1)" "unprognostic (5.16e-2)" "unprognostic (3.45e-1)" "unprognostic (3.81e-1)" "unprognostic (1.16e-1)" "prognostic favorable (3.68e-5)" "unprognostic (7.97e-2)" "unprognostic (1.71e-1)" "unprognostic (2.87e-3)" "unprognostic (2.64e-2)" 41.6 35.3 18.1 13.1 19.5 17.0 23.9 17.4 16.9 20.2 44.9 26.5 15.7 48.1 21.1 15.3 30.8 20.5 15.1 80.0 15.6 15.5 41.3 71.7 17.7 19.3 21.6 13.1 27.3 37.5 29.8 23.5 21.3 24.8 21.9 32.2 23.6 21.1 16.6 117.5 23.3 66.4 25.1 27.8 24.0 24.1 18.7 19.0 25.2 25.1 41.3 24.6 26.9 18.8 15.3 28.9 12.4 32.2 13.5 17.6 26.0 23.6 21.1 13.9 22.7 55.2 34.5 11.8 18.5 20.0 19.1 16.6 26.6 23.0 15.6 12.2 32.6 19.7 15.1 24.3 35.9 17.3 35.0 29.8 23.4 22.4 44.3 19.0 29.4 17.2 35.3 23.6 27.1 27.3 20.0 32.0 16.8 31.8 31.7 24.6 29.0 12.8 33.0 11.9 17.8 40.7 11.9 30.0 33.5 21.9 28.5 9.8 19.5 21.8 22.7 25.1 11.3 12.1 28.6 29.3 11.1 16.5 16.7 13.6 10.4 20.6 27.8 17.4 34.9 13.4 8.1 27.7 12.4 12.3 32.2 14.8 15.3 14.2 15.0 28.9 11.2 16.7 15.3 7.4 13.5 28.0 11.0 17.6 26.0 18.1 19.5 17.4 16.9 15.6 15.5 21.6 13.1 24.8 19.0 83.4 81.9 90.4 122.8 79.0 34.1 285.8 71.4 101.7 126.3 73.3 49.1 149.8 111.0 102.7 26.5 92.1 406.5 23.3 94.5 78.0 88.0 61.7 134.2 168.3 142.3 19.1 87.7 68.7 130.6 58.2 85.7 124.9 77.6 129.0 139.2 61.8 86.9 196.4 79.2 150.1 61.9 51.8 104.9 121.4 35.2 90.3 108.0 105.4 168.5 92.1 HSD11B1 "HSD11, HSD11B, SDR26C1" ENSG00000117594 "Hydroxysteroid 11-beta dehydrogenase 1" P28845 1 209686178-209734950 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "liver: 183.4" "Cell type enriched" "Detected in many" 13 "Hepatocytes: 560.1" "Cancer enriched" "Detected in all" 28 "liver cancer: 197.4" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 9.2" "Lineage enriched" "Detected in single" 20 "T-cells: 9.2" "Cell line enriched" "Detected in some" 5 "ASC diff: 151.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047729 Enhanced NA NA 77000 "HPA047729: AB_2680135" "unprognostic (1.08e-3)" "unprognostic (2.13e-1)" "unprognostic (2.32e-1)" "unprognostic (1.40e-1)" "unprognostic (1.57e-1)" "unprognostic (3.68e-1)" "unprognostic (2.02e-2)" "unprognostic (1.12e-1)" "unprognostic (1.30e-1)" "unprognostic (3.63e-2)" "unprognostic (8.35e-3)" "unprognostic (8.69e-2)" "prognostic unfavorable (1.97e-10)" "unprognostic (3.41e-2)" "unprognostic (3.91e-2)" "unprognostic (6.45e-2)" "unprognostic (1.59e-2)" 4.6 1.6 1.1 3.0 3.1 0.3 2.4 9.9 3.9 0.6 1.0 1.6 2.7 0.5 0.8 8.7 1.5 0.9 1.9 3.0 1.8 0.9 2.6 183.4 7.2 1.3 8.2 2.0 12.6 0.9 0.3 1.5 26.5 3.3 7.1 0.9 1.5 0.6 3.0 1.5 6.3 0.9 2.7 1.3 3.5 1.4 2.3 2.5 0.0 1.0 0.6 0.6 3.9 1.4 0.2 0.0 0.2 0.1 0.4 9.2 0.8 0.0 0.0 0.0 0.0 151.9 15.8 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 31.7 0.0 0.0 0.8 0.0 1.0 0.0 0.1 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 1.2 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.8 0.2 0.0 0.0 0.1 0.0 0.3 0.0 0.6 0.2 9.2 2.0 0.0 0.0 0.2 0.0 0.2 0.4 0.0 0.0 2.4 0.8 1.1 3.1 9.9 3.9 1.8 0.9 8.2 2.0 3.3 2.5 3.0 0.0 2.4 0.5 0.1 0.0 0.8 43.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 10.8 0.5 0.0 560.1 8.7 0.0 0.0 8.6 8.9 2.2 27.0 2.2 0.0 1.0 0.0 15.4 0.2 0.0 7.4 0.0 0.3 0.0 2.1 0.0 0.2 0.1 0.2 0.5 0.0 1.6 HSD11B2 SDR9C3 ENSG00000176387 "Hydroxysteroid 11-beta dehydrogenase 2" P80365 16 67430652-67437553 "Disease related genes, Predicted membrane proteins" Oxidoreductase "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 62.8;kidney: 119.9;salivary gland: 66.0" "Group enriched" "Detected in many" 5 "Collecting duct cells: 181.5;Enterocytes: 273.5;Mucus-secreting cells: 229.5;Paneth cells: 137.2;Syncytiotrophoblasts: 95.8;Undifferentiated cells: 114.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NTERA-2: 8.7;OE19: 21.3;RPMI-8226: 10.2;RT4: 10.3;SCLC-21H: 11.4;SK-BR-3: 10.2" "Not detected" "Not detected" "Not detected" "Not detected" "CAB032443, HPA042186, HPA056385" Enhanced Approved "Nucleoplasm,Lipid droplets" NA NA "Lipid droplets" Nucleoplasm "CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110" "unprognostic (2.87e-3)" "unprognostic (5.24e-2)" "unprognostic (7.10e-2)" "unprognostic (6.55e-2)" "unprognostic (9.29e-3)" "unprognostic (3.14e-1)" "unprognostic (2.68e-2)" "unprognostic (2.07e-1)" "unprognostic (2.21e-3)" "unprognostic (2.25e-3)" "unprognostic (3.27e-2)" "unprognostic (2.34e-1)" "prognostic favorable (9.51e-5)" "unprognostic (7.20e-2)" "unprognostic (3.19e-1)" "unprognostic (1.55e-2)" "unprognostic (1.84e-1)" 0.4 1.0 0.6 22.2 2.3 0.0 3.2 2.0 1.7 4.8 42.8 0.3 1.3 9.4 3.8 3.6 2.5 2.4 8.3 0.5 0.5 0.1 119.9 1.2 2.3 0.7 0.3 0.8 4.8 2.1 0.0 0.4 42.3 1.1 3.7 24.5 0.4 66.0 1.4 0.4 13.8 62.8 4.3 0.3 1.5 2.1 1.4 1.3 0.5 3.8 3.3 1.6 1.5 4.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 2.6 0.8 0.3 1.1 0.1 1.3 2.8 0.0 0.0 0.1 0.1 4.5 1.0 0.0 2.1 0.0 0.1 5.8 3.9 0.4 0.0 0.0 1.3 0.0 0.5 4.8 0.4 0.5 0.0 1.3 2.3 0.2 0.0 0.0 0.0 3.5 0.3 0.0 0.0 2.8 0.1 0.1 8.7 21.3 0.7 0.0 0.1 10.2 0.4 10.3 11.4 0.7 0.6 10.2 0.4 1.0 4.9 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 2.3 2.0 1.7 0.5 0.1 0.3 0.8 1.1 1.3 0.0 0.3 0.0 8.0 1.3 0.0 0.5 33.1 0.0 1.2 181.5 0.0 0.8 38.1 1.7 0.1 0.0 273.5 0.0 2.7 0.7 3.1 15.6 9.2 1.3 1.3 0.0 25.8 1.3 0.0 0.0 23.6 0.0 1.7 0.0 229.5 0.0 0.8 137.2 6.3 14.6 0.0 12.9 0.4 0.2 1.0 3.0 95.8 0.0 114.3 5.7 HSD17B1 "EDH17B2, EDHB17, HSD17, MGC138140, SDR28C1" ENSG00000108786 "Hydroxysteroid 17-beta dehydrogenase 1" P14061 17 42549214-42555213 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "placenta: 217.6" "Cell type enriched" "Detected in many" 5 "Syncytiotrophoblasts: 1251.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 8 "BEWO: 89.7" "Low region specificity" "Detected in single" "HPA021032, HPA065296" Enhanced Supported Cytosol NA NA Cytosol "HPA021032: AB_1844345, HPA065296: AB_2685457" "unprognostic (1.13e-1)" "unprognostic (1.40e-2)" "unprognostic (1.68e-2)" "unprognostic (9.25e-2)" "unprognostic (1.73e-1)" "unprognostic (3.88e-2)" "unprognostic (1.14e-1)" "unprognostic (1.10e-1)" "unprognostic (9.35e-2)" "unprognostic (6.04e-2)" "unprognostic (2.88e-5)" "unprognostic (2.17e-1)" "unprognostic (1.30e-1)" "unprognostic (2.60e-2)" "unprognostic (5.09e-1)" "unprognostic (4.98e-1)" "unprognostic (1.32e-2)" 2.8 1.5 2.0 1.7 2.1 1.1 1.8 2.7 3.1 1.3 1.3 1.3 1.3 1.9 1.5 1.3 4.3 1.4 1.3 1.4 2.4 1.4 1.4 1.3 1.3 1.6 2.4 1.3 5.8 2.6 0.2 1.4 217.6 1.3 1.5 0.2 1.3 2.9 1.3 3.5 4.1 1.9 1.3 1.9 2.1 2.0 2.3 1.3 1.3 1.8 1.3 1.3 1.3 1.8 6.0 5.5 7.5 8.6 6.1 5.4 5.5 1.6 1.8 0.9 4.6 0.6 0.1 89.7 1.2 0.0 0.0 0.0 1.0 0.9 0.0 1.2 0.0 1.0 2.6 0.1 0.7 0.0 2.4 2.8 1.2 1.1 1.5 0.2 1.0 1.4 0.2 2.6 0.1 0.5 1.5 0.0 1.3 1.7 0.4 0.0 1.6 1.3 1.1 0.4 0.6 0.8 1.3 1.1 0.8 0.1 1.4 1.3 1.8 0.7 9.1 1.4 1.0 11.0 0.8 1.4 1.4 1.8 1.0 0.8 2.6 1.5 0.6 0.6 0.9 1.1 3.6 7.6 7.5 4.9 8.6 5.3 5.6 5.4 5.1 5.5 6.0 5.1 4.4 7.2 6.1 5.3 4.3 3.7 5.5 2.0 2.1 2.7 1.5 2.4 1.4 2.4 1.3 1.3 1.3 0.0 2.1 0.5 6.3 2.7 8.7 2.4 2.5 4.0 2.3 5.2 11.8 250.4 19.9 1.5 1.0 4.1 3.2 0.0 4.9 23.6 3.4 13.0 2.3 5.6 26.4 9.5 4.1 4.9 0.8 1.7 1.7 0.5 1.7 1.0 2.4 9.0 2.0 2.5 3.2 10.5 8.2 0.0 2.8 0.7 2.6 6.5 1251.0 1.3 1.9 8.4 HSD17B10 "17b-HSD10, ABAD, CAMR, ERAB, HADH2, MHBD, MRPP2, MRXS10, SDR5C1" ENSG00000072506 "Hydroxysteroid 17-beta dehydrogenase 10" Q99714 X 53431258-53434373 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "tRNA processing" Oxidoreductase "Disease mutation, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Hepatocytes: 343.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001432 Approved NA NA 1800000 "HPA001432: AB_1078740" "unprognostic (1.27e-1)" "prognostic favorable (2.80e-4)" "unprognostic (2.60e-1)" "unprognostic (2.15e-1)" "unprognostic (2.10e-1)" "unprognostic (1.30e-1)" "unprognostic (8.37e-2)" "unprognostic (5.24e-2)" "unprognostic (1.02e-1)" "unprognostic (8.64e-3)" "unprognostic (4.08e-3)" "unprognostic (2.04e-1)" "unprognostic (1.95e-2)" "unprognostic (8.38e-2)" "unprognostic (3.07e-3)" "unprognostic (2.92e-1)" "unprognostic (9.51e-2)" 20.9 29.8 13.2 19.1 14.5 16.4 15.9 7.9 14.0 16.9 20.6 16.2 20.2 17.2 17.1 19.0 31.3 14.8 19.6 42.6 11.9 14.0 33.9 96.7 12.7 21.6 16.1 9.7 21.0 32.7 12.5 18.4 25.0 14.9 15.3 19.4 13.0 23.2 17.8 35.4 22.9 17.4 18.6 14.8 19.7 17.4 8.6 14.0 25.6 28.4 39.0 26.0 16.1 17.9 30.4 53.2 12.8 38.2 27.7 33.3 32.9 22.3 38.3 18.7 34.7 18.4 8.1 28.3 13.9 13.9 37.1 24.4 39.3 19.3 38.2 12.7 15.9 24.1 23.5 60.2 28.1 20.4 30.2 33.8 18.0 54.9 32.5 30.9 33.9 28.2 17.3 26.7 28.7 16.1 8.1 27.1 34.4 25.7 30.3 17.2 78.9 30.0 51.0 51.8 30.3 49.5 30.7 34.6 67.6 28.5 24.8 33.1 43.6 40.0 47.9 25.3 24.9 50.4 31.6 12.1 15.9 25.3 33.1 21.0 24.8 34.5 47.2 22.1 71.4 23.4 12.8 38.2 11.4 27.0 36.7 27.8 30.0 25.1 26.7 53.2 30.4 21.1 22.2 3.2 27.7 26.8 29.0 33.3 32.9 13.2 14.5 7.9 14.0 11.9 14.0 16.1 9.7 14.9 14.0 44.7 34.1 58.8 68.9 76.7 11.0 53.6 96.8 29.4 30.7 96.0 3.9 152.6 240.4 110.3 1.3 54.5 72.5 116.8 117.5 226.1 88.0 68.7 56.4 343.1 121.0 12.7 100.4 52.8 71.2 4.5 72.5 86.0 91.1 131.7 59.9 45.2 90.4 42.1 89.1 333.9 11.4 77.6 85.6 15.1 62.3 101.6 126.8 78.8 78.6 62.3 HSD17B11 "17-BETA-HSD11, 17-BETA-HSDXI, DHRS8, PAN1B, RetSDR2, SDR16C2" ENSG00000198189 "Hydroxysteroid 17-beta dehydrogenase 11" Q8NBQ5 4 87336610-87391386 "Enzymes, Predicted intracellular proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 100.1;intestine: 81.3" "Cell type enhanced" "Detected in many" 5 "Enterocytes: 489.8;Paneth cells: 501.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 100.1" "Group enriched" "Detected in all" 4 "granulocytes: 100.1;monocytes: 25.8" "Cell line enhanced" "Detected in many" "CAPAN-2: 68.5" "Low region specificity" "Detected in all" HPA021608 Enhanced Supported "Lipid droplets" "Intracellular and membrane" NA NA 14000 "Lipid droplets" "HPA021608: AB_1847660" "unprognostic (4.53e-2)" "unprognostic (1.61e-1)" "unprognostic (2.35e-2)" "unprognostic (4.14e-2)" "unprognostic (9.68e-2)" "unprognostic (1.92e-1)" "unprognostic (3.35e-1)" "unprognostic (3.70e-2)" "unprognostic (1.78e-1)" "unprognostic (8.53e-2)" "unprognostic (1.24e-3)" "unprognostic (1.83e-1)" "unprognostic (2.65e-3)" "unprognostic (5.53e-2)" "unprognostic (2.13e-2)" "unprognostic (2.44e-2)" "unprognostic (1.04e-2)" 22.0 23.8 11.1 15.5 8.4 23.6 18.9 23.8 12.8 19.6 58.3 7.2 9.5 53.0 19.1 15.7 6.5 14.6 26.3 9.0 10.1 6.4 18.1 57.4 25.3 14.7 14.2 7.9 18.0 24.5 3.0 12.6 11.4 9.7 15.5 36.2 5.7 6.7 9.0 6.4 6.2 81.3 15.2 14.2 12.2 11.6 11.6 10.6 15.8 8.1 8.4 8.2 21.0 15.9 7.7 14.2 100.1 25.8 10.4 10.3 18.7 0.2 10.7 5.2 13.1 16.1 22.2 7.4 5.8 9.1 3.8 7.0 8.9 68.5 0.0 11.2 5.9 3.6 0.2 15.2 1.2 4.2 16.9 3.2 14.7 5.9 30.0 9.1 26.2 27.5 15.7 0.4 5.2 1.8 12.1 7.3 6.4 15.3 7.6 7.0 0.4 5.3 32.1 8.9 33.3 1.8 14.7 4.8 17.3 10.5 16.4 1.7 16.7 11.4 0.3 19.5 7.0 0.0 25.6 6.1 2.6 11.8 10.5 3.0 3.7 1.5 1.6 4.9 18.6 17.8 61.0 25.8 55.9 8.7 18.4 10.3 7.7 8.8 9.0 14.2 6.6 8.1 9.0 100.1 10.4 15.2 4.8 9.9 18.7 11.1 8.4 23.8 12.8 10.1 6.4 14.2 7.9 9.7 10.6 291.8 133.2 72.8 64.6 24.8 1.2 4.4 310.8 75.0 111.5 41.8 2.0 27.4 21.6 38.6 0.9 71.4 489.8 0.0 51.8 45.8 75.4 36.7 98.1 303.2 118.3 17.5 90.0 101.9 213.8 0.9 96.4 169.0 64.1 36.1 155.1 34.2 52.9 501.0 55.9 148.1 3.9 71.1 54.2 2.6 13.1 18.7 12.5 110.7 226.2 80.0 HSD17B12 "KAR, SDR12C1" ENSG00000149084 "Hydroxysteroid 17-beta dehydrogenase 12" Q53GQ0 11 43680558-43856617 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016427 Approved NA NA 200000 "HPA016427: AB_1844347" "unprognostic (1.93e-1)" "unprognostic (1.92e-2)" "unprognostic (1.53e-1)" "unprognostic (1.62e-2)" "unprognostic (1.10e-1)" "unprognostic (1.14e-3)" "prognostic unfavorable (2.76e-4)" "unprognostic (2.99e-1)" "unprognostic (3.31e-2)" "unprognostic (9.16e-3)" "unprognostic (5.16e-2)" "unprognostic (7.54e-2)" "prognostic favorable (2.10e-8)" "unprognostic (6.87e-2)" "unprognostic (1.49e-1)" "unprognostic (2.43e-1)" "unprognostic (2.28e-2)" 27.2 32.6 33.5 16.6 31.9 10.5 30.4 12.8 33.1 26.3 30.7 31.4 29.3 32.0 22.3 25.3 24.3 20.1 28.0 36.9 30.9 31.1 42.9 59.8 25.8 19.9 38.5 21.4 22.4 26.4 66.6 29.4 19.4 45.7 26.4 29.4 26.6 25.3 22.9 16.1 18.2 30.8 23.3 44.9 23.5 25.6 17.6 24.4 15.2 32.4 32.5 17.5 19.4 18.6 12.8 18.7 9.8 12.7 13.5 15.0 9.6 9.0 14.8 16.5 16.7 55.3 52.6 10.8 23.4 23.1 16.3 17.8 17.9 19.1 22.7 16.6 21.0 27.0 35.7 11.5 29.5 20.2 4.2 21.3 10.5 8.3 15.6 28.1 32.5 30.1 32.3 22.7 16.4 46.8 20.8 22.5 14.3 9.9 37.9 14.0 5.2 8.6 14.5 30.2 11.4 10.8 14.6 24.5 25.6 31.1 22.4 6.0 13.6 31.3 26.4 22.8 16.2 18.9 26.2 21.5 17.6 6.9 45.7 27.3 19.5 24.5 13.6 19.1 5.8 13.2 6.1 12.2 5.5 11.0 12.7 11.7 11.0 8.8 9.2 18.7 12.8 15.0 12.9 9.8 13.5 6.5 15.1 5.0 9.6 33.5 31.9 12.8 30.8 30.9 31.1 38.5 21.4 45.7 24.4 59.6 94.5 60.7 41.7 28.2 71.5 81.5 76.5 89.7 64.8 48.8 72.6 50.4 23.2 87.7 47.4 65.0 71.5 23.3 72.4 37.6 41.7 54.4 152.4 109.0 55.3 114.4 132.6 70.0 43.0 14.4 31.7 49.6 37.1 32.5 68.5 118.3 65.6 45.6 53.4 39.7 63.0 77.6 48.4 11.4 11.5 40.0 62.6 27.4 93.1 38.3 HSD17B2 "HSD17, SDR9C2" ENSG00000086696 "Hydroxysteroid 17-beta dehydrogenase 2" P37059 16 82035004-82098534 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 83.1;liver: 52.9;placenta: 110.8" "Cell type enhanced" "Detected in many" 14 "Cholangiocytes: 137.6;Enterocytes: 250.1;Hepatocytes: 98.5;Paneth cells: 199.9" "Cancer enhanced" "Detected in many" "liver cancer: 10.9" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BJ hTERT+: 22.4;Hep G2: 17.8;hTERT-HME1: 10.7;OE19: 32.8;RT4: 36.8;TIME: 20.6" "Group enriched" "Detected in some" 5 "midbrain: 2.6;pons and medulla: 3.5" "Not detected" "Not detected" "HPA021826, HPA050235" Enhanced Approved "Endoplasmic reticulum" NA NA "Endoplasmic reticulum" "HPA021826: AB_10961148, HPA050235: AB_2681059" "unprognostic (1.50e-1)" "unprognostic (2.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.48e-2)" "unprognostic (2.58e-1)" "unprognostic (1.77e-1)" "unprognostic (4.29e-2)" "unprognostic (2.60e-1)" "unprognostic (7.35e-2)" "unprognostic (6.05e-3)" "unprognostic (4.98e-2)" "unprognostic (7.35e-2)" "unprognostic (6.31e-4)" "unprognostic (5.39e-2)" "unprognostic (1.14e-1)" "unprognostic (4.30e-2)" "prognostic favorable (3.83e-4)" 0.7 0.1 0.2 4.1 0.2 0.0 3.9 0.2 0.3 0.7 41.3 0.3 0.2 71.3 0.6 0.2 1.7 0.2 13.3 0.2 0.2 0.2 2.8 52.9 1.0 0.2 0.2 0.2 0.2 16.0 0.0 0.6 110.8 0.4 3.1 9.4 21.3 9.4 0.2 0.3 1.8 83.1 1.5 0.2 0.2 3.2 0.2 0.2 0.2 0.2 1.1 1.3 21.4 6.6 1.3 1.4 3.6 1.1 1.0 0.7 0.1 0.1 0.0 0.1 0.0 0.0 0.3 0.2 0.0 22.4 0.0 0.0 4.1 0.6 0.0 4.5 0.0 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.1 0.1 17.8 0.1 0.1 0.1 0.0 1.2 0.0 10.7 0.2 0.3 0.0 0.0 0.1 3.3 0.0 0.0 0.3 0.1 32.8 8.1 0.0 0.0 0.4 0.4 36.8 0.2 0.6 0.0 1.0 0.1 0.0 0.0 0.0 20.6 0.2 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 1.6 1.1 0.6 0.7 0.5 0.4 0.6 0.4 0.4 0.3 1.3 0.4 0.6 3.6 1.0 0.6 1.4 0.3 0.1 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.4 0.2 3.0 3.8 0.0 2.7 0.3 0.1 0.4 137.6 6.7 2.3 0.0 0.0 2.1 0.0 47.5 0.1 0.2 250.1 0.0 5.5 1.5 3.1 1.8 0.0 98.5 3.0 0.0 2.9 3.1 2.4 0.8 0.0 0.0 1.7 0.0 19.3 42.0 13.6 199.9 0.0 1.0 0.6 0.0 0.3 0.0 0.0 1.0 5.4 0.0 33.8 10.0 HSD17B4 "DBP, MFE-2, SDR8C1" ENSG00000133835 "Hydroxysteroid 17-beta dehydrogenase 4" P51659 5 119452443-119637199 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Isomerase, Lyase, Oxidoreductase" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Hepatocytes: 203.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021302, HPA021311, HPA021479" Enhanced Enhanced Peroxisomes NA NA 6900000 Peroxisomes "HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352" "unprognostic (1.03e-1)" "unprognostic (1.05e-1)" "prognostic favorable (1.33e-4)" "unprognostic (3.21e-2)" "unprognostic (1.24e-2)" "unprognostic (3.12e-2)" "unprognostic (2.83e-3)" "unprognostic (5.47e-2)" "unprognostic (1.54e-1)" "unprognostic (2.03e-2)" "unprognostic (1.02e-1)" "unprognostic (3.85e-1)" "prognostic favorable (6.31e-6)" "unprognostic (1.60e-1)" "unprognostic (8.26e-2)" "unprognostic (1.80e-1)" "unprognostic (6.65e-3)" 25.1 42.4 22.1 15.5 21.3 6.4 46.0 12.3 23.6 27.8 30.1 24.1 83.8 28.6 16.2 20.7 24.6 15.1 20.6 27.3 23.8 21.2 31.3 116.3 30.5 16.7 27.0 21.7 15.1 29.9 33.2 20.5 19.0 23.9 20.9 25.2 10.7 20.0 86.2 20.7 19.2 30.5 15.6 33.6 16.9 20.7 8.1 25.5 10.8 48.9 17.3 14.5 24.1 25.3 6.1 11.1 31.4 13.6 3.2 4.2 5.3 17.8 15.4 29.0 38.4 72.4 34.0 15.3 17.4 23.5 16.5 30.1 12.7 29.8 23.9 35.9 18.8 24.3 18.0 21.3 37.9 25.8 26.1 19.7 31.4 16.8 24.2 18.4 9.9 49.2 29.6 15.9 17.7 16.7 19.4 28.2 16.5 10.7 13.9 17.9 15.5 15.1 6.4 21.5 44.1 10.9 19.3 29.1 25.8 26.4 49.4 21.9 18.9 40.9 6.4 19.0 28.7 23.7 16.7 20.0 16.2 11.1 17.8 14.2 7.1 14.8 8.8 18.4 26.5 15.9 31.4 13.6 24.7 3.4 8.0 4.2 6.1 3.2 2.9 11.1 5.8 3.1 2.9 2.4 3.2 7.8 6.9 2.0 5.3 22.1 21.3 12.3 23.6 23.8 21.2 27.0 21.7 23.9 25.5 68.5 94.4 20.8 34.3 13.3 18.5 62.9 81.5 24.1 47.8 34.9 13.7 57.8 71.3 28.8 7.4 26.4 50.3 0.0 31.4 21.8 24.2 32.2 65.9 203.2 70.1 14.3 31.7 31.3 50.9 9.3 31.9 35.3 8.5 103.6 42.6 44.1 23.2 24.6 48.1 50.5 15.4 6.5 20.0 15.9 22.2 15.1 54.3 13.1 51.1 31.4 HSD17B6 "HSE, RODH, SDR9C6" ENSG00000025423 "Hydroxysteroid 17-beta dehydrogenase 6" O14756 12 56752161-56787790 "Enzymes, Predicted intracellular proteins" "Lipid metabolism, Steroid metabolism" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 18 "liver: 241.2" "Cell type enriched" "Detected in many" 10 "Hepatocytes: 1569.2" "Cancer enriched" "Detected in many" 5 "liver cancer: 170.3" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 11.8;U-266/84: 14.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA059141 Enhanced Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA059141: AB_2683922" "unprognostic (7.70e-2)" "unprognostic (8.76e-2)" "unprognostic (5.08e-2)" "unprognostic (1.92e-2)" "unprognostic (2.01e-1)" "unprognostic (3.79e-2)" "prognostic favorable (6.32e-4)" "unprognostic (1.06e-2)" "unprognostic (3.21e-1)" "unprognostic (1.44e-1)" "unprognostic (1.35e-1)" "unprognostic (6.74e-2)" "unprognostic (2.50e-10)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (1.08e-1)" "unprognostic (1.05e-1)" 1.1 0.5 3.6 1.4 5.2 0.2 0.3 1.2 2.4 9.4 3.3 0.5 2.6 0.6 4.1 0.7 1.6 0.9 2.6 0.4 1.6 1.4 0.5 241.2 8.7 0.3 2.0 2.6 1.1 0.3 0.2 0.0 0.9 0.6 7.9 1.3 1.4 0.2 10.2 0.2 0.2 0.7 11.3 1.0 6.2 0.8 3.2 0.8 0.0 13.3 0.0 0.3 9.9 2.3 2.0 2.0 0.1 1.3 0.1 3.4 0.8 0.3 0.7 1.7 0.3 1.7 1.2 2.0 3.6 3.1 1.7 1.7 0.4 0.4 10.2 1.5 0.4 0.5 0.3 5.3 0.9 1.0 6.5 2.0 3.2 1.0 0.5 1.1 1.6 5.3 0.9 0.3 1.0 0.5 0.5 0.0 9.0 0.9 11.8 0.8 2.1 4.6 1.0 6.6 0.6 0.6 6.3 0.7 2.5 0.2 1.2 9.7 2.0 1.7 3.1 0.8 0.6 0.5 1.3 0.3 0.8 0.8 3.6 0.9 10.3 14.6 6.7 1.2 5.9 0.6 0.0 0.2 0.1 3.0 0.6 3.4 2.0 2.5 2.4 0.6 1.1 3.3 2.2 0.0 0.1 1.3 2.0 2.8 0.8 3.6 5.2 1.2 2.4 1.6 1.4 2.0 2.6 0.6 0.8 160.8 89.7 28.7 2.3 1.1 0.2 0.2 35.7 2.7 17.0 0.0 0.0 1.3 0.0 0.0 2.5 0.4 0.0 23.3 0.0 2.4 4.8 9.9 0.0 1569.2 0.3 0.0 0.0 31.3 41.1 1.5 11.5 0.1 0.0 1.8 0.3 1.0 0.1 0.0 1.4 0.0 0.6 12.9 3.7 13.6 10.6 1.4 0.3 4.4 0.3 0.9 HSD17B7 "PRAP, SDR37C1" ENSG00000132196 "Hydroxysteroid 17-beta dehydrogenase 7" P56937 1 162790702-162812817 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 16.3;liver: 16.8" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 58.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047496 Approved NA NA "HPA047496: AB_2680068" "unprognostic (2.93e-1)" "unprognostic (1.36e-2)" "unprognostic (6.03e-2)" "unprognostic (1.12e-1)" "unprognostic (2.34e-1)" "unprognostic (1.63e-3)" "unprognostic (2.57e-1)" "unprognostic (2.51e-2)" "unprognostic (1.36e-1)" "unprognostic (1.38e-1)" "unprognostic (1.94e-1)" "unprognostic (1.37e-1)" "prognostic unfavorable (8.47e-5)" "unprognostic (6.25e-2)" "unprognostic (1.90e-1)" "unprognostic (6.35e-2)" "unprognostic (3.17e-2)" 1.9 9.2 1.4 2.0 1.0 0.7 4.3 1.4 1.9 2.8 2.9 3.1 2.1 4.4 4.7 2.2 1.6 1.6 1.9 2.6 2.2 16.8 4.3 3.7 1.5 3.6 2.6 2.5 4.1 1.8 2.8 4.0 3.1 1.3 2.0 3.6 3.1 1.8 3.2 2.9 2.9 0.6 2.8 3.9 2.2 2.8 12.5 9.6 15.8 7.4 7.0 16.3 10.5 6.3 6.5 17.3 7.7 10.0 10.8 11.3 2.6 8.3 5.1 10.2 9.0 20.6 15.3 5.9 2.2 31.0 10.3 15.7 22.2 5.3 6.7 8.4 3.9 4.9 14.1 8.3 6.9 6.9 6.5 12.4 19.6 6.4 4.0 8.4 10.7 7.3 10.6 4.3 4.5 8.9 7.4 11.0 12.3 8.1 5.0 10.4 9.8 18.0 10.2 14.8 7.7 4.1 4.0 3.9 15.6 6.5 8.8 4.9 2.3 5.6 3.5 5.0 6.5 6.4 15.2 3.7 0.6 5.7 15.8 6.0 11.2 13.9 6.1 14.6 12.5 10.5 13.4 6.5 10.9 13.0 13.1 5.0 7.0 7.4 9.6 16.3 10.5 0.0 23.8 19.9 22.2 9.7 23.0 2.0 15.3 18.7 15.9 10.4 58.9 14.2 3.3 11.4 1.7 11.7 10.9 0.0 23.7 12.6 13.1 20.2 4.7 22.5 11.6 11.1 5.8 7.4 2.8 1.0 6.4 13.0 16.9 10.0 7.9 14.1 12.6 14.0 6.7 9.3 42.9 0.0 11.3 2.1 5.4 11.0 16.0 20.2 8.5 11.5 HSD17B8 "D6S2245E, FABGL, H2-KE6, HKE6, KE6, RING2, SDR30C1" ENSG00000204228 "Hydroxysteroid 17-beta dehydrogenase 8" Q92506 6 33204642-33206831 "Enzymes, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 47.8" "Cell type enhanced" "Detected in many" 5 "Distal tubular cells: 106.1;Proximal tubular cells: 106.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPMI-8226: 14.8;T-47d: 9.6;U-266/70: 14.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042132 Enhanced NA NA 52000 "HPA042132: AB_10793978" "prognostic favorable (9.99e-4)" "unprognostic (4.24e-1)" "unprognostic (2.43e-1)" "unprognostic (1.48e-1)" "unprognostic (2.10e-1)" "unprognostic (8.11e-2)" "prognostic favorable (1.90e-5)" "unprognostic (1.50e-3)" "unprognostic (3.12e-1)" "unprognostic (1.34e-2)" "unprognostic (1.58e-1)" "unprognostic (1.89e-1)" "prognostic favorable (2.18e-12)" "unprognostic (2.82e-2)" "unprognostic (5.57e-1)" "unprognostic (3.09e-1)" "unprognostic (3.23e-2)" 3.5 11.5 4.1 5.4 4.1 3.0 6.1 3.4 5.9 5.3 12.4 5.3 17.7 6.6 3.2 14.7 11.3 8.1 8.6 11.0 4.1 3.7 13.9 24.0 8.1 7.7 5.3 4.6 3.3 47.8 12.8 6.6 3.5 4.7 4.5 5.6 9.3 16.7 30.1 14.6 10.6 11.2 4.1 5.3 5.4 5.8 5.1 2.4 10.3 11.2 15.5 10.7 5.3 5.2 4.8 4.8 0.4 3.1 4.1 7.8 6.0 1.1 2.1 1.0 1.3 0.3 0.6 0.4 0.1 0.7 0.0 0.0 1.5 2.5 7.0 2.0 0.1 0.3 4.2 1.0 3.2 0.1 1.2 1.2 0.3 2.0 3.8 3.0 0.0 0.5 0.7 4.3 0.0 7.4 0.0 0.3 2.5 0.1 6.8 0.6 2.3 5.2 0.1 0.3 3.3 0.9 3.0 0.1 14.8 4.1 0.1 2.0 1.1 0.4 5.6 1.3 0.7 9.6 0.2 0.1 0.2 1.2 0.0 0.0 14.6 7.0 2.6 0.4 0.1 0.2 0.0 1.4 0.4 4.8 3.1 7.8 4.8 7.2 7.3 2.8 3.1 7.6 7.8 0.1 4.1 3.1 4.8 5.2 6.0 4.1 4.1 3.4 5.9 4.1 3.7 5.3 4.6 4.7 2.4 17.9 16.3 6.7 21.5 26.4 10.3 24.3 38.2 26.8 14.8 21.0 5.9 25.7 106.1 24.6 5.1 8.5 30.9 23.3 28.3 10.1 10.0 13.7 6.9 60.4 14.9 1.6 17.2 6.7 8.9 11.1 6.9 10.0 47.2 10.0 23.7 28.7 19.1 21.0 5.6 106.8 11.8 0.0 5.9 7.5 5.5 32.5 14.5 14.0 43.6 21.3 HSD3B1 "HSD3B, HSDB3, SDR11E1" ENSG00000203857 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1" P14060 1 119507198-119515054 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism, Steroidogenesis" "Isomerase, Multifunctional enzyme, Oxidoreductase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 19 "placenta: 231.4" "Group enriched" "Detected in some" 23 "Extravillous trophoblasts: 115.9;Syncytiotrophoblasts: 419.8" "Cancer enhanced" "Detected in single" "urothelial cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "CACO-2: 36.4;SuSa: 16.3" "HPA043261, HPA043264, HPA044028" Supported Approved "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" NA NA "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781" "unprognostic (1.53e-1)" "unprognostic (7.11e-2)" "unprognostic (1.15e-1)" "unprognostic (1.04e-1)" "prognostic favorable (4.59e-5)" 0.1 0.6 0.0 0.0 0.3 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.1 0.5 0.0 0.0 231.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.5 11.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 36.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 4.0 0.4 0.5 16.3 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.7 0.0 0.0 115.9 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 419.8 0.0 0.0 0.0 HSD3B2 SDR11E2 ENSG00000203859 "Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2" P26439 1 119414931-119423035 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Steroidogenesis "Isomerase, Multifunctional enzyme, Oxidoreductase" "Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "adrenal gland: 223.2" "Cell type enhanced" "Detected in some" 17 "Enterocytes: 1.6;Exocrine glandular cells: 1.1;Peritubular cells: 2.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Region enriched" "Detected in single" 198 "basal ganglia: 19.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "SCLC-21H: 1.5;SH-SY5Y: 1.4;SK-MEL-30: 5.1;SuSa: 1.9;TIME: 1.2;WM-115: 3.2" "HPA043261, HPA043264, HPA044028" Supported Uncertain "Nucleoli,Endoplasmic reticulum,Cytokinetic bridge" NA NA "Nucleoli, Endoplasmic reticulum" "Cytokinetic bridge" "HPA043261: AB_2630368, HPA043264: AB_2678398, HPA044028: AB_2678781" "unprognostic (3.56e-1)" "unprognostic (1.85e-1)" "unprognostic (2.80e-1)" "unprognostic (2.72e-2)" "unprognostic (8.87e-2)" "unprognostic (3.91e-2)" "unprognostic (3.43e-2)" "unprognostic (1.94e-1)" "unprognostic (6.51e-2)" "unprognostic (1.97e-2)" "unprognostic (1.55e-1)" 0.0 223.2 0.0 0.8 19.8 0.0 0.0 0.0 0.0 0.0 0.5 43.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 1.9 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 1.4 0.0 0.0 5.1 1.9 0.0 0.0 1.2 0.2 0.1 0.1 0.7 0.0 0.0 0.0 0.8 0.0 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 SRD5A1 ENSG00000145545 "Steroid 5 alpha-reductase 1" P18405 5 6633343-6674386 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Differentiation, Sexual differentiation" Oxidoreductase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 42.4" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 75.4;monocytes: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" HPA051402 Approved NA NA "HPA051402: AB_2681470" "unprognostic (1.40e-2)" "unprognostic (1.33e-2)" "unprognostic (2.30e-3)" "prognostic unfavorable (8.73e-6)" "unprognostic (9.38e-3)" "unprognostic (8.90e-2)" "unprognostic (3.78e-2)" "unprognostic (5.90e-2)" "unprognostic (3.83e-1)" "unprognostic (1.42e-1)" "unprognostic (7.70e-3)" "unprognostic (1.54e-1)" "unprognostic (1.56e-3)" "unprognostic (3.01e-1)" "unprognostic (2.24e-1)" "unprognostic (1.59e-1)" "unprognostic (5.47e-2)" 2.4 3.3 7.7 2.9 8.2 3.2 14.8 9.2 11.8 5.6 5.2 5.3 0.7 5.7 3.1 4.6 24.2 2.9 4.0 1.9 9.3 7.5 6.4 42.4 3.0 3.5 6.2 5.5 4.1 4.3 3.0 1.9 2.1 13.4 2.6 3.6 2.4 5.0 2.1 2.2 17.5 10.4 2.6 3.1 2.9 3.9 2.7 2.9 3.3 2.4 15.3 12.1 2.6 10.1 1.9 3.7 7.0 3.3 1.3 1.3 1.3 5.6 5.5 7.4 6.3 7.1 7.0 3.4 5.4 4.2 5.4 3.4 5.5 5.0 6.8 9.0 7.9 8.8 9.1 6.0 3.6 5.8 4.2 2.6 2.1 13.9 3.4 3.3 3.0 1.8 5.1 10.4 3.8 3.0 4.0 2.6 2.7 3.6 6.3 6.9 6.6 1.4 3.5 4.7 3.7 4.4 4.7 5.7 2.0 7.2 5.2 14.0 6.3 16.6 7.4 5.1 7.7 3.0 0.9 5.5 8.2 4.1 13.3 6.8 3.4 4.5 2.4 6.8 3.6 7.4 7.0 3.3 1.4 1.0 2.4 0.7 1.7 1.0 1.3 3.7 1.9 0.9 1.0 2.0 1.3 2.6 1.8 1.1 1.3 7.7 8.2 9.2 11.8 9.3 7.5 6.2 5.5 13.4 2.9 3.0 2.4 8.2 5.5 16.5 4.4 2.4 5.1 8.1 2.3 5.2 3.9 0.7 6.6 9.1 7.8 3.1 7.8 0.0 4.1 6.1 3.7 6.5 1.1 75.4 12.0 6.4 2.4 4.3 19.6 1.9 3.1 7.9 6.8 55.1 5.6 3.5 6.5 8.7 7.4 19.5 3.7 0.0 4.2 2.7 2.6 26.6 0.7 4.4 11.7 9.6 SRD5A2 ENSG00000277893 "Steroid 5 alpha-reductase 2" P31213 2 31522480-31581067 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Differentiation, Sexual differentiation" Oxidoreductase "Cancer-related genes, Disease mutation, FDA approved drug targets, Pseudohermaphroditism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "epididymis: 17.9;liver: 30.9;prostate: 28.4" "Cell type enhanced" "Detected in some" 23 "Ciliated cells: 13.4;Early spermatids: 70.2;Hepatocytes: 14.7;Late spermatids: 41.4" "Group enriched" "Detected in some" 6 "endometrial cancer: 1.1;liver cancer: 4.2;prostate cancer: 3.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "BJ hTERT+: 2.9;RT4: 5.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "unprognostic (6.75e-3)" "unprognostic (2.00e-2)" "unprognostic (1.66e-1)" "unprognostic (1.08e-3)" "unprognostic (5.92e-3)" "unprognostic (3.37e-2)" "unprognostic (2.79e-3)" "unprognostic (6.56e-2)" "unprognostic (9.10e-2)" "unprognostic (1.39e-2)" "unprognostic (3.06e-2)" "unprognostic (9.79e-3)" "unprognostic (6.61e-6)" "unprognostic (4.37e-2)" "unprognostic (2.04e-1)" "unprognostic (3.85e-1)" "unprognostic (3.48e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 10.1 0.0 0.2 17.9 0.0 10.4 0.0 0.0 0.0 0.0 30.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.4 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.4 0.0 0.3 0.0 0.0 0.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 2.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.1 0.0 0.3 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.4 2.5 13.4 1.2 0.0 0.0 0.0 0.0 0.0 70.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 14.7 0.0 0.0 0.0 0.0 0.0 41.4 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.2 0.0 0.0 0.0 1.1 0.6 0.0 0.0 0.0 0.0 4.7 SRD5A3 "FLJ13352, SRD5A2L, SRD5A2L1" ENSG00000128039 "Steroid 5 alpha-reductase 3" Q9H8P0 4 55346109-55373096 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Cataract, Congenital disorder of glycosylation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 92.9;Extravillous trophoblasts: 88.2;Pancreatic endocrine cells: 133.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 42.6" "Low region specificity" "Detected in all" HPA027006 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA027006: AB_1857469" "unprognostic (1.12e-2)" "unprognostic (1.01e-1)" "unprognostic (4.02e-2)" "prognostic favorable (9.39e-4)" "unprognostic (1.50e-2)" "unprognostic (4.81e-2)" "prognostic unfavorable (1.80e-6)" "unprognostic (9.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.81e-2)" "unprognostic (3.29e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.85e-10)" "unprognostic (4.16e-2)" "unprognostic (1.42e-1)" "unprognostic (1.43e-2)" "unprognostic (9.52e-2)" 13.8 12.2 11.5 5.9 13.4 6.6 17.8 7.3 18.3 22.9 11.3 20.3 3.5 6.9 13.8 9.6 24.4 5.9 22.6 10.5 13.2 10.7 12.3 15.0 12.4 10.1 15.5 12.0 3.5 26.8 14.0 7.0 8.8 13.6 8.9 10.9 6.8 16.3 6.6 5.8 15.6 8.3 6.2 22.1 6.9 13.8 4.0 15.3 10.0 7.6 9.9 12.1 12.1 12.1 5.9 28.4 10.3 25.2 3.6 9.2 10.3 4.8 3.2 5.8 5.5 19.5 12.5 2.9 5.3 6.2 2.2 3.6 3.2 10.1 11.5 6.0 8.3 6.2 3.8 4.1 4.9 2.8 3.3 7.3 6.3 3.6 8.6 5.2 11.6 3.5 11.4 9.1 3.8 3.5 4.8 9.0 21.5 10.7 25.8 12.6 6.3 17.0 5.1 7.3 27.6 4.3 5.5 1.8 6.5 7.4 5.2 9.0 5.0 5.6 42.6 3.8 6.0 5.2 10.2 4.4 14.2 2.6 1.0 4.0 13.8 7.6 4.2 18.0 16.0 13.8 10.3 16.5 4.9 7.9 25.1 9.2 5.9 6.0 7.4 14.1 5.2 5.3 7.1 0.8 3.6 25.2 28.4 5.8 10.3 11.5 13.4 7.3 18.3 13.2 10.7 15.5 12.0 13.6 15.3 8.9 15.7 3.0 9.5 12.0 4.6 4.6 45.9 12.0 12.5 5.2 3.9 22.7 3.3 67.0 2.0 14.3 8.4 0.0 92.9 88.2 17.0 22.1 13.9 17.1 62.0 9.5 11.5 17.8 20.9 0.0 1.7 27.9 23.6 24.4 19.3 18.6 133.4 5.8 5.3 12.2 3.8 12.9 9.5 2.1 18.8 26.0 6.3 4.9 20.9 49.7 STAR "StAR, STARD1" ENSG00000147465 "Steroidogenic acute regulatory protein" P49675 8 38143649-38151265 "Disease related genes, Predicted intracellular proteins" "Lipid transport, Steroidogenesis, Transport" "Congenital adrenal hyperplasia, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 311.3;ovary: 124.6" "Cell type enriched" "Detected in some" 5 "Leydig cells: 46.3" "Cancer enhanced" "Detected in some" "testis cancer: 3.0" "Region enriched" "Detected in some" 8 "basal ganglia: 10.6" "Cell type enriched" "Detected in single" 11 "basophil: 5.7" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.7" "Cell line enriched" "Detected in some" 5 "K-562: 101.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA023644, HPA027318, CAB032598" Enhanced NA NA "CAB032598: AB_2115937, HPA023644: AB_10598916, HPA027318: AB_10601574" "unprognostic (1.60e-4)" "unprognostic (3.20e-2)" "unprognostic (9.17e-2)" "unprognostic (3.28e-2)" "unprognostic (9.22e-2)" "unprognostic (1.32e-3)" "unprognostic (1.96e-2)" "unprognostic (2.12e-5)" "unprognostic (3.30e-2)" "unprognostic (2.36e-1)" "unprognostic (1.77e-3)" "unprognostic (6.65e-2)" "unprognostic (4.75e-9)" "unprognostic (1.58e-1)" "unprognostic (1.33e-1)" "unprognostic (9.48e-2)" "unprognostic (6.16e-2)" 0.2 311.3 0.5 0.3 10.6 0.3 0.0 0.0 1.0 0.0 0.0 11.6 0.0 0.0 0.1 0.8 0.2 0.4 0.0 0.1 0.3 0.5 0.0 0.0 0.0 0.3 0.2 0.9 124.6 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.2 0.4 0.0 0.0 29.5 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.3 0.1 5.7 0.1 0.0 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.9 0.1 1.3 0.3 1.0 0.0 3.5 0.0 0.0 0.0 0.2 0.0 0.0 101.9 0.0 0.0 0.0 0.0 12.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 12.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 5.7 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.5 0.1 0.5 10.6 0.0 1.0 0.3 0.5 0.2 0.9 1.2 0.1 0.0 0.0 0.0 0.6 8.4 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.6 46.3 0.0 3.3 0.0 0.0 0.5 0.1 0.0 3.9 0.0 0.7 0.0 0.2 1.4 0.7 9.8 0.1 0.0 0.0 0.1 STARD10 "CGI-52, NY-CO-28, PCTP2, SDCCAG28" ENSG00000214530 "StAR related lipid transfer domain containing 10" Q9Y365 11 72754729-72794168 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 130.6" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 585.1;Late spermatids: 1716.5;Mucus-secreting cells: 590.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 15.8" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 75.1;OE19: 160.9;SK-BR-3: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026661 Uncertain Supported Cytosol NA NA Cytosol "HPA026661: AB_1857538" "prognostic favorable (6.92e-4)" "unprognostic (2.07e-1)" "unprognostic (8.03e-2)" "unprognostic (1.74e-3)" "unprognostic (3.71e-2)" "unprognostic (1.37e-2)" "unprognostic (2.50e-2)" "unprognostic (2.16e-1)" "unprognostic (4.16e-1)" "unprognostic (4.69e-2)" "unprognostic (5.81e-2)" "unprognostic (1.67e-1)" "unprognostic (4.24e-3)" "unprognostic (8.42e-2)" "unprognostic (2.29e-1)" "unprognostic (2.12e-2)" "unprognostic (1.04e-1)" 4.5 34.0 11.3 6.8 16.0 2.0 16.0 17.6 15.9 18.6 42.8 5.5 16.6 11.5 6.5 26.2 10.9 6.2 28.7 15.5 10.3 6.8 11.1 130.6 10.0 3.1 10.6 5.4 8.2 47.3 16.4 9.5 22.6 10.1 17.6 46.0 9.1 21.7 12.1 15.0 12.7 15.0 6.7 4.4 4.6 47.4 40.0 14.8 3.3 21.3 12.0 9.3 7.8 10.2 2.9 2.0 15.8 1.8 5.6 1.3 0.6 6.1 1.9 0.9 3.6 1.2 1.2 12.4 0.6 3.2 2.2 2.2 25.9 4.5 0.5 2.1 2.3 5.3 3.9 2.9 5.8 2.5 3.4 1.1 0.7 1.3 26.4 4.5 0.1 1.1 0.8 16.1 2.4 3.4 6.0 2.2 1.2 1.4 2.7 0.4 75.1 0.5 1.3 0.4 160.9 2.5 0.5 1.6 0.4 2.9 7.5 1.6 1.2 1.0 53.7 7.6 4.3 29.6 0.7 1.6 2.2 1.4 0.7 1.2 2.7 2.2 0.9 0.5 0.7 0.7 7.9 1.8 11.4 1.2 0.9 1.0 2.9 1.1 1.3 0.8 2.3 1.1 1.3 15.8 5.6 0.4 2.0 1.2 0.6 11.3 16.0 17.6 15.9 10.3 6.8 10.6 5.4 10.1 14.8 32.8 67.8 18.8 64.0 27.9 9.3 39.6 239.5 24.1 33.0 52.4 21.6 163.2 104.5 65.2 406.8 12.9 92.8 0.0 83.1 75.5 15.7 146.3 25.3 585.1 23.0 31.8 290.1 26.4 19.3 1716.5 24.2 11.8 15.1 1.0 590.8 39.3 80.3 364.7 23.7 47.4 15.5 6.5 15.6 61.3 15.6 48.1 294.5 10.7 374.8 96.0 STARD13 "ARHGAP37, DLC2, GT650, LINC00464" ENSG00000133121 "StAR related lipid transfer domain containing 13" Q9Y3M8 13 33103135-33350630 "Plasma proteins, Predicted intracellular proteins" "GTPase activation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 26.8;Smooth muscle cells: 31.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 1.3;plasmacytoid DC: 3.4" "Group enriched" "Detected in many" 8 "dendritic cells: 3.4;monocytes: 1.3" "Cell line enhanced" "Detected in many" "LHCN-M2: 26.4;TIME: 18.7;WM-115: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039535, HPA058867" Supported NA NA "HPA039535: AB_10965929, HPA058867: AB_2683839" "unprognostic (7.42e-2)" "unprognostic (6.71e-2)" "unprognostic (1.99e-1)" "unprognostic (4.99e-2)" "unprognostic (1.17e-2)" "unprognostic (1.47e-1)" "unprognostic (1.43e-1)" "unprognostic (2.89e-1)" "unprognostic (1.48e-1)" "unprognostic (7.13e-3)" "unprognostic (3.42e-2)" "unprognostic (4.66e-2)" "prognostic unfavorable (1.23e-4)" "unprognostic (1.36e-1)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (5.29e-2)" 18.7 13.3 10.0 7.5 17.8 1.0 13.6 6.4 18.2 16.4 30.0 11.5 12.2 6.3 19.1 9.4 9.6 10.7 13.8 12.5 12.7 5.6 9.0 7.9 14.1 3.3 15.7 11.4 9.9 13.6 9.5 5.5 30.0 15.2 11.1 9.1 9.1 7.8 15.3 7.6 6.3 8.3 23.3 9.7 9.1 13.9 3.9 16.3 0.0 25.8 6.6 2.3 14.7 15.7 0.0 3.4 0.0 1.3 0.0 0.3 0.3 5.7 0.8 1.8 1.3 3.7 8.7 0.3 11.0 13.7 9.3 5.8 0.4 2.1 0.0 1.5 5.3 5.7 5.4 0.7 3.9 11.8 5.0 1.9 2.6 1.9 2.6 3.1 0.0 2.4 7.2 2.3 10.5 12.9 5.2 8.9 0.1 0.0 0.9 26.4 1.7 0.0 0.0 1.2 0.6 3.0 0.1 8.8 0.0 5.6 1.7 0.0 2.9 1.7 4.2 1.3 1.6 9.7 2.4 18.7 4.6 5.0 11.7 5.6 1.5 0.0 0.0 3.7 0.0 21.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.3 0.3 10.0 17.8 6.4 18.2 12.7 5.6 15.7 11.4 15.2 16.3 26.8 10.0 0.0 3.3 2.2 5.4 16.9 2.5 8.1 2.3 8.7 0.0 6.5 0.0 6.4 0.6 11.7 4.5 0.0 1.9 2.5 5.9 4.0 4.7 8.6 13.1 4.8 6.4 13.5 7.0 1.2 6.6 4.3 13.5 1.0 5.5 2.0 4.1 3.5 7.1 1.4 0.2 12.9 31.9 0.0 0.1 1.9 6.3 0.5 5.0 1.4 STARD4 ENSG00000164211 "StAR related lipid transfer domain containing 4" Q96DR4 5 111496033-111512590 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046177, HPA048081" Approved Approved "Plasma membrane" NA Yes "Plasma membrane" "HPA046177: AB_2679570, HPA048081: AB_2680253" "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (1.53e-2)" "unprognostic (1.64e-1)" "unprognostic (1.01e-1)" "unprognostic (1.21e-2)" "prognostic unfavorable (4.80e-5)" "unprognostic (1.31e-1)" "unprognostic (1.11e-1)" "unprognostic (4.26e-1)" "unprognostic (6.27e-2)" "unprognostic (1.39e-1)" "prognostic unfavorable (5.89e-5)" "unprognostic (2.00e-1)" "unprognostic (3.82e-3)" "unprognostic (4.01e-3)" "prognostic unfavorable (2.84e-4)" 5.2 12.4 9.7 11.2 27.3 12.6 3.2 20.7 17.5 8.5 11.0 6.8 5.5 30.0 6.4 12.9 8.4 4.6 7.6 11.0 12.5 12.5 8.2 25.3 22.0 8.8 10.5 7.3 6.6 4.7 17.2 10.8 27.8 25.5 16.5 13.1 7.1 5.9 8.0 1.6 2.6 29.9 5.4 17.0 8.8 13.2 5.1 16.3 5.1 7.7 5.7 7.4 5.2 8.8 2.8 2.8 11.0 3.1 2.9 4.2 2.1 6.8 3.4 16.7 10.0 15.0 30.1 5.7 7.0 16.0 10.6 31.6 12.6 20.5 8.2 2.9 4.5 31.0 3.0 8.4 24.4 10.1 7.8 3.6 6.3 10.9 7.6 16.7 3.1 4.0 16.0 16.8 22.4 16.7 12.4 19.4 8.0 3.5 15.9 7.1 1.3 7.7 5.7 5.7 0.2 1.8 1.8 18.6 7.5 15.4 2.2 9.5 37.1 0.0 4.2 6.3 11.6 5.5 10.1 28.7 8.9 8.1 5.9 2.9 5.5 5.0 7.3 8.5 11.8 4.5 11.0 2.1 1.5 4.2 3.1 2.2 2.8 2.0 3.0 2.8 2.7 2.1 3.1 0.0 2.9 2.2 1.9 1.2 2.1 9.7 27.3 20.7 17.5 12.5 12.5 10.5 7.3 25.5 16.3 23.8 33.3 11.0 1.2 0.9 9.5 17.7 12.7 1.4 4.5 8.7 7.9 13.3 1.7 6.8 6.1 14.6 33.7 0.0 8.1 5.1 5.1 3.1 31.2 16.4 16.3 6.4 20.5 4.9 18.3 7.0 6.6 18.3 3.3 6.4 21.7 6.0 7.4 17.5 7.4 5.3 7.3 19.4 8.7 7.7 9.7 2.3 11.8 8.6 15.5 2.8 STARD5 MGC10327 ENSG00000172345 "StAR related lipid transfer domain containing 5" Q9NSY2 15 81309053-81324183 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 59.6" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 22.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "cerebellum: 20.8" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 7.8;RPMI-8226: 7.8;U-266/70: 9.5;U-937: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040662 Approved Approved Vesicles,Cytosol NA NA Vesicles Cytosol "HPA040662: AB_10959593" "unprognostic (5.35e-4)" "unprognostic (1.55e-1)" "unprognostic (2.58e-2)" "unprognostic (2.76e-1)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (2.22e-4)" "unprognostic (1.17e-1)" "unprognostic (2.36e-1)" "unprognostic (1.10e-2)" "unprognostic (2.08e-2)" "unprognostic (8.08e-2)" "unprognostic (6.81e-2)" "unprognostic (2.08e-2)" "unprognostic (1.46e-2)" "unprognostic (4.84e-3)" "unprognostic (7.55e-3)" 2.8 1.0 1.2 8.6 1.5 5.9 2.7 20.8 3.4 14.3 7.7 1.5 6.6 3.5 7.3 22.3 9.2 4.3 4.4 1.9 1.0 1.1 1.4 59.6 4.3 11.1 1.1 1.0 3.2 1.1 0.6 1.0 9.3 1.2 6.1 5.9 1.5 3.2 6.6 0.9 12.4 7.7 3.6 1.9 10.8 3.3 4.4 1.4 1.7 2.5 10.6 9.8 6.1 7.9 2.1 4.8 6.9 4.6 4.8 7.6 5.6 0.4 0.1 0.1 1.2 3.0 3.1 0.2 0.4 0.4 1.0 1.6 0.1 0.1 6.2 0.0 1.8 0.3 5.2 1.5 1.2 0.8 0.1 0.5 2.3 0.3 0.5 0.6 3.5 7.8 2.5 2.6 0.4 0.8 2.0 0.1 2.5 0.7 1.7 0.7 0.2 0.6 5.0 0.4 0.3 0.0 0.1 0.9 7.8 0.4 1.8 0.4 0.1 0.2 0.7 0.7 0.5 0.8 0.8 0.2 1.7 0.9 1.7 0.1 9.5 1.9 2.4 1.2 8.8 0.5 6.9 3.0 4.2 5.8 4.6 5.0 2.1 5.4 6.1 4.8 1.6 7.6 7.5 2.4 4.8 4.0 2.5 6.3 5.6 1.2 1.5 20.8 3.4 1.0 1.1 1.1 1.0 1.2 1.4 0.0 0.6 6.7 12.4 11.7 1.8 0.2 0.0 4.0 2.3 0.0 5.9 2.0 3.3 1.2 11.0 1.0 19.1 0.0 1.2 3.1 7.5 2.2 10.3 22.1 4.8 1.6 10.9 3.7 5.3 0.5 4.6 6.1 1.7 0.0 18.1 1.7 1.6 11.4 9.2 0.5 0.7 0.0 2.1 0.5 0.4 14.3 4.1 4.5 14.0 6.8 STARD6 ENSG00000174448 "StAR related lipid transfer domain containing 6" P59095 18 54324358-54357964 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "testis: 25.3" "Group enriched" "Detected in some" 4 "Early spermatids: 147.4;Late spermatids: 184.8" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Group enriched" "Detected in many" 5 "NK-cells: 2.2;T-cells: 1.9" "Cell line enhanced" "Detected in some" "HDLM-2: 4.4;Karpas-707: 5.9;U-266/70: 7.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" NA NA "unprognostic (7.81e-2)" "unprognostic (1.50e-1)" "unprognostic (5.56e-3)" "unprognostic (1.70e-1)" "unprognostic (3.25e-1)" "unprognostic (8.14e-2)" "unprognostic (1.31e-1)" "unprognostic (8.98e-3)" "unprognostic (6.98e-5)" "unprognostic (1.90e-1)" "unprognostic (2.33e-3)" "unprognostic (2.68e-1)" "unprognostic (9.97e-2)" "unprognostic (1.91e-3)" "unprognostic (1.16e-3)" 0.1 0.3 0.3 0.0 0.8 0.1 0.1 0.3 0.6 0.1 0.1 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.1 0.0 0.4 1.2 0.1 0.0 0.0 0.1 0.1 1.2 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.7 0.1 0.0 25.3 0.0 0.7 0.3 0.0 0.1 0.1 0.0 0.3 0.2 0.2 0.3 2.2 1.9 0.2 0.1 0.0 1.7 0.2 0.4 0.0 0.1 0.4 0.4 0.8 0.2 0.4 0.8 0.6 0.3 0.0 1.0 0.2 0.0 1.6 0.4 4.4 0.8 0.2 0.0 0.3 0.6 1.6 0.8 1.1 0.2 0.5 0.3 0.4 0.7 1.7 0.3 5.9 0.8 0.3 0.4 0.3 0.0 0.0 0.4 0.4 0.1 0.0 1.7 0.7 1.6 1.5 0.9 0.0 0.4 0.6 0.1 0.5 1.7 0.6 1.3 0.6 0.5 7.3 3.4 0.8 2.1 0.6 1.8 0.2 0.2 0.1 1.1 0.1 0.9 0.3 0.3 1.9 0.2 0.3 0.2 1.1 0.2 2.2 0.3 0.2 1.0 0.2 0.3 0.8 0.3 0.6 0.4 0.3 0.4 1.2 1.2 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 147.4 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 184.8 2.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.1 0.0 0.5 0.0 0.1 40.0 1.3 0.0 0.2 0.0 0.0 0.0 STARD7 GTT1 ENSG00000084090 "StAR related lipid transfer domain containing 7" Q9NQZ5 2 96184859-96208825 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033965, HPA064958, HPA064978" Supported Approved Mitochondria "Intracellular and membrane" NA NA Mitochondria "CAB033965: AB_2302780, HPA064958: AB_2685391, HPA064978: AB_2685397" "unprognostic (3.75e-2)" "unprognostic (1.54e-2)" "unprognostic (1.67e-1)" "prognostic unfavorable (8.56e-5)" "prognostic favorable (3.89e-6)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.22e-4)" "unprognostic (2.72e-3)" "unprognostic (2.38e-1)" "unprognostic (2.93e-1)" "unprognostic (4.66e-2)" "unprognostic (1.78e-1)" "prognostic favorable (4.38e-6)" "unprognostic (1.02e-1)" "unprognostic (2.04e-1)" "unprognostic (2.64e-2)" "unprognostic (2.42e-2)" 17.3 26.6 30.3 20.6 27.1 11.5 32.1 26.5 28.7 14.4 22.6 24.4 15.2 21.6 13.9 12.8 17.0 18.0 13.5 66.7 26.1 24.5 32.5 29.1 24.0 30.1 34.1 17.1 12.4 24.6 28.2 11.7 11.4 23.6 16.1 22.8 17.3 24.2 19.7 74.4 14.4 22.2 15.0 24.1 21.7 17.4 8.1 29.9 26.3 22.7 24.1 32.9 16.4 15.2 26.4 25.0 14.5 18.6 18.1 24.1 13.7 32.3 20.1 26.3 27.2 35.5 17.8 39.8 31.9 27.3 31.4 33.9 47.2 29.9 57.7 35.3 24.7 24.9 26.3 46.6 26.9 41.1 39.1 35.8 50.9 19.8 54.4 16.3 39.0 28.6 17.2 19.9 26.0 25.8 20.0 31.3 23.9 52.6 22.9 27.8 28.1 44.1 39.6 44.8 27.4 30.1 43.7 40.5 57.3 18.9 41.0 50.7 24.2 16.1 51.8 28.5 34.2 15.4 42.9 26.1 26.1 27.1 29.1 31.8 30.6 28.4 51.8 24.1 44.0 28.8 14.5 14.9 13.9 16.4 18.6 16.9 26.4 14.1 17.1 22.7 21.5 16.2 15.0 1.7 18.1 11.8 25.0 24.1 13.7 30.3 27.1 26.5 28.7 26.1 24.5 34.1 17.1 23.6 29.9 125.0 43.6 35.0 37.3 56.6 26.0 163.8 63.7 30.8 52.4 43.6 102.1 30.8 63.0 27.4 2.1 47.5 46.7 0.0 32.7 31.1 29.1 59.0 15.1 103.7 60.0 38.1 42.7 37.4 105.5 5.2 21.6 53.5 40.5 98.2 56.1 31.6 31.3 10.5 23.7 53.6 55.8 25.8 48.4 12.4 39.7 50.2 29.6 41.5 67.9 31.4 STARD8 "ARHGAP38, KIAA0189" ENSG00000130052 "StAR related lipid transfer domain containing 8" Q92502 X 68647666-68725842 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 8.9;Cardiomyocytes: 8.7;Endothelial cells: 12.3;Ito cells: 21.5;Kupffer cells: 12.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "classical monocyte: 2.4;intermediate monocyte: 5.2;myeloid DC: 5.2;non-classical monocyte: 6.5" "Group enriched" "Detected in many" 16 "dendritic cells: 5.2;monocytes: 6.5" "Cell line enhanced" "Detected in many" "HEL: 12.9;K-562: 16.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA060788 Uncertain NA NA "HPA060788: AB_2684365" "unprognostic (2.00e-1)" "unprognostic (8.98e-2)" "unprognostic (1.56e-3)" "unprognostic (4.94e-3)" "unprognostic (1.73e-1)" "unprognostic (2.61e-2)" "unprognostic (2.77e-2)" "unprognostic (1.58e-1)" "unprognostic (1.71e-1)" "unprognostic (5.09e-3)" "unprognostic (9.72e-2)" "unprognostic (9.58e-2)" "unprognostic (5.19e-3)" "unprognostic (4.89e-3)" "unprognostic (9.46e-2)" "unprognostic (4.88e-2)" "unprognostic (1.07e-2)" 18.6 5.7 7.4 8.6 8.5 4.6 14.0 3.4 8.8 8.1 4.3 3.7 6.2 2.4 10.5 10.9 5.4 9.1 7.9 9.3 7.8 4.0 19.2 10.9 22.3 6.6 7.5 2.6 4.6 7.0 3.3 10.7 15.7 9.4 10.7 2.7 19.4 3.4 13.6 9.7 3.3 4.8 9.1 5.8 15.8 4.8 2.7 8.0 1.5 11.8 5.7 3.0 7.5 5.8 0.3 5.2 0.1 6.5 0.0 0.0 2.1 0.0 1.5 2.3 1.1 0.0 0.0 1.7 3.1 6.5 1.8 1.3 0.0 0.4 0.0 8.1 1.3 0.2 0.0 0.6 0.0 3.0 0.0 0.4 12.9 1.1 0.1 0.3 0.0 0.0 1.1 0.0 4.5 0.0 5.1 8.2 0.0 16.1 0.0 4.4 0.6 0.0 7.6 1.3 0.0 0.3 0.0 8.4 4.3 8.1 0.0 0.0 0.6 0.1 0.7 0.3 4.9 1.0 1.7 5.7 8.1 3.5 2.6 2.9 0.0 0.0 0.0 6.1 5.3 4.7 0.0 2.4 0.0 0.0 5.2 0.0 0.3 0.0 0.0 5.2 0.0 0.0 0.0 0.1 0.0 6.5 0.2 0.0 2.1 7.4 8.5 3.4 8.8 7.8 4.0 7.5 2.6 9.4 8.0 0.0 8.9 0.5 0.0 1.9 0.0 8.7 0.0 4.0 3.4 0.0 0.0 0.3 1.7 0.0 0.1 12.3 0.0 0.0 0.0 0.2 1.0 0.1 6.9 5.9 3.0 0.0 0.0 21.5 12.1 0.0 0.3 4.7 0.0 1.0 0.0 0.2 0.6 0.0 0.0 1.8 0.4 0.0 2.1 0.1 0.1 1.3 0.1 0.0 0.0 0.0 STARD9 "KIAA1300, KIF16A" ENSG00000159433 "StAR related lipid transfer domain containing 9" Q9P2P6 15 42575659-42720981 "Predicted intracellular proteins" "Motor protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 49.1;Early spermatids: 49.0;Rod photoreceptor cells: 60.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.2" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014562 Uncertain NA NA "HPA014562: AB_10603033" "unprognostic (2.69e-2)" "unprognostic (2.93e-1)" "unprognostic (1.14e-1)" "unprognostic (1.34e-1)" "unprognostic (6.74e-2)" "unprognostic (5.54e-5)" "unprognostic (7.45e-2)" "unprognostic (1.59e-1)" "unprognostic (1.01e-1)" "unprognostic (1.94e-2)" "unprognostic (1.91e-2)" "unprognostic (8.60e-3)" "unprognostic (1.45e-3)" "unprognostic (1.53e-2)" "unprognostic (3.92e-2)" "unprognostic (3.13e-1)" "unprognostic (1.83e-3)" 9.7 1.7 5.6 5.4 14.2 1.7 7.0 10.4 11.1 9.7 13.1 14.5 5.6 3.2 20.3 6.9 5.2 5.6 6.4 5.7 4.6 2.5 2.2 1.2 7.7 2.8 14.3 4.9 13.4 1.3 1.2 1.9 8.4 5.7 4.8 6.5 8.1 2.7 7.5 5.0 5.0 5.4 12.5 6.1 4.4 6.1 15.5 10.7 2.6 3.2 5.4 2.6 7.2 10.4 0.1 0.0 0.0 1.2 0.5 0.4 0.0 1.2 0.7 8.7 3.4 4.8 6.9 0.5 1.5 1.9 2.7 4.1 0.0 0.0 1.0 0.2 1.7 1.9 0.2 3.0 1.3 3.6 4.9 2.5 0.4 5.4 1.8 2.1 1.2 1.6 3.9 0.6 2.2 1.5 2.2 2.7 3.6 2.2 5.6 2.2 0.0 1.0 1.0 1.3 0.0 1.6 7.2 4.7 1.6 1.1 0.0 1.8 4.4 1.9 0.0 0.6 1.1 0.1 0.6 5.2 3.8 2.9 1.4 3.5 5.7 3.1 2.0 1.6 3.2 1.7 0.0 0.0 0.0 0.2 1.2 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.3 0.0 0.5 0.0 0.0 0.0 0.0 5.6 14.2 10.4 11.1 4.6 2.5 14.3 4.9 5.7 10.7 11.9 3.2 0.0 0.8 3.2 7.7 5.6 0.0 10.7 1.2 1.8 49.1 0.2 0.0 0.3 49.0 11.7 0.0 0.0 0.0 0.2 10.0 1.2 2.3 0.0 2.3 11.1 8.1 7.4 1.6 12.2 22.7 3.0 8.5 3.6 1.9 2.4 0.2 0.0 20.8 0.3 60.4 19.4 11.2 2.7 6.4 2.8 0.2 5.7 0.2 0.6 STS "ARSC, ARSC1" ENSG00000101846 "Steroid sulfatase" P08842 X 7219456-7354810 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid metabolism, Pregnancy, Steroid metabolism" Hydrolase "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "placenta: 258.8" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 34.3;Syncytiotrophoblasts: 78.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 20.3;RPMI-8226: 25.9;U-266/70: 43.0;U-698: 18.0" HPA002904 Enhanced NA NA "HPA002904: AB_1080116" "unprognostic (1.09e-1)" "unprognostic (3.90e-2)" "unprognostic (1.44e-2)" "unprognostic (2.75e-1)" "unprognostic (6.72e-2)" "unprognostic (1.94e-2)" "unprognostic (2.62e-1)" "unprognostic (1.84e-1)" "unprognostic (8.23e-2)" "unprognostic (4.67e-2)" "prognostic unfavorable (3.47e-4)" "unprognostic (4.05e-2)" "unprognostic (2.78e-2)" "unprognostic (2.77e-1)" "unprognostic (2.56e-1)" "unprognostic (1.92e-2)" "unprognostic (1.34e-1)" 10.3 2.2 3.0 2.2 3.9 0.0 4.1 2.3 9.0 3.4 3.5 2.3 2.2 0.8 2.4 2.2 2.2 2.6 4.1 3.6 3.9 4.0 2.5 4.7 5.0 2.2 3.8 2.4 2.4 2.2 1.6 2.2 258.8 2.4 2.9 3.0 2.3 2.2 3.3 4.0 2.3 2.4 3.8 2.4 2.2 6.7 2.2 2.3 2.2 2.4 2.2 2.2 4.9 2.7 0.9 1.9 1.9 4.7 1.0 0.7 1.0 4.1 1.3 2.8 0.9 20.3 10.5 15.0 8.4 3.0 2.3 2.1 7.4 3.9 7.7 1.6 6.1 1.8 1.0 1.6 1.4 2.3 0.6 3.2 0.4 4.7 2.1 1.1 1.1 4.4 3.4 0.2 1.4 0.8 1.5 3.4 0.6 0.4 8.1 6.0 0.9 0.6 1.0 1.0 0.0 1.9 1.1 1.6 25.9 5.7 6.0 2.0 1.7 1.7 3.0 0.9 4.8 1.3 0.4 6.0 9.1 0.5 11.6 1.3 43.0 0.0 18.0 2.1 0.9 2.4 0.0 3.2 0.6 0.5 4.7 0.2 0.6 0.2 0.3 1.9 0.9 0.1 0.5 1.9 1.0 2.5 0.3 0.7 1.0 3.0 3.9 2.3 9.0 3.9 4.0 3.8 2.4 2.4 2.3 11.9 2.1 1.5 1.7 0.8 3.1 5.0 2.5 0.0 1.2 1.8 0.0 34.3 0.0 6.9 0.1 4.3 4.1 0.0 17.1 18.7 4.1 7.6 6.9 7.4 6.6 1.6 3.5 2.5 5.9 0.0 2.6 2.7 1.7 2.8 2.3 3.1 8.7 7.4 6.3 1.4 0.8 0.0 4.7 0.0 1.4 0.9 78.6 0.0 2.2 7.4 SULT2A1 "DHEA-ST, STD" ENSG00000105398 "Sulfotransferase family 2A member 1" Q06520 19 47870466-47886397 "Enzymes, Predicted intracellular proteins" "Bile acid catabolism, Lipid degradation, Lipid metabolism, Steroid metabolism" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 211.7" "Cell type enriched" "Detected in some" 24 "Hepatocytes: 1127.7" "Cancer enriched" "Detected in some" 52 "liver cancer: 244.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "basophil: 5.3" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 34 "Hep G2: 26.6;RT4: 18.1" "Low region specificity" "Detected in all" "CAB018755, HPA041487, HPA063633" Enhanced Supported Cytosol NA NA 210000 Cytosol "CAB018755: AB_650242, HPA041487: AB_2677507, HPA063633: AB_2685066" "unprognostic (2.14e-1)" "unprognostic (6.79e-3)" "unprognostic (6.82e-2)" "unprognostic (1.36e-1)" "unprognostic (1.31e-2)" 0.1 46.9 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 11.4 1.1 1.1 8.2 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.0 0.1 211.7 0.1 0.1 0.1 0.1 0.1 0.1 1.1 0.1 0.1 0.2 0.6 0.0 0.1 0.1 3.9 0.1 0.0 42.7 0.1 0.1 0.1 2.8 0.7 0.1 0.1 0.2 0.1 0.1 0.6 0.2 1.3 1.0 5.3 0.8 2.3 1.3 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 26.6 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.3 0.2 0.0 18.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.1 0.0 5.3 0.8 0.7 0.9 0.4 0.6 0.7 1.0 0.6 0.3 1.3 1.3 1.0 3.1 2.3 0.4 1.0 0.6 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 7.0 0.5 0.1 0.6 0.6 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 46.7 0.0 0.0 0.1 0.3 0.0 1127.7 0.0 0.0 0.0 38.6 31.7 0.0 2.8 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.4 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.5 0.8 0.0 0.3 TPO TPX ENSG00000115705 "Thyroid peroxidase" P07202 2 1374223-1543711 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen peroxide, Thyroid hormones biosynthesis" "Oxidoreductase, Peroxidase" "Congenital hypothyroidism, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 58 "thyroid gland: 411.3" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 2.2;Early spermatids: 3.0;Endothelial cells: 1.1;Late spermatids: 3.8;Peritubular cells: 3.5" "Cancer enriched" "Detected in some" 364 "thyroid cancer: 188.3" "Not detected" "Not detected" "Group enriched" "Detected in some" 13 "memory CD4 T-cell: 5.1;T-reg: 3.0" "Lineage enriched" "Detected in single" 21 "T-cells: 5.1" "Group enriched" "Detected in some" 5 "Karpas-707: 14.3;RPMI-8226: 6.0" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA007987, CAB009587" Enhanced "Intracellular and membrane" NA NA "CAB009587: , HPA007987: AB_1080270" "unprognostic (1.55e-1)" "unprognostic (1.04e-1)" "unprognostic (2.88e-1)" "unprognostic (1.77e-2)" "unprognostic (3.56e-2)" "unprognostic (9.11e-2)" "unprognostic (2.24e-2)" "unprognostic (1.85e-1)" "unprognostic (1.32e-1)" "unprognostic (1.19e-4)" "unprognostic (2.61e-2)" "unprognostic (3.29e-1)" "unprognostic (5.44e-4)" "unprognostic (1.21e-1)" "unprognostic (3.73e-2)" "unprognostic (4.98e-3)" "unprognostic (7.10e-3)" 1.1 0.0 0.1 0.1 0.1 0.0 0.9 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.4 1.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.2 0.1 0.5 0.0 0.2 0.1 0.1 7.1 0.2 0.1 0.1 0.1 411.3 0.1 0.1 0.1 0.1 0.1 0.0 0.2 0.0 0.0 5.1 0.9 0.1 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 14.3 0.0 1.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 6.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.1 1.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 5.1 0.3 0.0 0.1 0.0 0.3 0.2 0.0 0.0 0.0 3.0 0.9 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 UGT1A1 "GNT1, UGT1, UGT1A" ENSG00000241635 "UDP glucuronosyltransferase family 1 member A1" P22309 2 233760248-233773299 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 16 "intestine: 48.6;liver: 120.3" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 83.9" "Cancer enriched" "Detected in some" 19 "liver cancer: 16.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 4.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 8.1;OE19: 35.4;RT4: 19.3" "Not detected" "Not detected" NA NA "unprognostic (7.28e-2)" "unprognostic (2.49e-2)" "unprognostic (3.60e-1)" "unprognostic (5.69e-2)" "unprognostic (4.17e-3)" "unprognostic (6.31e-3)" "unprognostic (1.94e-5)" "unprognostic (2.78e-3)" "unprognostic (2.99e-4)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.2 35.6 0.1 0.1 48.6 0.1 0.1 4.3 0.0 0.3 0.1 0.1 0.0 4.5 120.3 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.3 0.4 0.1 0.7 0.1 0.1 0.9 48.2 0.5 0.1 0.1 1.3 0.2 0.1 0.1 0.2 0.1 0.1 5.2 0.8 1.0 0.4 4.7 0.4 1.1 0.5 0.2 0.2 0.6 0.1 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.0 3.1 0.2 0.1 1.4 0.0 0.0 8.1 0.0 0.1 0.0 0.1 0.1 0.0 0.3 0.8 0.0 0.3 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 0.4 0.0 0.2 0.3 35.4 3.6 0.0 0.1 0.3 0.0 19.3 0.1 0.2 1.4 0.2 0.0 0.1 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.1 0.1 0.4 0.2 0.1 2.1 0.4 0.4 0.4 0.3 0.3 0.4 0.4 0.3 0.1 1.0 0.4 0.5 4.7 1.1 0.4 0.4 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 2.7 6.8 1.8 0.0 0.0 0.0 0.2 2.8 0.0 3.5 0.0 0.0 0.0 0.0 0.9 0.0 83.9 0.0 0.0 0.0 1.3 3.3 0.8 0.0 0.0 0.0 0.0 0.6 0.0 0.5 1.4 0.0 1.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 6.2 UGT1A10 UGT1J ENSG00000242515 "UDP glucuronosyltransferase family 1 member A10" Q9HAW8 2 233636454-233773305 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 9.4;gallbladder: 8.4;intestine: 31.1;stomach 1: 12.4" "Cell type enhanced" "Detected in some" 22 "Club cells: 1.2;Enterocytes: 2.1" "Cancer enhanced" "Detected in many" "urothelial cancer: 9.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 142 "RT4: 109.0" "Intracellular and membrane" NA NA "unprognostic (9.33e-2)" "unprognostic (7.64e-2)" "unprognostic (2.45e-3)" "unprognostic (1.73e-1)" "prognostic unfavorable (4.55e-4)" "unprognostic (1.49e-10)" "unprognostic (2.90e-1)" "unprognostic (1.50e-1)" "unprognostic (3.59e-3)" 0.3 0.0 0.3 2.6 0.3 0.0 0.3 0.3 0.3 0.3 19.2 0.3 0.3 31.1 0.3 0.3 9.4 0.1 8.4 0.3 0.3 0.0 0.3 1.4 0.6 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 14.3 0.3 0.9 0.3 0.3 0.3 20.2 0.5 0.3 0.3 12.4 1.0 0.3 0.3 0.3 0.3 1.4 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 109.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.3 0.3 0.3 0.0 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 UGT1A3 UGT1C ENSG00000243135 "UDP glucuronosyltransferase family 1 member A3" P35503 2 233729108-233773299 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 15 "liver: 40.6" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 6 "liver cancer: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "HaCaT: 16.7" NA NA "unprognostic (5.15e-2)" "unprognostic (9.93e-2)" "unprognostic (2.97e-1)" "unprognostic (4.59e-2)" "unprognostic (1.04e-4)" "unprognostic (8.22e-2)" "unprognostic (2.08e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT1A4 "HUG-BR2, UGT1D" ENSG00000244474 "UDP glucuronosyltransferase family 1 member A4" P22310 2 233718778-233773299 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 51 "liver: 99.4" "Group enriched" "Detected in some" 8 "Club cells: 4.5;Hepatocytes: 10.5" "Cancer enriched" "Detected in single" 487 "liver cancer: 24.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 1.6;HL-60: 1.4;RH-30: 2.2" NA NA "unprognostic (9.89e-3)" "unprognostic (6.77e-5)" "unprognostic (2.59e-1)" "unprognostic (3.50e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 99.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 0.0 2.2 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT1A5 UGT1E ENSG00000240224 "UDP glucuronosyltransferase family 1 member A5" P35504 2 233712992-233773299 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "gallbladder: 3.7;intestine: 13.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RPMI-8226: 1.7;RT4: 1.6" NA NA "unprognostic (2.18e-3)" "unprognostic (1.36e-1)" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 11.2 0.0 0.0 0.2 0.0 3.7 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 9.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.6 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT1A6 "GNT1, HLUGP, UGT1F" ENSG00000167165 "UDP glucuronosyltransferase family 1 member A6" P19224 2 233691607-233773300 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "kidney: 111.7;liver: 50.1;urinary bladder: 32.7" "Group enriched" "Detected in some" 5 "Early spermatids: 37.7;Late spermatids: 19.3" "Cancer enhanced" "Detected in many" "renal cancer: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 40.4;OE19: 160.5" "CAB009819, HPA054065" Enhanced NA NA "CAB009819: AB_2241481, HPA054065: AB_2682367" "unprognostic (9.09e-2)" "unprognostic (6.07e-2)" "unprognostic (5.43e-2)" "unprognostic (6.03e-2)" "prognostic unfavorable (2.89e-6)" "unprognostic (2.79e-1)" "unprognostic (6.18e-2)" "unprognostic (2.09e-3)" "unprognostic (9.97e-2)" "unprognostic (2.16e-2)" "unprognostic (3.52e-1)" "unprognostic (7.50e-2)" "unprognostic (2.01e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.8 0.5 0.2 0.5 2.0 0.3 0.9 13.0 0.0 1.1 0.1 0.1 0.0 111.7 50.1 1.9 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.3 0.1 3.3 0.4 0.1 1.3 1.2 0.1 3.8 1.2 2.3 0.1 0.1 8.1 0.2 0.1 0.5 0.2 5.6 8.7 32.7 2.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.2 0.0 11.3 0.0 0.1 40.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 160.5 0.0 0.0 0.0 0.0 0.4 20.4 0.0 0.0 0.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 1.5 0.8 0.0 0.3 0.0 0.0 4.5 1.8 0.0 0.0 0.0 0.0 37.7 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.0 0.0 0.6 0.0 19.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.7 0.0 1.0 0.0 0.0 0.0 2.1 UGT1A7 UGT1G ENSG00000244122 "UDP glucuronosyltransferase family 1 member A7" Q9HAW7 2 233681938-233773299 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 12 "esophagus: 54.4;lymphoid tissue: 40.2;tongue: 23.6" "Cell type enriched" "Detected in some" 5 "Urothelial cells: 8.4" "Group enriched" "Detected in some" 10 "cervical cancer: 1.2;head and neck cancer: 2.3;lung cancer: 3.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 14 "SiHa: 50.6" NA NA "unprognostic (6.27e-2)" "unprognostic (1.02e-1)" "unprognostic (7.76e-2)" "unprognostic (1.03e-2)" "unprognostic (1.09e-1)" "unprognostic (7.92e-2)" "unprognostic (1.71e-7)" "unprognostic (2.14e-1)" "unprognostic (4.57e-2)" 0.1 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.7 0.1 0.0 0.0 0.1 0.0 0.0 54.4 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 2.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.6 40.2 0.2 2.8 0.2 0.1 1.6 0.2 0.6 0.1 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 50.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.2 0.1 0.0 0.2 0.6 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.2 8.4 UGT1A8 UGT1H ENSG00000242366 "UDP glucuronosyltransferase family 1 member A8" Q9HAW9 2 233617645-233773310 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 13.0;urinary bladder: 15.7" "Not detected" "Not detected" "Cancer enhanced" "Detected in some" "urothelial cancer: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 58 "RT4: 52.5" NA NA "unprognostic (1.27e-2)" "unprognostic (1.35e-1)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (4.78e-1)" "unprognostic (9.71e-12)" "unprognostic (9.26e-2)" "unprognostic (1.96e-1)" 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 7.3 0.0 0.0 0.0 0.0 0.0 3.3 5.5 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 3.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 52.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 UGT1A9 "HLUGP4, LUGP4, UGT1AI" ENSG00000241119 "UDP glucuronosyltransferase family 1 member A9" O60656 2 233671853-233773300 "Cancer-related genes, Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "kidney: 169.8" "Cell type enhanced" "Detected in some" 29 "Club cells: 1.2;Hepatocytes: 5.9;Proximal tubular cells: 3.3" "Group enriched" "Detected in some" 157 "liver cancer: 16.1;renal cancer: 16.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "A549: 4.9;RT4: 4.0" NA NA "unprognostic (2.46e-2)" "unprognostic (3.56e-1)" "prognostic unfavorable (5.04e-5)" "unprognostic (4.26e-2)" "unprognostic (1.60e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 169.8 39.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2A1 ENSG00000173610 "UDP glucuronosyltransferase family 2 member A1 complex locus" Q9Y4X1 4 69588417-69653249 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Olfaction, Sensory transduction" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "kidney: 10.6;liver: 14.5;pituitary gland: 21.2" "Cell type enriched" "Detected in some" 6 "Proximal tubular cells: 32.3" "Cancer enhanced" "Detected in some" "liver cancer: 0.7" "Region enriched" "Detected in single" 17 "pons and medulla: 1.7" "Cell type enhanced" "Detected in some" "neutrophil: 2.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 3.2;HUVEC TERT2: 1.9;U-266/70: 3.6" "HPA017261, HPA045108" Uncertain NA NA "HPA017261: AB_10963582, HPA045108: AB_2679218" "unprognostic (3.93e-3)" "unprognostic (5.62e-1)" "unprognostic (1.28e-4)" "unprognostic (1.74e-1)" "unprognostic (2.76e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 14.5 2.4 0.0 0.0 0.0 0.0 0.0 0.0 21.2 0.0 1.7 0.0 0.0 1.5 0.0 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.5 2.0 0.5 0.9 0.4 0.0 0.0 0.0 0.1 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.1 0.0 3.6 0.0 0.0 0.0 0.0 0.2 1.7 0.5 0.4 0.2 0.2 0.1 0.1 0.4 0.2 0.1 0.3 0.2 0.1 2.0 0.9 0.2 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 3.5 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2A3 FLJ21934 ENSG00000135220 "UDP glucuronosyltransferase family 2 member A3" Q6UWM9 4 68928463-68951791 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "intestine: 150.5;kidney: 43.2" "Cell type enhanced" "Detected in some" 11 "Cholangiocytes: 94.3;Enterocytes: 115.5;Hepatocytes: 49.3;Paneth cells: 52.6;Proximal tubular cells: 125.8;Undifferentiated cells: 72.7" "Cancer enriched" "Detected in many" 5 "renal cancer: 46.9" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 10 "eosinophil: 5.3" "Lineage enriched" "Detected in single" 53 "granulocytes: 5.3" "Cell line enriched" "Detected in some" 9 "Hep G2: 21.0" HPA045108 Supported NA NA "HPA045108: AB_2679218" "prognostic favorable (3.31e-4)" "unprognostic (3.97e-3)" "unprognostic (8.87e-3)" "prognostic favorable (6.07e-7)" "unprognostic (2.10e-2)" 0.1 0.1 0.1 4.3 0.1 0.0 0.7 0.1 0.1 0.1 63.8 0.1 0.1 31.9 0.1 1.7 0.1 0.1 14.6 0.3 0.1 0.1 43.2 9.6 0.1 0.1 0.1 0.1 0.1 12.0 0.0 0.1 0.1 0.1 0.1 8.6 0.1 0.1 0.1 0.1 0.1 150.5 0.1 0.1 0.1 0.3 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.1 94.3 0.0 0.0 3.5 0.0 0.0 10.0 21.3 0.0 0.0 115.5 0.0 2.3 0.0 0.0 0.0 0.0 49.3 0.0 0.0 11.7 0.0 1.8 0.0 0.0 0.0 0.0 0.0 28.2 0.0 6.0 52.6 0.0 125.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 72.7 0.0 UGT2B10 ENSG00000109181 "UDP glucuronosyltransferase family 2 member B10" P36537 4 68815993-68831196 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 277 "liver: 120.4" "Cell type enriched" "Detected in some" 15 "Hepatocytes: 221.7" "Cancer enriched" "Detected in single" 296 "liver cancer: 93.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 39 "Hep G2: 16.1" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" "unprognostic (3.50e-3)" "unprognostic (1.92e-3)" "unprognostic (4.17e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 120.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 221.7 0.0 0.0 0.0 1.3 4.7 1.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 UGT2B11 ENSG00000213759 "UDP glucuronosyltransferase family 2 member B11" O75310 4 69199951-69214731 "Enzymes, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "breast: 77.4" "Cell type enriched" "Detected in some" 7 "Cholangiocytes: 12.7" "Group enriched" "Detected in some" 17 "breast cancer: 17.4;liver cancer: 13.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 62 "basophil: 6.8;eosinophil: 5.6" "Lineage enriched" "Detected in single" 68 "granulocytes: 6.8" "Cell line enhanced" "Detected in some" "Hep G2: 1.5;HL-60: 3.1;NB-4: 2.5;RPTEC TERT1: 3.7;U-2197: 1.5" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" "unprognostic (1.12e-1)" "unprognostic (1.18e-3)" "unprognostic (1.49e-1)" "unprognostic (6.53e-2)" "unprognostic (2.26e-2)" "unprognostic (1.65e-1)" "unprognostic (7.84e-3)" "unprognostic (5.47e-1)" "unprognostic (1.32e-1)" "unprognostic (1.51e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 77.4 0.1 0.1 0.1 0.6 0.1 0.1 0.0 0.1 0.1 0.1 0.0 3.3 0.1 0.1 0.0 1.2 7.3 0.1 0.1 0.1 0.1 0.1 0.5 0.0 0.1 0.1 0.1 0.1 0.0 0.1 7.0 0.1 0.1 1.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.9 0.1 0.1 0.1 0.1 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 3.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.0 0.1 0.0 3.7 0.2 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.1 0.6 0.0 0.0 6.8 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2B15 UGT2B8 ENSG00000196620 "UDP glucuronosyltransferase family 2 member B15" P54855 4 68646630-68670628 "Enzymes, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "gallbladder: 22.4;intestine: 50.7;liver: 65.4" "Group enriched" "Detected in some" 6 "Cholangiocytes: 168.2;Hepatocytes: 134.4" "Cancer enriched" "Detected in many" 10 "liver cancer: 120.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 2.7" "Lineage enhanced" "Detected in single" "B-cells: 2.7" "Cell line enhanced" "Detected in some" "A549: 3.2;HL-60: 2.2;RH-30: 1.2;RPMI-8226: 1.1" HPA045108 Approved NA NA "HPA045108: AB_2679218" "unprognostic (1.40e-1)" "unprognostic (2.25e-1)" "unprognostic (2.22e-2)" "unprognostic (3.86e-1)" "unprognostic (1.94e-1)" "prognostic favorable (9.82e-4)" "unprognostic (6.73e-2)" "unprognostic (3.49e-2)" "unprognostic (7.84e-2)" "unprognostic (5.81e-3)" "unprognostic (2.39e-2)" "unprognostic (5.38e-2)" "prognostic favorable (4.50e-4)" 0.1 0.0 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 48.0 0.1 0.1 5.4 0.1 0.1 0.2 0.0 22.4 0.1 0.1 0.0 0.1 65.4 0.1 0.1 0.1 0.1 0.1 5.3 0.0 0.1 0.1 0.1 0.2 1.6 0.1 0.1 0.1 0.1 0.0 50.7 0.1 0.1 0.1 5.7 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 2.7 0.0 0.9 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.4 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 1.2 1.1 0.0 0.2 0.1 0.6 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.8 0.2 0.4 0.1 0.5 0.0 0.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 168.2 0.0 0.0 0.0 0.0 0.0 0.0 14.9 1.9 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 134.4 0.0 0.0 0.0 1.8 2.5 0.0 0.0 0.0 0.0 1.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 0.5 UGT2B17 ENSG00000197888 "UDP glucuronosyltransferase family 2 member B17" O75795 4 68537184-68568527 "Enzymes, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 68.1;liver: 21.6" "Cell type enhanced" "Detected in some" 11 "Alveolar cells type 2: 2.2;Cholangiocytes: 2.5;Ciliated cells: 1.4;Club cells: 1.2;Hepatocytes: 1.3;Intestinal endocrine cells: 1.7;Melanocytes: 3.3" "Group enriched" "Detected in many" 7 "colorectal cancer: 16.3;liver cancer: 10.1" "Not detected" "Not detected" "Group enriched" "Detected in some" 38 "memory B-cell: 3.3;naive B-cell: 11.9" "Lineage enriched" "Detected in single" 59 "B-cells: 11.9" "Group enriched" "Detected in some" 7 "BEWO: 3.1;NB-4: 3.6;RPMI-8226: 5.2;SH-SY5Y: 2.3;U-2197: 2.1" HPA045108 Supported NA NA "HPA045108: AB_2679218" "unprognostic (1.66e-1)" "unprognostic (2.97e-2)" "unprognostic (2.96e-2)" "unprognostic (2.41e-1)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (2.36e-1)" "unprognostic (8.44e-3)" "unprognostic (9.67e-2)" "unprognostic (4.80e-3)" "unprognostic (8.52e-2)" "unprognostic (2.45e-1)" "unprognostic (6.44e-2)" "unprognostic (1.75e-1)" "unprognostic (1.76e-1)" 0.4 0.1 0.4 4.7 0.4 0.0 0.4 0.4 0.4 0.4 55.6 0.4 0.4 54.1 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.1 0.4 21.6 0.4 0.4 0.4 0.4 0.4 0.4 0.0 0.4 0.4 0.4 0.4 20.7 0.4 0.4 0.4 0.4 0.1 68.1 1.1 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.4 11.9 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.6 0.0 0.2 0.0 0.0 0.0 5.2 0.2 0.0 0.3 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.4 0.1 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.3 0.0 0.0 0.0 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.4 0.4 0.4 0.4 0.1 0.4 0.4 0.4 0.4 0.0 2.2 0.0 0.0 0.0 0.0 0.0 2.5 1.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 UGT2B28 ENSG00000135226 "UDP glucuronosyltransferase family 2 member B28" Q9BY64 4 69280499-69295050 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 11 "breast: 71.7;salivary gland: 25.6" "Cell type enriched" "Detected in single" 178 "Cholangiocytes: 17.8" "Cancer enriched" "Detected in single" 8 "breast cancer: 1.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "basophil: 2.5;eosinophil: 4.0" "Lineage enriched" "Detected in single" 14 "granulocytes: 4.0" "Group enriched" "Detected in some" 10 "Daudi: 7.1;NB-4: 6.5" HPA045108 Uncertain "Intracellular and membrane" NA NA "HPA045108: AB_2679218" "unprognostic (1.81e-1)" "unprognostic (1.40e-1)" "unprognostic (7.20e-3)" "unprognostic (1.51e-2)" "unprognostic (4.37e-5)" "unprognostic (9.79e-4)" 0.0 0.0 0.0 0.0 0.0 0.0 71.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 25.6 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.1 0.0 0.2 4.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2B4 UGT2B11 ENSG00000156096 "UDP glucuronosyltransferase family 2 member B4" P06133 4 69480165-69526014 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 105 "liver: 175.1" "Cell type enriched" "Detected in some" 12 "Hepatocytes: 831.9" "Cancer enriched" "Detected in some" 96 "liver cancer: 351.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "RH-30: 10.4" "CAB033260, HPA045108" Enhanced "Intracellular and membrane" NA NA "CAB033260: AB_2241496, HPA045108: AB_2679218" "unprognostic (7.46e-2)" "unprognostic (1.50e-1)" "unprognostic (9.37e-2)" "unprognostic (1.51e-1)" "unprognostic (2.47e-2)" "unprognostic (1.47e-1)" "unprognostic (9.43e-3)" "unprognostic (3.52e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.1 175.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 10.4 0.1 0.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 34.2 15.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70.0 0.0 0.0 0.0 0.0 0.0 831.9 0.1 0.0 0.0 14.7 12.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 UGT2B7 UGT2B9 ENSG00000171234 "UDP glucuronosyltransferase family 2 member B7" P16662 4 69051363-69112987 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Lipid metabolism, Steroid metabolism" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "kidney: 125.4;liver: 156.0" "Group enriched" "Detected in many" 6 "Hepatocytes: 539.4;Proximal tubular cells: 775.7" "Group enriched" "Detected in many" 7 "liver cancer: 116.4;renal cancer: 101.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "EFO-21: 21.0;RPTEC TERT1: 83.6" HPA045108 Uncertain NA NA "HPA045108: AB_2679218" "unprognostic (1.04e-1)" "unprognostic (1.65e-1)" "prognostic favorable (7.65e-5)" "unprognostic (1.11e-2)" "unprognostic (2.10e-1)" "unprognostic (2.30e-2)" "unprognostic (5.41e-3)" "unprognostic (1.68e-1)" "unprognostic (1.74e-2)" "unprognostic (1.17e-3)" "unprognostic (1.98e-1)" "prognostic favorable (3.79e-4)" "unprognostic (1.08e-2)" "unprognostic (2.55e-1)" "unprognostic (6.23e-3)" "prognostic favorable (5.38e-4)" 0.1 0.1 0.1 0.2 0.1 0.0 0.4 0.1 0.1 3.1 7.9 0.1 2.5 6.4 0.6 4.7 0.1 4.7 1.5 0.1 0.1 0.1 125.4 156.0 0.2 0.1 0.1 0.1 0.6 14.7 0.0 0.1 0.2 0.1 0.3 0.4 0.2 1.0 2.7 0.3 0.2 27.7 0.1 0.1 0.2 0.1 0.6 0.1 0.2 0.1 0.1 0.3 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 21.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 83.6 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.5 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 3.9 0.6 0.1 0.0 0.0 58.6 0.0 0.0 118.7 0.0 0.0 82.9 5.6 0.2 0.0 6.7 0.0 9.1 0.0 0.0 0.4 0.0 539.4 0.1 0.0 3.4 6.2 10.7 0.0 1.7 0.0 3.3 0.0 20.1 0.0 11.8 11.9 0.0 775.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 2.0 UGT3A1 FLJ34658 ENSG00000145626 "UDP glycosyltransferase family 3 member A1" Q6NUS8 5 35951010-36001028 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "kidney: 44.0;liver: 47.7" "Group enriched" "Detected in some" 5 "Collecting duct cells: 47.1;Early spermatids: 91.4;Hepatocytes: 63.1;Proximal tubular cells: 58.6" "Group enriched" "Detected in some" 15 "liver cancer: 6.7;renal cancer: 4.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 42 "RH-30: 25.3" "HPA047697, HPA056290" Uncertain Approved Vesicles,Cytosol NA NA "Vesicles, Cytosol" "HPA047697: AB_2680122, HPA056290: AB_2683088" "unprognostic (2.41e-3)" "unprognostic (4.47e-1)" "unprognostic (4.04e-1)" "unprognostic (4.62e-1)" "unprognostic (1.42e-2)" "unprognostic (6.05e-2)" "unprognostic (9.14e-2)" "unprognostic (1.76e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.5 0.0 0.0 5.1 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 44.0 47.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.1 0.0 3.2 0.1 6.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.1 0.0 0.4 0.2 0.2 0.0 0.4 0.2 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 47.1 0.0 0.0 3.3 0.0 91.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.1 0.1 0.0 0.0 2.5 2.2 12.5 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 58.6 0.3 6.5 0.0 1.0 0.8 0.0 0.0 0.0 0.0 0.0 UGT3A2 ENSG00000168671 "UDP glycosyltransferase family 3 member A2" Q3SY77 5 36035017-36071358 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "lymphoid tissue: 37.0;skin 1: 14.4;testis: 13.2" "Group enriched" "Detected in some" 5 "Collecting duct cells: 3.5;Early spermatids: 3.6;Late spermatids: 5.7;Proximal tubular cells: 3.3" "Cancer enriched" "Detected in some" 5 "testis cancer: 4.4" "Region enhanced" "Detected in single" "pons and medulla: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 5.2;MOLT-4: 9.3;REH: 21.8;SuSa: 9.8;T-47d: 5.7;THP-1: 12.8" HPA059475 Uncertain Approved "Nucleoplasm,Golgi apparatus,Cytosol" Yes NA Nucleoplasm "Golgi apparatus, Cytosol" "HPA059475: AB_2684031" "unprognostic (1.83e-4)" "unprognostic (9.94e-2)" "unprognostic (8.87e-2)" "unprognostic (4.82e-4)" "unprognostic (3.18e-1)" "unprognostic (3.52e-2)" "unprognostic (1.56e-1)" "unprognostic (6.08e-2)" "unprognostic (2.04e-1)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (4.17e-2)" "unprognostic (1.36e-3)" "unprognostic (6.65e-2)" "unprognostic (7.52e-2)" "unprognostic (7.38e-2)" "unprognostic (4.52e-3)" 0.1 1.1 0.1 0.0 0.2 6.4 1.6 0.1 0.6 0.1 0.1 0.5 0.4 0.0 0.1 0.8 0.1 0.1 0.2 0.2 0.1 0.6 5.6 0.8 0.1 0.0 0.5 0.0 0.2 0.0 0.0 1.7 0.2 2.0 0.6 0.0 2.9 0.1 0.0 0.1 14.4 0.1 0.0 0.3 1.4 0.1 13.2 0.0 37.0 0.1 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 1.0 0.0 0.4 5.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 9.3 0.0 3.9 0.0 0.0 21.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 5.7 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.2 0.1 0.6 0.1 0.6 0.5 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.5 0.0 0.1 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0